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Organometallic compounds derived from tin, boron, and zinc, have been used extensively in 
transition metal-catalysed cross-coupling, and continue to hold status as the go-to reagents to 
form new carbon-carbon bonds. Recently, organosilicon compounds have emerged as an 
attractive alternative to these established reagents, benefitting from low toxicity, low cost, and 
general ease of handling. While the fundamental reactivity of arylsilane reagents (Ar–SiR3) is 
well known, their role in transition metal-catalysed reactions is generally less well studied.  
This thesis comprises an investigation into the effect of ortho-substitution of these arylsilane 
reagents, and specifically, their application in gold-catalysed direct arylation. In Chapter 2, the 
transmetalation of these reagents to gold(III) is assessed using a combination of in situ reaction 
monitoring coupled with kinetic simulations. This allowed a scale of reactivity to be 
constructed for a range of structurally diverse arylsilanes, and uncovered that more sterically 
hindered arylsilanes actually exhibit accelerated rates of transmetalation. 
In Chapter 3, the reactivity of ortho-substituted arylsilanes in gold-catalysed arylation is 
addressed. The majority of arylsilanes tested in the previous chapter were found to be unable 
to undergo coupling, despite the viability of transmetalation having been demonstrated. Slight 
modification of the ortho-substituent, to incorporate a tethered ligand, was found to have a 
dramatic effect on reactivity, and allowed the coupling of a variety of substrates. The nature 
of the ligand, as well as the substitution of the tether was found to have a significant impact 
on the rate of coupling. 
Chapter 4 describes the way in which the reactivity of ortho-substituted arylsilanes might be 
exploited in a “Catch and Release” protocol for catalyst recovery. This aims to combine the 
established benefits of homogeneous and heterogeneous catalysis to offer an alternative to 
current methods of catalyst recycling in industrial chemistry. A number of different “Catch 
and Release” mechanisms were considered, and the validity of the concept was demonstrated 




The ability to construct complex molecules lies at the heart of synthetic chemistry, allowing 
scientists to create chemical compounds that can be used for a multitude of applications 
throughout modern-day life. The advent of metal-catalysed cross-coupling in the late 
20th century has revolutionised the way in which synthetic chemists conceptualise and 
construct molecules, providing a method to synthesise hugely important, but often challenging, 
carbon-carbon bonds. The field of cross-coupling remains vibrantly active to this day, with 
initiatives to reduce manufacturing costs and the environmental impact of chemical synthesis 
driving the continued development of new and improved synthetic methods. 
Previous research in the Lloyd-Jones group described a novel gold-catalysed cross-coupling 
reaction that relies on the use of silicon-containing reagents (arylsilanes). These are an 
attractive class of chemical feedstock due to their ease of preparation, low toxicity, and 
amenability to long-term storage. While the practical advantage of these reagents is well 
documented, their application in catalysis is somewhat limited, and the exact way in which 
they react (the reaction mechanism) is often poorly understood. 
The work in this thesis aims to describe how these compounds behave under the conditions of 
gold catalysis, and to highlight the profound effect that minor structural modifications to the 
arylsilane reagent can have. This is expected to be of broad benefit to those attempting to apply 
the chemistry to the synthesis of complex molecules, while providing fundamental mechanistic 
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1.1. Oxidative Gold Catalysis in Organic Synthesis 
1.1.1. Reactivity of Gold Complexes 
It has long been known that gold(III) complexes are capable of formally activating aryl C-H 
bonds. The earliest reports by Kharasch and co-workers date back to the 1930s, and describe 
the auration of simple aromatic compounds with anhydrous AuCl3 to generate the 
corresponding arylgold(III) complexes (Scheme 1.1).1  Over the following 80 years, a number 
of reports expanded upon these findings to offer access to a variety of functionalised gold(III) 
arene complexes, using stoichiometric quantities of gold(III) precursors with stabilising 
ligands.2–5 Electrophilic auration of arenes is regioselective, with the site of substitution 
governed by the established rules of electrophilic aromatic substitution (SEAr).6  
 
 
Scheme 1.1. Formal C-H activation of toluene by gold(III) chloride reported by Kharasch in 
1931.1 
Other methods of arylgold(III) formation have utilised organometallic reagents such as 
organomercurials (R2Hg) to transfer aryl groups to gold(III) via transmetalation 
(Scheme 1.2).7–10 Vicente and co-workers  demonstrated that the resultant arylgold(III) 
complexes can be isolated in neutral form by substitution of a chloride anion for a suitable 
ligand (e.g. PPh3). Alternatively, addition of a second equivalent of R2Hg allows access to 
either symmetrical or unsymmetrical diarylgold(III) complexes via the same protocol. These 
cis-diarylgold(III) complexes can undergo reductive elimination to form symmetrical or 








Building upon the earlier work of Vicente, a number of alternative methods to generate 
arylgold(III) species have since been developed, typically involving transmetalation from 
organometallic reagents derived from tin,12 lithium,13 boron,14 and  silver.13 
Although gold(I) is isoelectronic with platinum(0), the two metals exhibit strongly contrasting 
reactivity. Few literature reports of oxidative addition into aryl halides or pseudo-halides exist 
for gold(I), a consequence of the high oxidation potential of Au(III).15,16 State-of-the-art 
examples include the use of rigid cis-chelating ligands,17,18 intramolecular delivery,19 
photo-activation,20 and hemi-labile (P,N)-ligands21 to promote the oxidative addition of aryl 
iodides (Scheme 1.3).i However, the generality of these procedures in their current state is 
somewhat limited, and as a result very few gold-catalysed reactions depend on an oxidative 
addition sequence. 
 
Scheme 1.3. Bourissou’s method to promote gold(I) oxidative addition using stabilising 
hemi-labile (P,N)-ligands. 
More commonly, redox based gold catalysis relies on the use of sacrificial, strong 2e– oxidants 
that are able to promote the oxidation of gold(I) to gold(III).22–25 Hypervalent iodine(III) 
species, as well as electrophilic “F+” sources, have been established as the most general 
reagents to facilitate the oxidation in both stoichiometric26–28 and catalytic29–31 examples 
(Scheme 1.4).ii  
 
                                                     
i Toste and co-workers have also reported an oxidative addition into a highly strained C-C bond.139 




Scheme 1.4. Common reagents used for gold(I) to gold(III) oxidation. 
 
 
1.1.2. Stoichiometric Examples of Oxidative Coupling 
Lippert and co-workers reported the homodimerisation of uracil derivatives in the presence of 
a stoichiometric quantity of Au(III) (Scheme 1.5).32 Isolation of aurated uracil complex 4 
provided evidence for initial activation of a C(sp2)-H bond, followed by oxidative coupling to 
form the corresponding dimer 5. 
 
Scheme 1.5. Oxidative dimerisation of uracil derivatives mediated by gold(III). 
Hashmi and co-workers described an oxidative coupling by gold(III), when identifying one of 
the by-products of a desired cyclisation reaction as hydrofuran dimer 8, resulting from the 
homocoupling of intermediate 7 (Scheme 1.6).33 As in the work of Lippert, due to the absence 
of an external oxidant the coupling is not catalytic, and the product was only formed in 





Scheme 1.6. Identification of a by-product arising from oxidative homocoupling. 
 
 
1.1.3. Applications in Catalysis 
The first gold-catalysed homocoupling of electron rich arenes was reported by Tse and 
co-workers in 2008 (Scheme 1.7).34,35 Using 2 mol% HAuCl4 as a catalyst, and iodobenzene 
diacetate (IBDA) as a stoichiometric oxidant, a variety of symmetrical biaryls could be 
synthesised in reasonable yield. Aryl halides were well tolerated, even under quite forcing 
conditions (95 °C, AcOH), highlighting the potential complementarity between gold- and 
other transition metal-catalysed transformations. In some cases, mixtures of regioisomers were 
obtained, as would be expected for selectivity governed by an SEAr mechanism. 
 
Scheme 1.7. Gold(III)-catalysed oxidative homocoupling of arenes. 
As the homocoupling of arenes has limited utility in synthesis, the use of oxidative gold 
catalysis to effect similar heterocoupling processes has been the focus of much attention. 
Zhang and co-workers successfully demonstrated that arylboronic acids could be used as 
coupling partners in an oxidative gold-catalysed arylheterofunctionalisation of alkenes 
(Scheme 1.8).30  Selectfluor® was used as a stoichiometric oxidant in this case, proposed to 
oxidise gold(I) with simultaneous formation of a gold(III) fluoride. It remained unclear 
however, whether this oxidation occurred prior to or directly after initial transmetalation from 





Scheme 1.8. Zhang’s proposed mechanism for the oxidative carboheterofunctionalisation of 
alkenes using Selectfluor® as a sacrificial oxidant. 
Toste and co-workers reported a variation of the reaction, together with a mechanistic 
investigation, in which [dppm(AuBr)2] was identified as an improved catalyst.31,36–38 It was 
proposed that reductive elimination occurs via a bimolecular interaction en route to the 
transition state rather than from a formal arylgold(III) intermediate (as had been suggested by 
Zhang). Evidence in support of this focused on the inability of Ph3PAuPh to act as an aryl 
donor in the absence of a suitable boronic acid. The isolation of an arylgold(III) fluoride 
species and its reactivity in the aforementioned coupling reaction was later documented.39 It 
was identified that the gold(III) fluoride has an important role in coupling, presumably through 




Figure 1.1. Toste’s proposed bimolecular reductive elimination. 
The scope of this coupling was simultaneously expanded by the groups of Toste,40 and 
Lloyd-Jones,41 to use aryltrimethylsilanes in place of boronic acids as the organometallic 
component (Scheme 1.9). The reaction is quite general, and tolerates a range of different 
alcohols, alkenes, and substituted arylsilanes as coupling partners. Interestingly, biphenyl 
derivatives, arising from homocoupling of the arylsilane reagent, were typically observed 
by-products in 3-5% yield. In contrast, the anticipated products of other side reactions, such 
as protodeauration and fluorination, could not be detected. 
 





1.2. Gold-catalysed Biaryl Forming Reactions 
1.2.1. Direct Arylation of Arylsilanes 
Following the successful application of aryltrimethylsilanes in oxyarylation chemistry, 
Lloyd-Jones and co-workers disclosed the first oxidative gold-catalysed coupling of 
arylsilanes and arenes to form functionalised biaryls (Scheme 1.10).42 The reaction proceeds 
at room temperature, with no necessary precaution to exclude oxygen, and a range of 
electronically diverse aryltrimethylsilanes and π-rich arenes can be used. Iodobenzene 
diacetate (IBDA) was identified as the most effective stoichiometric oxidant with 
camphorsulfonic acid (CSA) as an additive. The addition of methanol as a co-solvent was 
required to facilitate solubility of the multi-component system. Extensive substrate screening 
identified that oxidatively sensitive groups, along with aryl halides were tolerated under the 
reaction conditions. 
 
Scheme 1.10. Oxidative gold-catalysed arylation of arylsilanes and representative examples 
of accessible products.  
Subsequently, a detailed mechanistic study was published in which the origin of selectivity 
and detailed catalytic cycle were proposed.43 Tetrahydrothiophene gold(III)bromide 
(thtAuBr3) was demonstrated to be an improved pre-catalyst, with evidence that the previously 
used phosphine ligand was simply oxidised to the phosphine oxide during catalyst activation.iii 
The exact ligation of the active catalyst in solution is unknown, and with a range of weakly 
co-ordinating species present (MeOH, CSA, arene π-complexes, camphorsulfonate), is 
                                                     
iii The tht ligand is also consumed during catalyst activation, but oxidation occurs rapidly such that no 
induction period is observed.  
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anticipated to vary throughout the catalytic cycle, similar to the concept of ‘Serial Ligand 
Catalysis’ pioneered by White and co-workers.44  
The regioselectivity of both silane and arene is predictable; arylsilanes are known to undergo 
aromatic substitution almost exclusively at the ipso-position due to the ability of the silicon 
group to stabilise β-cations.45 While transmetalation of aryl groups to gold(III) is reasonably 
well documented,  the mechanism of transmetalation from aryl silanes has not been studied in 
detail. It is proposed that in similar Pd(II) and Pt(II) chemistry, arylsilanes react in an SEAr 
type mechanism.46,47 Hammett analysis of the transmetalation to gold(III) was found to 
correlate with σ, corresponding to a value of ρ = –1.6 (Figure 1.2).43 The observation that 
electron-releasing substituents accelerate the rate of transmetalation is consistent with an 
electrophilic aromatic substitution mechanism of transmetalation.   
 
Figure 1.2. Hammett analysis of the transmetalation from arylsilane to gold(III). 
The site of auration of the arene is dictated by the rules of classical electrophilic aromatic 
substitution. In cases where more than one C–H bond is similarly activated, mixtures of 



















Scheme 1.11. Established catalytic cycle for intermolecular gold-catalysed direct arylation. 
Extensive experimental evidence suggests that, following irreversible pre-catalyst activation, 
the arylsilane undergoes an electrophilic auration by a ‘ligand-free’ gold(III) species (II) 
(Scheme 1.11). The origin of chemoselectivity in this step is determined by the irreversible 
formation of a Wheland intermediate (IV), in which the silane is able to outcompete the arene 
due to stabilisation of this intermediate through the β-silicon effect. Removal of the 
trimethylsilyl group by MeOH affords an arylgold(III) species. Substitution of a ligand for 
camphorsulfonate is needed in order to generate the more electrophilic gold species V prior to 
the second (turnover-limiting) auration, leading to an inverse dependence on MeOH in the 
overall rate law. Unlike initial auration of the silane, π-complexation is now irreversible, 
leading to chemoselectivity for the π-rich arene in the second auration. Following Wheland 
intermediate formation (VII) and subsequent dissociation of a ligand, reductive elimination 
can occur from a 3-48,49 or 4-50 coordinate complex to form the heterocoupled biaryl and gold(I) 
species, VIII. Rapid oxidation then occurs to regenerate the initial gold(III) species and close 
the catalytic cycle.   
11 
 
Itami and co-workers reported a variation of the reaction in which NHC ligand L1 was able to 
promote the coupling of a range of heteroarenes, albeit in modest yield (Scheme 1.12).51 A 
slightly higher catalyst loading (5 mol%) and elevated temperature (65 °C) were found to be 
optimal in this instance. PPh3AuCl was also demonstrated to be catalytically competent, 
though led to a significantly reduced rate of reaction and pronounced induction period.   
 
Scheme 1.12. Use of an NHC-gold(I) pre-catalyst to facilitate the coupling of heteroarenes. 
Lloyd-Jones and co-workers subsequently expanded the substrate scope of the arene coupling 
partner with the development of bespoke hypervalent iodine(III) and silyl reagents 
(Scheme 1.13).52 These facilitated the coupling of more electron rich arenes (including a 
number of heterocycles) by retarding the formation of diaryliodonium side-products, and 
accelerating the desired coupling reaction (Scheme 1.14). The alcohol-containing 
hydroxypropyldimethylsilyl (HPDMS) group allowed the reaction to proceed in the absence 








Scheme 1.14. Self-cleaving silyl group forming siloxane 30 as a by-product. 
The original reaction conditions were later optimised to enable intramolecular coupling, in 
which the silane and arene components are joined by a tether (Scheme 1.15).53 Catalyst 
loadings could typically be reduced to 1 mol% without detriment to the yield, and a range of 
different ring sizes (5 through to 9) could be formed. Owing to the local proximity of the arene 
partner in these examples, the reaction is significantly more tolerant of electron-withdrawing 
substituents. A mechanistic study revealed that, unlike the intermolecular coupling (in which 
arene π-complexation was turnover limiting), these cyclisation reactions were often governed 
by the rate of reductive elimination. The reaction (Scheme 1.15) has subsequently been 





Scheme 1.15. Selected examples of the intramolecular arylation reaction to form 5- to 
9-membered rings. 
Employing more forcing conditions, Jeon and co-workers were able to couple 
diethylmethylsilane reagents with a range of arenes (Scheme 1.16).55 The arylsilane reagents 
33, were accessed via a sequential iridium- and rhodium-catalysed C-H silylation of phenol 
derivatives with H2SiEt2. Product yields for the arylation step were generally good and the 
remaining sulfonate groups could be subjected to Suzuki-Miyaura cross-coupling conditions 
to synthesise 1,2-triaryls.  
 




1.2.2. Coupling of Electron Deficient Arenes 
The contrasting reactivity of gold(I) and gold(III) species was exploited by Larrosa and 
co-workers in a redox-controlled gold-catalysed dehydrogenative coupling of electron-rich 
and polyfluorinated (hetero)arenes (Scheme 1.17).56 A variety of (hetero)arenes can be used 
as the electron-rich component and the electron poor coupling partner can be modified to some 
extent (the presence of two ortho-fluorine substituents is critical).  
 
Scheme 1.17. Dehydrogenative coupling of electron-rich and electron-deficient arenes, with 
representative examples. 
While the exact reaction mechanism is unclear, the regioselectivity for the electron-rich arene 
partner is consistent with an electrophilic auration at gold(III). In contrast, the reactive site of 
the electron-deficient arene is dictated by the most acidic C-H bond, consistent with a 
concerted metalation-deprotonation (CMD) or deprotonation-metalation mechanism at 
gold(I).57–59 The addition of a suitable silver salt (AgOPiv) was found to be essential for 
catalytic turnover, and its role proven to be more complex than a simple halide extraction 
(potentially involved in C-H activation of the polyfluorinated arene). Likewise, the role of 
DMSO as an additive was not fully understood, possibly aiding solubility or serving to ligate 
the catalyst. 
The cross-coupling of polyfluorinated organometallic reagents is generally considered to be 
challenging due to fast competing protodemetalation pathways, particularly under the basic 
conditions common to most palladium-catalysed cross-couplings.60–63 To overcome this, 
15 
 
Nevado and co-workers reported a neutral gold-catalysed coupling of electron-rich arenes and 
polyfluorinated boronic acid derivatives (Scheme 1.18).64  
 
Scheme 1.18. Gold-catalysed oxidative coupling of polyfluoroboronic acids with arenes. 
[a] X = pinacol ester; [b] X = 2,4-pentanediol ester; [c] 10 mol% catalyst. 
This methodology again relies on the disparate reactivity of gold(I) and gold(III) species to 
enable heterocoupling to take place. Unlike traditional palladium cross-coupling, no external 
base is needed in this case, as the acetate ligand is sufficiently basic to perform the 
deprotonation. Following a series of stoichiometric studies, a mechanism involving initial 






Scheme 1.19. Nevado’s proposed catalytic cycle for the gold-catalysed arylation of 
polyfluorinated boronic acid derivatives. 
 
1.2.3. Aryldiazonium Salts 
In 2015, Shi and co-workers reported the first gold-catalysed coupling of arylboronic acids 
and aryldiazonium salts to synthesise non-symmetrical biaryls (Scheme 1.20).65 The 
aryldiazonium salt serves as both a coupling partner and oxidant, removing the requirement 
for addition of a strong, sacrificial oxidant, and generating N2(g) as a benign by-product.iv 
Cationic triazole-ligated catalyst 45 was found to give reliably higher yields, an outcome 
attributed to the high stability of the complex.66 
                                                     





Scheme 1.20. Gold-catalysed cross-coupling of arylboronic acids and aryldiazonium salts, 
with representative examples. 
The addition of 2,2ʹ-bipyridine was found to be critical for catalytic turnover, with 
stoichiometric studies suggesting that it plays an important role in the promotion of N2 
extrusion. Radical trapping experiments suggested that “free” aryl radicals are not generated 
under the reaction conditions, instead favouring a simultaneous transmetalation and loss of N2. 
The boronic acid component could be directly substituted for a terminal alkyne to enable the 
corresponding alkynylation of various aryldiazonium salts. 
The reaction conditions were simultaneously adapted by Lee,67 Fouquet,68 and their respective 









Scheme 1.22. Fouquet’s photoredox modification of the gold-catalysed coupling of 
aryldiazonium salts. 
Both protocols exhibit an impressive tolerance for electronically diverse substituents on both 
aryl partners, as well as some examples of sterically challenging couplings. However, given 
that there is precedent to suggest that the reaction can proceed in the absence of 
photocatalyst,65,68 care must be taken when considering if the reaction mechanisms are truly 




1.3. Arylsilanes in Transition Metal Catalysis 
Organometallic reagents derived from tin, zinc, and boron have found widespread application 
in transition metal catalysis, particularly in the field of palladium cross-coupling, due to their 
broad functional group compatibility.70–72 Organosilicon compounds, while less commonly 
encountered, represent an attractive alternative owing to their comparably low toxicity, high 
stability, and ease of handling.73  
 
1.3.1. Palladium-Catalysed Hiyama-Denmark Coupling 
Hiyama and co-workers first demonstrated the potential for organosilanes to be used as 
organometallic reagents in the synthesis of biaryls almost 30 years ago (Figure 1.3).74,75 
Aryl(dihalo)silanes could be activated toward transmetalation to palladium using a 
superstoichiometric quantity of a fluoride source, and reacted with aryl halides to afford 
non-symmetrical biaryls.76–78 It is proposed that the reaction proceeds via formation of a 
pentavalent silicon species, which is required to facilitate transmetalation to the palladium 
catalyst (Scheme 1.23).  
 
 






Scheme 1.23. General catalytic cycle for fluoride-activated Hiyama coupling. 
DeShong, Shibata, and co-workers demonstrated that it was possible to replace the moisture-
sensitive (dihalo)silanes with more robust trialkoxysilanev reagents.79–83 Shortly after this, 
Hiyama and co-workers reported that triallyl silanes could be used, offering improved product 
yields, while still exhibiting stability toward moisture, acids, and bases.84–86 All of these 
methods however, are restrictive in their requirement for a superstoichiometric fluoride source, 
limiting their appeal to the broader synthetic community; many natural product syntheses rely 
on the use of silyl protecting groups, which are readily cleaved in the presence of fluoride 
sources.87,88 
The earliest demonstrated use of arylsilanols in a palladium-catalysed cross-coupling with aryl 
iodides was reported by Hiyama and co-workers in 1999 (Scheme 1.24).89,90 Ag2O was 
required as a stoichiometric activator, likely serving the dual purpose of catalyst activation 
(through iodide abstraction) and facilitating transmetalation of the arylsilanol. While 
advantageous in that a fluoride activator was not necessary, reaction times were often 
protracted.vi 
                                                     
v Alkenylalkoxylsilanes had previously been used in palladium-catalysed couplings by Tamao and 
Ito.143 
vi Denmark and co-workers reported the use of aryl(halo)siletanes in cross-coupling. However, it was 





Scheme 1.24. Hiyama coupling of arylsilanols using silver(I) oxide as an additive. 
Alternatively, the reaction can be promoted by cesium-containing bases, typically carbonate 
or hydroxide (Scheme 1.25).91,92 However, it is essential in this case that the salts are used as 
hydrates, as the water ensures that formation of inactive disiloxane by-products is reversible. 
Under these Brønsted base-activated conditions, the deprotonated silanol (silanoate) is formed 
in situ, and is likely the species responsible for transmetalation (Scheme 1.26). Depending on 
the base strength, this silanoate formation may or may not be quantitative under the reaction 
conditions. The use of strong alkoxide base helps to ensure that complete deprotonation 
occurs, but limits the compatibility with various functional groups.  
 
 





Scheme 1.26. In situ formation of a caesium silanoate, the species likely involved in 
transmetalation. 
The problematic dimerisation of silanols to form disiloxanes can be avoided if the preformed 
metal silanoates are prepared and used instead (Scheme 1.27). This can be achieved in a one-
pot stepwise manner, using a strong base (such as a metal hydride) to ensure quantitative 
deprotonation,93,94 or alternatively the metal silanoate salt can be prepared and isolated prior 
to use. Championed by Denmark and co-workers, these conjugate bases of the free silanols are 




Scheme 1.27. Problematic disiloxane formation (left) and isolated silanoate (right) to avoid 
dimerization. 
Using potassium arylsilanoates in the presence of a Pd(P(t-Bu)3)2 catalyst, Denmark and 
co-workers were able to cross-couple an impressive range of aryl chlorides and bromides 
(Scheme 1.28).97 Yields were typically high, and sensitive functional groups (esters, cyclic 
acetals, TBS-protected alcohols) as well as various heterocycles were well tolerated. The 
choice of catalyst and ligand proved vital for effective coupling, with other combinations 
resulting in limited reactivity.98 Mechanistic studies support a general catalytic cycle involving 
initial coordination of the silanoate to the metal centre, before an external base-free 





Scheme 1.28. Denmark’s external base-free coupling of metal silanoates and aryl halides. 
 
 
Scheme 1.29. Proposed mechanism for Hiyama-Denmark cross-coupling reactions involving 
preformed arylsilanoates. 
In 2005, Hiyama and co-workers reported the use of a modified silyl reagent that incorporated 
a pendant alcohol on the arene (Scheme 1.30). Termed HOMSi reagents, they undergo in situ 
deprotonation to form pentavalent silicate species that are capable of transferring aryl, alkenyl, 
and alkynyl groups in metal-catalysed reactions.99–102 Depending on the nature of the 
substituents at silicon, the reagent can either act as a transfer reagent (Hiyama pathway) or as 





Scheme 1.30. Different pathways for HOMSi reagent activation and reactivity.vii 
The same intermediates have more recently been utilised by Smith III and co-workers in a 
formal palladium-catalysed coupling of organolithium reagents, which represents an 
alternative to existing Murahashi104,105 and Feringa106–108 couplings (Scheme 1.30). The 
1-oxa-2-silacyclopentene transfer reagents are regenerated following transmetalation, and can 
therefore be easily recovered and reused.109–113 Rational modification of the transfer reagent 
has enabled the more challenging cross-coupling of aryl chlorides at room temperature 
(Scheme 1.31).  
                                                     




Scheme 1.31. Cross-coupling of organolithium compounds using an arylsilane transfer 
reagent. 
Hartwig and co-workers reported a dehydrogenative silylation of arenes (catalysed by either 
rhodium or irdium) followed by cross coupling in the presence of a palladium catalyst to form 
biaryls, as well as other functionalised products (Scheme 1.32).114–117 The regioselectivty of 
the silylation is largely governed by steric effects, and the reaction conditions are tolerant of 
an impressive range of functional groups. This was showcased in the silylation of a range of 
natural products, offering a convenient method for the late-stage functionalisation of highly 
complex molecules.  
 




1.3.2. Other Palladium-Catalysed Reactions of Arylsilanes 
Similar conditions to those required for Hiyama coupling can also promote the synthesis of 
diarylketones. Van der Eycken and co-workers reported the desulfitative coupling of 
arylthioesters with arylsiloxanes, to generate the corresponding diarylketones in good yield 
(Scheme 1.33).118 More recently, Sakai and co-workers have shown that the analogous reaction 
using acyl chlorides (or fluorides) is also possible.119 Alternatively, the polarity of the coupling 
partners can be reversed in the coupling of aryl halides and acylsilanes, as demonstrated by 
Krska and co-workers.120 
 
 





Kitamura and co-workers reported an oxidative palladium-catalysed acetoxylation of 
arylsilanes using PIFA as a terminal oxidant in AcOH at 80 °C (Scheme 1.34).121 The 
acetoxyarenes are obtained in good yield, and both electron-rich and electron-poor arylsilanes 
are compatible. Performing the reaction in alternative carboxylic acid solvents leads to 
formation of the corresponding esters. The mechanism is suggested to proceed via a 
palladium(II/IV) redox cycle, though experimental evidence in support of this is lacking. 
 
Scheme 1.34. Kitamura’s palladium-catalysed carboxylation of arylsilanes. 
A variety of oxidative palladium-catalysed C-H activation reactions employing arylsilanes are 
possible (Scheme 1.35).122–128 Copper salts are typically added as an external oxidant, and in 
most cases a fluoride source is required to activate the arylsilane to transmetalation.  
28 
 
Scheme 1.35. Overview of C-H functionalisation reactions involving arylsilanes.viii 
Interestingly, Itami and co-workers were able to use cationic palladium catalyst 
Pd(MeCN)4(SbF6)2 in the K-region selective arylation of pyrenes, without the need for any 
additional fluoride additive (Scheme 1.36).129 Parallels can be drawn between this reaction and 
gold-catalysed arylation, in which the presence of a highly electrophilic catalyst allows the 
transmetalation of non-activated, neutral aryltrimethylsilanes. 
 
Scheme 1.36. Itami’s fluoride-free palladium-catalysed annulation reaction using 
arylsilane 80.  
 
                                                     
viii A select number of nickel-147 and rhodium-148 catalysed C-H functionalisations using arylsilane 




1.3.3. Nickel-Catalysed Reactions of Arylsilanes 
In addition to palladium, a range of transformations utilising arylsilane reagents can be carried 
out in the presence of a nickel catalyst. For example, a nickel-phenanthrene complex was 
shown by Fu and co-workers to promote the coupling of aryl(trifluoro)silanes with secondary 
alkyl bromides (Scheme 1.37).130 The reaction exhibits reasonable functional group tolerance 
and can also be applied to a select number of primary alkyl halides. The stereochemical 
outcome of some couplings suggest that the mechanism may be radical in nature, though 
current experimental evidence is inconclusive. 
 
Scheme 1.37. Fu’s nickel-catalysed alkylation of arylsilanes. [a] 95:5 exo/endo 
(starting material 6:94); [b] 55:45 cis/trans (starting material 95:5). 
Ogoshi and co-workers reported the use of a chiral nickel NHC complex to effect an 
intramolecular asymmetric addition of arylsilanes across aldehydes (Scheme 1.38).131,132 The 
method is high yielding and the resulting products are generated with excellent control over 
enantioselectivity. Using diphenylarylsilane reagents as precursors allows two quaternary 




Scheme 1.38. Ogoshi’s asymmetric nickel-catalysed intramolecular addition into aldehydes. 
 
1.3.4. Copper-Catalysed Reactions of Arylsilanes 
While copper has often been used as a co-catalyst or additive in palladium-catalysed reactions 
of organosilanes, there are some notable examples in which a copper species is able to act as 
the sole catalyst. Giri and co-workers described a copper-catalysed cross-coupling of 
arylsiloxanes with (hetero)aryl iodides (Scheme 1.39).133,134 Product yields for most couplings 
were found to be reliably higher when using bidentate P,N-ligand L5, though 
nitrogen-containing heteroarenes underwent more efficient coupling in the absence of any 
additional ligand. It is proposed that both the ligand and CsF help to prevent the formation of 





Scheme 1.39. Copper-catalysed cross-coupling of (hetero)arylsiloxanes and (hetero)aryl 
iodides. 
Similarly, Takeda and co-workers demonstrated that aryl HOMSi reagents could be used in 
the presence of a copper catalyst to enable the alkylation of arenes (Scheme 1.40).135 Primary 
alkyl iodides, as well as allyl/benzyl chlorides can be used as the alkyl donor, and a number of 
different arenes were shown to be effective. Notably, free alcohols could be tolerated without 
significant detriment to the product yield. 
 
Scheme 1.40. Copper-catalysed alkylation of aryl HOMSi reagents. 
Aryl HOMSi reagents could also be used to facilitate a copper-catalysed electrophilic 
amination independently reported by Smith III,112 and Hirano, Miura and co-workers 
(Scheme 1.41 and 1.42).136 Both methods exhibit a reasonably broad substrate scope, though 






Scheme 1.41. Smith III method for electrophilic amination using HOMSi reagents. 
 
 
Scheme 1.42. Hirano and Miura method for electrophilic amination using HOMSi reagents. 
 
1.3.5. Rhodium-Catalysed Reactions of Arylsilanes 
A variety of rhodium catalysts have been used to enable enantioselective 1,4-additions of 
arylsilanes to α,β-unsaturated carbonyl compounds. Hiyama and co-workers reported that aryl 
HOMSi reagents can undergo transmetalation with a rhodium hydroxide derived catalyst in 
the presence of a catalytic amount of KOH, under mild conditions (40 °C, THF), to enable 
conjugate additions with a range of Michael acceptors (Scheme 1.43).137 Chiral dienes (of the 
general structure L7) were used to render the reaction asymmetric, resulting in reliably high 




Scheme 1.43. Hiyama’s asymmetric rhodium-catalysed conjugate addition reaction using 
HOMSi reagents. 
Oi and co-workers independently reported that trialkoxyarylsilanes could also be used in the 
presence of an (S)-BINAP ligated rhodium catalyst to enable conjugate addition into 
α,β-unsaturated ketones (Scheme 1.44).138 The level of enantiocontrol is similar to the Hiyama 
method despite the more forcing reaction conditions. In this instance, with a cationic rhodium 
species, it was found that no external base was needed to activate the arylsilane reagent. 
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      







Despite the emergence of arylsilicon reagents as a viable alternative to established 
organometallic reagents for a variety of cross-coupling reactions, they remain largely 
underutilised by the broader synthetic community. This is in part due to the common 
requirement for a superstoichiometric (often fluoride-containing) activating agent to enable 
the silyl reagent to undergo transmetalation with a transition metal catalyst. Gold(III) catalysis 
offers a convenient solution to this issue, with the highly electrophilic nature of the catalyst 
facilitating an additive-free transmetalation (using simple trialkylarylsilanes).  
While oxidative gold catalysis has emerged as a powerful synthetic tool to form C−C bonds, 
key information regarding the reaction mechanism under operation is often lacking. It is 
broadly appreciated that a better understanding of the fundamental mechanistic limitations of 
the chemistry will aid the design and development of future methodologies. 
The work detailed in this thesis summarises our investigation into a class of unreactive 
arylsilane reagents, and the subsequent development of a method to enable them to be used as 
coupling reagents in gold catalysis. We anticipate that the findings will be of interest not only 
within the remit of direct arylation, but perhaps also to the wider community of late transition 
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2. Transmetalation of ortho-Substituted Arylsilanes 




2.1  Introduction 
2.1.1 Limitations in Gold-Catalysed Direct Arylation 
The complexity of target molecules throughout industrial chemistry is driving the development 
of synthetic methods that are tolerable of a wide variety of different functional groups. 
Likewise, methods for the late-stage incorporation of structural and electronic diversity are 
highly desirable in compound library syntheses, placing a great deal of importance on the 
generality of synthetic procedures.  
One of the key strengths of the gold-catalysed arylation reaction in this respect is versatility 
with regard to the coupling partners. A range of π-rich (hetero)arenes are suitable, along with 
an electronically diverse range of aryltrimethylsilanes.1,2 The fact that aryl halides, along with 
selected boronic acid derivatives, are tolerated under the reaction conditions provides an 
orthogonal reactivity to established transition metal-catalysed cross-coupling. Given the 
number of commercial syntheses involving palladium-catalysed reactions,3 this can be 
expected to offer a broadly practical advantage with respect to the synthetic planning of 
multi-step sequences. 
Despite the substrate scope in previous studies having been demonstrated to be reasonably 
broad, only select examples exist for the intermolecular coupling of ortho-substituted 
arylsilanes, typically requiring elevated temperatures and/or prolonged reaction times in order 
to reach reasonable conversion. Indeed, nearly all examples of products that possess 
substitution at the ortho-position are derived from the arene coupling partner rather than the 
arylsilane (Scheme 2.1). It is unclear at which step the catalytic cycle is adversely affected by 
ortho-substitution of the arylsilane, with transmetalation, C-H auration and reductive 





Scheme 2.1. Products of cross-coupling that have substituents adjacent to the site of 
arylation.1 
While presently inaccessible via gold-catalysed arylation, sterically congested biaryls are an 
attractive synthetic target due to their prevalence in natural products4 and ligand structures5,6 
(Figure 2.1). Sufficient substitution on both coupling partners can render the products of 
cross-coupling axially chiral, with a range of associated properties and applications (See 




Figure 2.1. Axially chiral natural product, Ancistrobrevine D, and biarylphosphine ligand, 
BrettPhos. 
 
2.1.2 Ortho-Substituted Arylsilanes in SEAr Chemistry 
The somewhat unusual reactivity of ortho-substituted arylsilanes has been noted in a number 
electrophilic aromatic substitution (SEAr) reactions. In protodesilylation for example, 
2,6-dimethyl-7 and 2-trimethylsilyl-8 substituents were found to be significantly more reactive 
than would be expected based on inductive effects alone. This is attributed to the alleviation 
of steric strain upon moving from the planar conformation of the ground state toward the 
pseudo-tetrahedral geometry of the Wheland intermediate (Scheme 2.2). Other 
ortho-substituents however, were found to have a minimal steric contribution to the rate of 
protodesilylation, resulting in a strong correlation between the relative rates of para- and 
ortho- substituents.8 
 
Scheme 2.2. Relief of steric strain en route to the Wheland Intermediate for ortho-substituted 
aryltrimethylsilanes. 
Similarly, Benkeser and co-workers found that the rate of mercuridesilylation was 
significantly accelerated for 2,6-dimethyl-substituted arylsilanes, as evidenced by the order of 
reactivity of the trimethylsilylxylenes (Scheme 2.3).9 In fact, such was the increase in 






Scheme 2.3. Order of reactivity of trimethylsilylxylenes in mercuridesilylation by 
Hg(OAc)2.  
The desilylation of trimethylsilylnapthalene is significantly faster for the 1-substituted isomer 
compared to the 2-substituted isomer.10 This is attributed to an analogous case of steric relief 
whereby the trimethylsilyl-substituent moves out of plane of the peri-hydrogen atom en route 
to Wheland intermediate formation (Scheme 2.4).  
 




2.1.3 Ortho-Substituted Arylsilanes in Gold-Catalysed Arylation 
While ortho-substituted arylsilanes were found to be largely unreactive in arylation (or at least 
unable to form arylated products), a direct competition between ortho- and para-substituted 
silanes 112 and 113 was demonstrated to exhibit a surprising selectivity for the more sterically 
hindered arylsilane (Scheme 2.5).11 This demonstrates that transmetalation is accelerated by 
substitution at the ortho-position rather than hindered by it, in agreement with the prior studies 
on electrophilic desilylations.7–9 However, in contrast to Eaborn’s findings on 
protodesilylation, in which the relative rate for 112 and 113 is similar, the gold-catalysed 
reaction appears to exhibit a significant steric acceleration effect for the ortho-methyl 
substituent. The reactivity of larger ortho-substituents in transmetalation to gold(III) was not 
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studied, with their reluctance to undergo arylation preventing straightforward analysis by the 
same method. 
 
Scheme 2.5. Competition between ortho- and para-substituted arylsilanes. 
In a prior mechanistic study on the arylation reaction, it was identified that addition of catalytic 
amounts of (o-biphenyl)trimethylsilane 118 to a gold-catalysed coupling reaction resulted in 
immediate stalling of catalysis, without any further consumption of silane, arene, or oxidant 





Scheme 2.6. Addition of (o-biphenyl)trimethylsilane to an intermolecular arylation 
reaction.ix  
It was proposed that this was due to the formation of a highly stable cycloaurate species 119 
which is unable to undergo reductive elimination to form the severely strained biphenylene 
product 120 (Scheme 2.7). Evidence in support of this was provided in the isolation of a 
DMAP coordinated, cycloaurated complex 121 from the resulting reaction mixture. 
Considering the established catalytic cycle, it was proposed that 118 acts as a potent catalyst 
poison by irreversibly competing for the gold(III) catalyst at the transmetalation step. The 
presence of an ortho-substituent in 118 offers a potential explanation for the observed potency 
of the catalyst poison, though the relative rate of transmetalation was not determined 
experimentally. 
 
                                                     






Scheme 2.7. Formation of a cycloaurated species following transmetalation (top) and the 




2.2 General Considerations 
For the benefit of continuity, the reaction conditions for couplings reported in this chapter are 
based on those used in a prior mechanistic study.11 The various components of the reaction 
serve a number of different roles that are essential for successful cross-coupling and/or 
straightforward reaction monitoring by in situ NMR spectroscopy. 
thtAuBr3 was demonstrated to be a convenient pre-catalyst for kinetic analysis due to its 
stability in chloroform solution (up to at least 1 month in dry CDCl3 at 6–8 °C) and rapid 
activation to form the in situ active catalyst with absence of a significant induction period.11 
This activation proceeds with concurrent oxidation of the tetrahydrothiophene (tht) ligand to 
form sulfoxide 123 and an uncharacterised ring opened by-product, along with the loss of two 
of the three Br ligands (Scheme 2.8). Formally released as a source of “Br+”, associated 
bromination by-products (either bromodesilylation of the arylsilane, path A, or bromination of 




Scheme 2.8. Summary of the by-products generated during pre-catalyst activation. 
Methanol is required to fully solubilise all of the reaction components, allowing for 
reproducible reaction kinetics to be observed by in situ NMR. However, there is also an inverse 
dependence on [MeOH] in the rate equation arising from inhibition of the turnover-limiting 




Scheme 2.9. Requirement for exchange of MeOH with CSA prior to turnover-limiting arene 
π-complexation. 
Iodobenzene diacetate (IBDA) is known to undergo rapid ligand exchange in the presence of 
sulfonic acids to form [hydroxy(sulfonyloxy)iodo]benzene species in both aqueous and 
organic reaction media.12–14 It is therefore assumed that the active oxidant species under these 
reaction conditions is either MCIB (arising from reaction with methanol) or HCIB (arising 
from reaction with residual H2O) depending on how thoroughly dried the reaction solvent is 
prior to use (Figure 2.2). HCIB can be prepared and isolated independently,15 and when used 
directly is equally as effective as the in situ generated oxidant.16 Due to the necessity of ligand 
exchange between CSA and MeOH prior to π-complexation, there is a requirement that 
[CSA] > [IBDA] to ensure that there is always an amount of “free” CSA in solution.  
  




2.3 Initial Studies 
Substrates in which the arylsilane and arene coupling partners are tethered by a methylene unit 
(such as 126) have been shown to cleanly undergo intramolecular coupling to form the 
corresponding fluorene products in almost quantitative yield (Scheme 2.10).17 Unlike the 
analogous intermolecular arylation reactions, which exhibit a rate-dependence on the 
concentration of arene, these substrates display pseudo-zero order kinetics in which the rate of 
reaction is unaffected by changes in the concentration of substrate. As a result, concentration-
time profiles for the reactions are greatly simplified.  
 
 
Scheme 2.10. Concentration-time profile for the cyclisation of 126 to form 127. 
Taking the representative coupling of 126 to form fluorene 127, it is possible to monitor the 
deviation in rate of reaction upon adding different quantities of the established catalyst poison 
118 (Scheme 2.11). As the reaction profile in the absence of any additive is linear, with a 
gradient that corresponds the rate of reaction, it is visually much easier to assess the rate at 
which active catalyst is being sequestered. Addition of 1 mol% 118 is sufficient to cause 
notable deviation from the original rate of reaction (orange data points, Scheme 2.11). 
Increasing the amount of catalyst poison further leads to more pronounced curvature in the 






















reaction profile, to the point that 8 mol% is sufficient to cause the reaction to promptly stall 
(blue data points, Scheme 2.11).  
 
 
Scheme 2.11. Effect of additive 118 on the rate of product formation, across a range of 
concentrations. 
This concentration dependence on the rate of trapping is indicative of a competitive removal 
of the catalyst whereby reaction with substrate 126 leads to productive turnover and product 
generation, while reaction with 118 irreversibly removes the catalyst from the reaction 
(Scheme 2.12).x As the first auration event is known to be silane transmetalation, the rate of 
catalyst trapping can be directly correlated to the relative partition at the transmetalation step 
between substrate and trap (kS/kT).   
                                                     
x The term “trapping” is used throughout this chapter to describe the irreversible sequestering of active 
catalyst from the reaction by a catalyst “trap”, in this case ortho-substituted arylsilanes. 





























Scheme 2.12. Reaction stalling caused by competitive (irreversible) catalyst removal at the 
transmetalation step of the catalytic cycle.  
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2.4 Competition Experiments 
2.4.1 Method of Analysis 
Conventional competition experiments, in which two substrates compete for a limiting amount 
of reactant or reagent, are typically analysed by the relative product distribution of the final 
reaction mixture (Scheme 2.13).18 The ratio of the two (or more) products thus offers an 
approximation for the relative selectivity between the substrates, provided that a suitable 
excess is used to ensure that the concentration of available substrates does not change 
significantly as a function of conversion (typically >5 equivalents relative to the limiting 
reagent). 
 
Scheme 2.13. General method for conventional competition experiments, analysed by 
product ratio. 
However, if one of the substrates is unable to generate product and turnover the catalyst, then 
this method of analysis is not possible (as only one product will be formed). This is problematic 
in the case of ortho-substituted arylsilanes, which while able to transmetalate to the gold(III) 
catalyst, are unable to undergo cross-coupling to form a detectable product. One alternative is 
to perform the competition experiment with a stoichiometric amount of catalyst, but this is 
impractical if the catalyst cost if significant, or in this case, where complex catalyst activation 
processes render this type of analysis difficult. 
Due to the simple reaction kinetics exhibited by the intramolecular variant of the arylation 
reaction, it is relatively straightforward to detect changes in catalyst concentration over the 
course of a reaction. This offers the possibility of a modified competition experiment whereby 
the partition between the two substrates is calculated based solely on the rate of formation of 





Scheme 2.14. Modified competition experiment, analysed by the change in rate of formation 
of product A. 
Kinetic modelling of the reaction profile (across a range of different starting concentrations) 
allows the relative rate of transmetalation between substrate and trap to be calculated 
computationally. Comparison of these values across a series of structurally different arylsilane 
traps then provides a reactivity scale to be constructed for arylsilanes that cannot be analysed 
by conventional methods. 
 
 
2.4.2 Reaction Monitoring 
The intramolecular cyclisation of 128 to form 129 is a convenient benchmark reaction to use 
due to the ease of analysis by 1H NMR spectroscopy and short reaction time in the absence of 
any additives (Scheme 2.15). Based on the preliminary studies in Section 2.3, the amount of 
added arylsilane trap was varied over the range 0 – 10 mol% to ensure that a range of rates of 
reaction stalling were observed. For the benefit of consistency between experiments, and to 
ensure accurate concentrations could be determined, the ‘trap’ was present from the beginning 






Scheme 2.15. The cyclisation reaction used in kinetic analysis (top) and an example of the 
typical appearance of concentration-time plots for trapping experiments (bottom). 
The above scheme provides a typical representation of the type of concentration-time graph 
generated for each individual ortho-substituted arylsilane. A minimum of four different sets 
of experimental data were obtained for each silane; one without any additive, and ≥ 3 with 
different additive concentrations. All graphs are shown as a function of product (129) 
formation but could equally display the decay of starting material (128), without any change 








2.5 Kinetic Modelling 
The construction of a robust kinetic model can allow rate constants and equilibria to be 
estimated computationally, based on experimental data. This can be particularly informative 
when it is not possible to directly measure the kinetics of certain steps in a catalytic cycle, or 
when the kinetic behaviour of a system is inherently complex. Using the concentration-time 
profiles described in Section 2.4, in conjunction with kinetic modelling software, it is possible 
to estimate the relative rate of transmetalation for the series of arylsilane ‘traps’. Experimental 
data was fitted using one of the two models discussed below (A or B) in order to calculate a 
ratio of transmetalation rates for each arylsilane trap; kT/kS (T = trap, S = substrate). 
Comparison of these values provides an indication of the structure-activity relationship across 
the series. 
Representative examples of experimental data alongside the corresponding simulations are 
shown in the main body of the text. For a complete overview of reaction profiles and associated 
fitting see Appendix A. 
 
 





2.5.1 Model A 
Arylsilanes 118, 130, and 131, were fitted to the simple model (Model A) shown in 
Scheme 2.16. The model dictates that trapping is irreversible, such that only the ratio between 
kT and kS influences the curvature in the concentration-time plots.  
 
 
Scheme 2.16. Visual schematic of Model A. 
The pre-catalyst activation step also accounts for the generation of bromodesilylation products 
that are observed in small quantities (Scheme 2.8). As the substrate is present in vast excess 
over the trap, it is almost exclusively the component that is sacrificially consumed during 
pre-catalyst activation in most cases. However, bromodesilylation of the trap can become 
kinetically significant, especially for the more reactive ortho-substituted silanes. During the 
course of these investigations we noted that even slight errors in initial trap concentration can 
lead to poorly fitting simulations. In some cases, stoichiometric studies were carried out in 




Figure 2.4. Representative example of simulated model for trapping by 118. White circles 
(experimental data points); blue lines (simulated reaction profiles).  
The results of the kinetic modelling for these arylsilane traps are summarised in Table 2.1. As 
expected, the more strongly electron donating t-Bu substituent was significantly more 
activating compared to the phenyl group in both bromodesilylation (during catalyst activation) 
and transmetalation to gold(III). It was calculated to be approximately six times more reactive 
than the cyclisation substrate in the initial bromodesilylation, corresponding to an effective 
loading of 2.1 mol% (rather than 2.5 mol%) for the smallest quantity added. In contrast, the 
independently measured value for the phenyl-substituted trap suggests that it is not reactive 
enough to significantly affect the initial trap concentration (exclusively the substrate is 
brominated). 
 
Table 2.1. Relative rates for bromodesilylation (precatalyst activation) and transmetalation 
using Model A. 
 t-Bu Ph 2,6-Me 
kBr-T/kBr-S  6.0a 0.4b >50a 
kT/kS 2.93 0.96 2.14 



























(2,6-Dimethylphenyl)trimethylsilane 131 is an unusual case, due to its abnormally high 
reactivity in SEAr chemistry compared to other ortho-substituted silanes (see Section 2.1.2). 
Such is the increase in reactivity, the trap is able to outcompete the substrate during 
pre-catalyst activation even though it is present in much lower concentration (Table 2.1). As a 
result, the concentration-time profile for the trapping experiments differ markedly in 
appearance compared to the rest of the series (Figure 2.5).  
 
 
Figure 2.5. Concentration-time profile for trapping by 131. 
The reaction rate is entirely unaffected by addition of 2.5 mol% 131 as a result of the trap 
being fully consumed in pre-catalyst activation (a total of 4 mol% “Br+” must be sequestered). 
Increasing the trap loading to 5 mol% results in a straight-line plot with kobs = 5.9 × 10-5 s-1. 
This is consistent with rapid, but incomplete, trapping to remove a portion of the active catalyst 
(comparison of the gradients suggests an effective catalyst loading of approximately 1 mol%). 
As the initial trap concentration is increased further a more pronounced rate of stalling is 
observed, as sufficient trap survives pre-catalyst activation to fully sequester the catalyst. 
The slower rate of transmetalation for the 2,6-disubstituted silane (compared to the t-Bu 
substrate) is best explained by an additional adverse steric effect. Considering the 
aforementioned steric relief argument, and the electron donating capability of the methyl 



























beyond a certain point, the approach of the incoming gold(III) electrophile (which is relatively 
large) is sufficiently hindered by the substitution that the preceding π-complexation becomes 
kinetically significant (Scheme 2.17).  
 






2.5.2 Model B 
Arylsilanes 113, 132, 133, and 134, require a more complex description than the model in 
Scheme 2.16, as they are able to slowly react with the cyclised fluorene product to release the 
catalyst (Scheme 2.18).xi This renders the trapping somewhat reversible, though the rate of the 
intermolecular release reaction is calculated to be very slow in most cases. 
 
Scheme 2.18. Slow release of active catalyst by arylation of the trapped complex. 
A slight modification to the model allows this to be accounted for and can actually provide 
calculated rate constants for the intermolecular coupling (Model B, Scheme 2.19). As might 
be expected, the rate of arylation decreases markedly from 113 to 132 and is much less 
significant for 133 and 134 (Table 2.2). 
                                                     
xi The arylated fluorene products have not been isolated and are only generated in trace amounts, but 





Scheme 2.19. Visual schematic of Model B. 
 
 
Figure 2.6. Simulated fitting for trapping by 113 using model B. 
The calculated rate constants for this class of ortho-substituted arylsilane are summarised in 
Table 2.2. The reactivity in transmetalation across the series covers a relatively narrow range, 
which is expected on electronic grounds, but implies that the effect of steric acceleration does 
not dramatically increase as the size of the neighbouring substituent is varied from methyl to 
cyclohexyl. However, the fact that the t-Bu substituent is approximately twice as activating 
can probably be attributed to a more pronounced steric alleviation affect, as the additional 



























Table 2.2. Relative rates for bromodesilylation and transmetalation using Model B. 
 Me Et i-Pr Cy 
kBr-T/kBr-S  3.3a 3.6a 3.2a 3.1a 
kR (calculated) / dm3 mol-1 s-1 0.0040 0.0018 0.0008 0.0012 
kT/kS 1.23 1.54 1.34 1.31 
[a] Measured value. 
 
 
2.5.3 Different Silyl Groups 
Interestingly, arylsilanes 136, and 137, were also found to be capable of transmetalating to the 
gold catalyst. In the originally reported reaction screening, triethylarylsilanes were found to 
be unreactive, presumably unable to transmetalate under the reaction conditions.20 However, 
ortho-methylation appears to sufficiently activate these less reactive silyl groups, that it 
enables them to transmetalate at room temperature.  
 
 



























Triethylsilane 137 is significantly less reactive than the analogous trimethylsilane 113, and as 
a result has a notably different concentration-time profile for trapping (Figure 2.7). Much 
higher trap loadings are required to cause the reaction to stall, with ≤ 5 mol% resulting in only 
minor deviation from the uninhibited reaction. The calculated rates of transmetalation suggest 
that the trimethyl-substituent is approximately six times more reactive, with the 
dimethylethylsilyl-group falling somewhere in between (Table 2.3).   
 
Table 2.3. Relative rates for bromodesilylation and transmetalation of different silyl groups 
using Model B. 
 -SiMe3 -SiEtMe2 -SiEt3 
kBr-T/kBr-S (measured) 3.3a < 0.5b < 0.5b 
kT/kS 1.23 0.73 0.19 
[a] Measured value; [b] Calculated value. 
 
This order of reactivity is opposite to that expected based on the inductive electron releasing 
effects of the substituents at silicon (inductive effects should better stabilise the Wheland 
intermediate). Similar to the 2,6-disubstituted system, it is likely that the larger substituents on 
silicon hinder π-complexation of the gold(III) species to the aryl group, resulting in slower 
rates of transmetalation (Scheme 2.20).xii This trend in reactivity is in agreement with studies 
on protodesilylation in which silyl groups were found to decrease in reactivity in the following 
order: SiMe3 > SiEt3 > Si(n-Pr)3 > Si(i-Pr)3.21,22  
 
Scheme 2.20. Possible blocking effect by the ethyl groups of the triethylsilyl substituent. 
 
 
                                                     
xii The larger silyl groups could also be expected to influence solvation of the Wheland intermediate, as 
postulated by Eaborn.31 
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2.5.4 HPDMS Examples 
In intermolecular cross-coupling, the hydroxypropyldimethylsilyl group (HPDMS) was found 
to significantly accelerate the rate of transmetalation – estimated to be approximately 5 times 
faster than the trimethylsilyl analogue.2,23 This effect is attributed to pre-complexation of the 
catalyst, followed by an intramolecular delivery of the gold catalyst from the pendant alcohol 
of the silyl group (Scheme 2.21).  
 
Scheme 2.21. Intramolecular delivery of catalyst by HPDMS group. 
While the effect was assumed to be general across a range of substituted HPDMS reagents, 
ortho-substituted arylsilanes 138 and 139, exhibited a similar rate of transmetalation (within 
error) to the analogous trimethylsilyl- analogues when subjected to the same trapping 
experiment conditions (Figure 2.8 and 2.9).  
 
 
Figure 2.8. Comparison of trapping by trimethylsilane 135 and HPDMS silane 138. Filled 






























Figure 2.9. Comparison of trapping by trimethylsilane 133 and HPDMS silane 139. Filled 
circles (133); hollow circles (139). 
This demands that the effects governing rate acceleration in both cases (ortho-substitution and 
modified silyl reagents) are not additive in nature. It is possible that the presence of a large 
ortho-substituent hinders (or altogether prevents) the intramolecular delivery (Scheme 2.22). 
Alternatively, the ortho-effect may simply be dominant such that the pre-complexation no 
longer provides a noticable rate enhancement.  
 





























The kinetic profile of the reaction is highly sensitive to small changes in catalyst and trap 
concentration, and thus necessitates very careful preparation of samples using stock solutions 
(see Appendix C for a full discussion). Even with such precautions, a degree of error in the 
final calculated values can be expected, arising from slight inaccuracies in the starting 
concentrations used. The use of at least four individual sets of experimental data in the 
construction of each model helps to mitigate this, although a number of repeat experiments 
would offer a greater degree of certainty in the final values.  
The use of thtAuBr3, although convenient in its absence of induction period, poses a number 
of complications to analysis. Two bromide ligands must be lost during catalyst activation 
(formally as Br+), and in turn consume a small amount of arylsilane through bromodesilylation. 
This has an impact on the initial concentrations of substrate and ‘trap’, both of which may be 
brominated, and must be accounted for in the kinetic model.  
Analysis of trapping by 1,2-bis(trimethylsilyl)benzene (135) proved particularly problematic, 
with attempts to simulate experimental data using either model resulting in unsatisfactory fits. 
This indicates that the kinetic model does not provide a good description of the chemical 
system in this instance. Significant steric acceleration effects have been observed in 
protodesilylation studies for neighbouring trimethylsilyl- substituents,8 and therefore the 
amount of trap consumed during pre-catalyst activation is likely to be significant (similar to 
the 2,6-dimethyl-substituted case). The product of bromodesilylation (140), can likely also 
undergo transmetalation, leading to a complex three-way competition for the active catalyst 
(Scheme 2.23). Deconvolution of the system is non-trivial and an accurate determination of 





Scheme 2.23. Complex three component competition in the case of arylsilane trap 135. 
 
2.6 Summary 
Using a combination of in situ reaction monitoring and kinetic modelling, the rate of 
transmetalation for a series of ortho-substituted arylsilanes has been calculated. This method 
of analysis allows relative rate constants to be calculated even though the substrates of interest 
are unable to generate arylated products, and therefore offers an alternative protocol to 
conventional competition experiments.  
In contrast to the previously held perception that ortho-substituted arylsilanes are unreactive 
in gold catalysis, the transmetalation of arylsilanes to gold(III) has been found to be 
significantly accelerated by substitution at the ortho-position, an affect attributed to the 
alleviation of steric strain upon formation of the Wheland Intermediate. While it is difficult to 
fully separate steric and electronic contributions to the rate of transmetalation, it appears that 
a significant, and favourable, steric relief effect is observed for the entire series of 
ortho-substituents examined in this study.  
It had previously been thought that the gold-catalysed arylation and related reactions were 
limited to the use of aryltrimethylsilane reagents.24–27 However, it is now apparent that the 
presence of an ortho-substituent is able to ‘activate’ larger silyl groups to transmetalate to gold 
under ambient conditions. The o-tolyl derived arylsilanes were found to react less rapidly as 
the size of the alkyl groups at silicon was increased, possibly by obstructing the approach of 




2.7 Future Work 
2.7.1 Method Improvements 
The results discussed in this chapter offer a comprehensive but largely qualitative analysis of 
the transmetalation of ortho-substituted arylsilanes to gold(III). While the described method 
of kinetic analysis allows the accurate calculation of rate constants by competition, the 
complex nature of the gold-catalysed arylation reaction introduces a degree of uncertainty to 
the calculated rate constants. In light of this, the system could be vastly simplified by the 
identification of a pre-catalyst that does not consume any arylsilane reagent(s) during 
activation. As the reaction is known to be sensitive to the nature of the remaining anionic 
ligand following activation,11 future endeavours should perhaps focus on readily activated 
gold(I) bromide derived pre-catalysts (Figure 2.10). 
 
Figure 2.10. Potential gold(I) bromide pre-catalysts that could be easily activated by 
protonation or oxidation. 
In order to fully understand the limitations of the trapping-kinetic modelling approach to 
competition experiments, a comparison against an established, well-studied process would be 
valuable. This would provide an indication as to how the degree of error in the calculated 
values varies as a function of the number of experiments carried out (how many different 
concentrations are needed). Generating large volumes of kinetic data is time consuming 
(particularly with respect to analytical instrument use), and therefore performing the minimum 
number of experiments required to generate reliable data is an important consideration.  
 
 
2.7.2 Alternative Silyl Groups 
Silyl groups that were previously thought to be unable to transmetalate to gold(III) were found 
to be ‘activated’ by ortho-methylation. Though the rate of transmetalation was found to 
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decrease across the series in Figure 2.11, it remains unclear if this trend remains consistent for 
larger ortho-substituents. While approach of the gold(III) species may be hindered to some 
extent, the unfavourable steric interactions in the ground state could be expected to increase 
markedly. As a result, the order of reactivity may be significantly altered, perhaps even to the 
point that bulkier silyl groups react fastest.  
 
Figure 2.11. Potential reversal of reactivity for larger ortho-substituents. 
The demonstration that other silyl groups may be compatible coupling partners in gold 
catalysis is interesting for a number of reasons. Firstly, the synthesis of aryltrimethylsilanes 
typically necessitates the preparation of an organometallic reagent (usually an aryl lithium or 
Grignard), and subsequent reaction with trimethylsilyl choride.28,29 While this is a reliable and 
high yielding method, it restricts the number of functional groups that can be readily 
incorporated into the arylsilane.xiii There are comparably more synthetic methods that are able 
to introduce larger silyl groups, owing to the ease with which the corresponding silyl hydrides 
can be handled (HSiMe3 is a gas at room temperature), and which are often tolerable of a range 
of functional groups.30  
Secondly, the assumption that larger arylsilane groups are benign under the reaction conditions 
required for gold catalysis must be reconsidered if there is neighbouring substitution. 
Substrates that may have been considered as candidates for sequential couplings may suffer 
from a lack of regiocontrol as a result of unwanted C-Si auration (Scheme 2.24). 
                                                     
xiii Some palladium-32,33 and rhodium-34,35 catalysed methods for the synthesis of aryltrimethylsilanes 




Scheme 2.24. Potential selectivity issues caused by ortho-substitution of other silyl groups. 
 
2.7.3 Further Applications of Trapping-Kinetic Modelling Approach 
The design of suitable catalyst traps could allow interrogation of other steps in the catalytic 
cycle. For example, a reagent that selectively reacts with gold in oxidation state +1 could be 
used to probe the mechanism of Au(I)/Au(III) oxidation (Scheme 2.25); a process that is 
poorly understood in many gold-catalysed reactions.  
 




Conventional competition reactions between two electronically differentiated iodine(III) 
reagents are complicated by the possibility of equilibration between the oxidant species. This 
issue could be bypassed by a trapping-modelling method, provided that the trap was designed 
to only interact with the gold(I) intermediate. 
 
Scheme 2.26. Possible equilibration between iodine(III) reagents that complicates 
competition experiments. 
The modified competition experiment used in this work has thus far been exclusively applied 
to oxidative gold-catalysed direct arylation. However, other transition metal-catalysed 
processes could feasibly be treated by an analogous method. The use of a system that exhibited 
zero-order kinetics greatly simplified the analysis in this case, but in principle the reaction 
order is not important provided that it is incorporated into the kinetic model. The trap 
component must be designed such that it can only interact with the catalyst at one step of the 
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The results discussed in Chapter 2 demonstrate that even severely hindered arylsilane reagents 
can effectively transmetalate to the gold(III) catalyst species used in direct arylation. 
Interestingly, this suggests that intermolecular arylation of these reagents is inhibited at a 
different step of the catalytic cycle, for example π-complexation, C−H auration, or reductive 
elimination.  
The coupling of arylsilane 144 and mesitylene 145 occurs under standard reaction conditions, 
at room temperature, to afford the coupled product 146 in good yield (A, Scheme 3.1).1 In 
contrast, 2,6-disubstituted arylsilane 131 does not undergo any reaction with a variety of 
arenes, even at elevated temperatures or with increased catalyst loadings (B, Scheme 3.1).  
 
Scheme 3.1. Attempted arylation of 131 under typical reaction conditions. 
Both sets of reactions could be expected to proceed through similar arylgold(III) intermediates 
prior to reductive elimination (Figure 3.1), precluding this step as a reasonable explanation for 
the observed lack of reactivity. 
 
Figure 3.1. Hypothetical pre-reductive elimination structures for both coupling reactions 
(S = Silane; A = Arene). 
A conformational equilibrium that favours a perpendicular geometry of the aryl group can be 
expected on steric grounds for ortho-substituted ring systems, as has been inferred in 
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analogous square planar complexes of the M2+ group 10 metals (Scheme 3.2).2 The more 
sterically imposing the substituent, the further this equilibrium can be anticipated to be biased 
toward the perpendicular geometry (right), avoiding increasingly unfavourable steric clashes 
with the neighbouring ligands.   
 
Scheme 3.2. Conformational equilibrium for arylgold(III) species. 
Based on present understanding of the reaction mechanism, the turnover-limiting 
π-complexation of the arene coupling partner is proposed to occur via an associative pathway.3 
Evidence in support of this includes a significant negative entropy of activation  
(ΔS‡ = –26.5 ± 0.5 cal K-1 mol-1), first order dependence on the arene coupling partner, and the 
fact that the arylation step occurs at an electrophilic gold(III) centre (in contrast to gold(I)). 
Based on this information, and the conformational equilibrium described in Scheme 3.2, it is 
likely that ortho-substitution of the arylsilane would hinder π-complexation by blocking the 
approach of the incoming arene above and below the square planar species (Figure 3.2).  
 
Figure 3.2. Proposed blocking effect resulting from ortho-substitution of the arylsilane. 
The trend in reactivity for simple ortho-alkyl substituted arylsilanes is in agreement with this 
hypothesis, with decreasing rates of reaction observed across the series Me > Et > i-Pr 
(Scheme 3.3), and larger substituents completely preventing the coupling reaction (no reaction 
observed in the case of t-Bu). As the size of the neighbouring group increases, the population 
of catalyst in the conformation required for reaction is necessarily reduced according to the 





































3.2. Tethered Ligands  
3.2.1. Initial Results 
Considering the perpendicular geometry hypothesis described in Scheme 3.2, it follows that if 
the equilibrium could be artificially biased toward the reactive conformation, then the 
π-complexation event and subsequent bond formation should be more favourable. To this end, 
we hypothesised that the introduction of a Lewis basic moiety tethered to the arylsilane might 
be able to act as a chelating ligand and force the aryl group to adopt the planar geometry 
required for catalysis (Scheme 3.4).  
 
Scheme 3.4. Anticipated conformational control through chelation. 
Gold(III) complexes are generally considered to be highly oxophilic,4,5 and the methanol 
co-solvent of the reaction is known to act as a labile ligand at certain points in the catalytic 
cycle.3,6 Likewise, modification of the silyl group to incorporate a pendant alcohol was found 
to significantly affect the rate of transmetalation,7 presumably through pre-complexation of 
the catalyst (see Section 2.5.4). Therefore, anticipating that an oxygen-containing substituent 
might coordinate with sufficient strength to alter the conformation of the aromatic ring, 
arylsilanes 153a, 153b, and 153c, bearing a pendant alcohol, were synthesised to test this 
hypothesis (Scheme 3.5).xiv  
                                                     
xiv In Toste’s gold-catalysed oxyarylation using aryltrimethylsilanes, the only ortho-substituted silane 





Scheme 3.5. Reactivity of alcohol-containing silanes 153a, 153b, and 153c in arylation with 
2-bromothiophene. [silane] = [arene] = 0.1 M. 
In stark contrast to most ortho-alkyl substituted silanes, these reactants readily underwent 
intermolecular coupling with 2-bromothiophenexv at ambient temperature (Scheme 3.5). The 
length of the tether could be extended to at least three methylene units without a significant 
change in reactivity (extended tethers were not tested), although the reaction with 153b stalled 
at approximately 50% conversion. In the case of this substrate, it is possible that a competitive 
elimination to form a styrene might occur, resulting in an inactive off-cycle species 
(Scheme 3.6). Arylsilanes possessing tethers of different lengths (such as 153a and 153c) are 
                                                     
xv 2-Bromothiophene is a convenient arene to use in the arylation reaction due to its moderate reactivity 










unable to undergo an analogous elimination (formation of a conjugated alkene is not possible), 
offering an explanation as to why the reaction does not stall in those instances. 
 
Scheme 3.6. Plausible explanation for the observed stalling in the reaction with 153b. 
 
 





Increasing the molar equivalents of 2-bromothiophene prevented the reaction from stalling, 
resulting in increased reaction rates and complete consumption of the arylsilane (Figure 3.3). 
This would be consistent with a competing elimination prior to the second arylation event, 
whereby increasing the arene concentration prevents generation of the off-cycle species by 
increasing the rate of π-complexation.  
The stability and conformation of the required metallocycle likely governs the reactivity of the 
substrate in arylation, as arene π-complexation is known to be turnover limiting for 
intermolecular coupling (Scheme 3.7). The nature of the tether (coordinating strength of the 
group) and its size (length as well as steric presence) could both be expected to have a 
significant impact on the rate of reaction, affecting both the position of the 
metallocycle-forming equilibrium (Keq) and the rate of coordination of the incoming arene (kr). 
 
Scheme 3.7. Formation of a cyclometalated intermediate en route to arylation.  
Consistent with this, varying the degree of substitution on the tether had a profound impact on 





Scheme 3.8. Rate of coupling with 2-bromothiophene for arylsilanes 153c, 153p, 153q, 
153r. [silane] = [arene] = 0.1 M. 
The rate of arylation is dramatically suppressed for tertiary alcohol 153p, reaching only 10% 
conversion in 12 hours. Efficient coordination to the metal centre is perhaps prevented in this 
case, causing the reactivity to more closely relate to that of the alkyl-substituted silanes 
discussed in Chapter 2. 
Considering the prevalence of the Thorpe-Ingold effect in organic reactivity,8 the 
geminally-disubstituted methyl groups of silane 153q might be expected to favour formation 
of the desired metallocycle (Scheme 3.9). Surprisingly though, the rate of arylation in this case 






























improved, the conformation required for reactivity would likely direct the methyl substituents 
of the tether above and below the square planar arrangement. A blocking effect by these groups 
could explain the significant decrease in reactivity compared to the unsubstituted propanol 
tether (153c).  
 
Scheme 3.9. Anticipated rate acceleration via Thorpe-Ingold effect (K). 
In marked contrast to these examples, the rate of arylation of silane 153r is much closer to that 
of the unsubstituted linker, despite heavy substitution of the pendant chain. While the cause of 
this disparity in reactivity is not immediately clear, it is possible that the added substitution 
favours a metallocycle in which one face is left relatively accessible (Scheme 3.10). In both 
cases, accurately predicting the favoured conformation of the corresponding metallocycle is 
non-trivial given the ambiguity concerning bond lengths and angles at the gold-centre. 
 
Scheme 3.10. Plausible explanation for the observed difference in reactivity. 
 
 
3.2.2. Reactivity of Ether Tethers 
Methyl ether containing tethers were also found to promote the arylation reaction, with a 
significantly faster rate of product formation (Scheme 3.11). The increase in reactivity is such 






Scheme 3.11. Increased rate of arylation for methyl ether-containing substrate 153e. 
[silane] = [arene] = 0.1 M.  
Once protected as the methyl ether, the coordinating tether is only able to act as a neutral 2e- 
(L-type) ligand. In contrast, two modes of coordination could be envisaged for the free alcohol; 
either as an analogous neutral (L-type) donor, or as an anionic (X-type) alkoxide ligand 
(Scheme 3.12). The marked difference in reactivity between the two substrates suggests that 
the activating effect is most effective with a neutral donor, and that a contribution from the 
































Scheme 3.12. Possible modes of coordination for ether- and alcohol-containing tethers. 
Arylsilanes 153e and 153f were found to have similar rates of arylation, with the ethanol 
derived tether no longer suffering from the stalling effect that was observed for the free 
alcohols (Scheme 3.13). However, adding an additional methylene unit to the tether caused a 
severe drop in reactivity. 
 
 
Scheme 3.13. Effect of tether length on the reactivity of methyl ether substituents. 



























This is again attributed to the highly sensitive nature of the metal chelate, in which the direction 
of the terminal methyl group likely impacts both the stability and reactivity (Figure 3.4). While 
predicting the exact conformation of these intermediates is not straightforward, it is apparent 
that seemingly minor structural modifications to the arylsilane can have a profound impact on 




Figure 3.4. Plausible reason for decrease in reactivity with increasing tether length. 
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3.3. Preparative Arylation Reactions    
Having demonstrated that pendant alcohols (and their methyl ether derivatives) were capable 
of promoting the arylation reaction, we speculated that other heteroatom-containing functional 
groups might also facilitate arylation. Pleasingly, a range of potentially-coordinating 
ortho-substituted arylsilanes proved to be effective coupling partners (Scheme 3.14). 
Preformed HCIB was employed as a stoichiometric oxidant in place of IBDA to avoid 
liberation of AcOH (which can undergo complicating transesterification with alcohols). 
 
Scheme 3.14. Scope of the ortho-substituted arylsilane coupling partner. 1.0 mmol silane, 
1.0 mmol arene. [a] 2 equiv arene; [b] 0.5 mmol scale. 
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Arylsilanes possessing tethered alcohols could be cleanly arylated at room temperature, with 
a slight improvement in yield when employing an excess of the arene (153a-c). Interestingly, 
a triethylsilane analogue (153d) could be coupled under the reaction conditions, benefitting 
from the activating effect of ortho-substitution in transmetalation. The reaction profile almost 
perfectly overlays with the corresponding trimethylsilane, suggesting that the 
turnover-limiting step is the same in both cases (Figure 3.5). 
 
Figure 3.5. Comparison of reaction profiles for TMS and TES substrates. Reaction 
monitored by in situ NMR at 294 K. 
Methyl ethers proved suitable coordinating substituents (153e,f), as well as the more sterically 
imposing neopentyl ether (153g). Esters (153h,i), sulfur-containing functional groups (153j-l), 
and phosphine oxides (153m) could all be arylated in good yield. When two silyl groups are 
present in the substrate there is completely selective coupling at the ortho-substituted position; 
the alternative regioisomer could not be detected (153o).xvi 
                                                     
xvi Near complete regioselectivity for ortho-substituted arylsilanes has also been observed in other 































Scheme 3.15. Summary of ortho-substituted arylsilanes that could not be effectively 
arylated. 
A number of ortho-substituents proved unsuitable for use in the arylation reaction. 
Acid-sensitive functional groups, such as Boc-protected phenol derivative (153t), can undergo 
facile deprotection in the presence of sulfonic acids. Tertiary benzylic alcohol (153u) 
underwent rapid conversion to an unidentified, but catalytically unreactive by-product 
(presumably via dehydration). The dimethyloxazoline substituent (153v) was unable to 
promote the desired coupling reaction, resulting in complete recovery of starting material.  
Unlike the protected benzyl alcohols 153e and 153i, longer chained alcohol derivatives 153w 
and 153x, were either impractically slow or unreactive (more forcing conditions were not 
tested). 2,6-Disubstituted arylsilane 155a suffered from a reduced rate of reaction that was 




Scheme 3.16. Selection of arenes that can be used in the arylation reaction of 
ortho-substituted arylsilanes. 
The scope of arene partners that can be used appears to be similar to the original methodology 
(based on the limited selection tested),1 though tolerance for ortho-substitution of the arene 




3.3.1. 2,6-Disubstituted Arylsilanes 
The fact that 2,6-disubstituted arylsilane 155a undergoes a competing desilylation reaction is 
perhaps unsurprising given the known reactivity of these substrates in protodesilylation and 
related reactions (see Section 2.12). However, evidence that arylation was also possible 
suggested that modification of the arylsilane reagent or the reaction conditions might enable 
successful coupling. Suppression of the protodesilylation pathway, or acceleration of the 
desired arylation (or a combination of both), should lead to an increase in product yield. 
 
Scheme 3.17. Attempted arylation of 2,6-disubstituted arylsilanes.xvii 
                                                     
xvii NMR yields estimated based on the conversion of 2-bromothiophene using signal at δ = 6.61 ppm 
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Using the standard reaction conditions, the arylated product could be observed in 
approximately 30% yield (by 1H NMR), with the remaining arylsilane consumed by 
protodesilylation (Scheme 3.17). Removing the methanol co-solvent, anticipated to increase 
the rate of the desired arylation reaction, resulted in rapid protodesilylation (full consumption 
of arylsilane within 15 minutes). Replacing methanol with the less strongly coordinating 
trifluoroethanol, known to accelerate the rate of intermolecular arylation,9 again led to fast 
desilylation. It is possible that under these conditions complexation to the iodine(III) reagent 
occurs, activating the substrate to protodesilylation (Scheme 3.18). 
 
Scheme 3.18. Possible explanation for accelerated rate of desilylation in the absence of 
methanol. 
Protecting the alcohol as a pivaloyl ester successfully prevented the undesired desilylation of 
the substrate to any significant extent, but also prevented the arylation reaction (155b). We 
envisaged that protecting the alcohol as an acetate may prevent protodesilylation, but allow 
slow release of the alcohol to enable coupling to take place (Scheme 3.19). 
 
Scheme 3.19. Proposed slow release strategy to maintain a low concentration of 155a in 
solution. 
Unfortunately, this led to a decrease the yield of the arylated product (155c). The liberation of 
CSA throughout the course of the reaction accelerates the rate at which the deprotection 
occurs, resulting in accumulation of the free alcohol, and a significant amount of observed 
desilylation. Aryltriethylsilanes (Ar–SiEt3) are typically less reactive than their trimethyl 
counterparts in desilylative reactions, and are therefore slightly more stable under acidic 
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conditions.10,11 However, the use of triethylsilane 155d did not lead to any improvement in the 
arylation reaction. 
However, protecting the alcohol as a methyl ether proved effective (155e), facilitating the 
desired coupling while significantly suppressing the rate of protodesilylation. Performing the 
reaction on a preparative scale afforded the arylated product in 69% yield.xviii This represents 
a significant result given the complete lack of reactivity exhibited by other heavily substituted 
arylsilanes in direct arylation (Figure 3.6). 
 
Figure 3.6. Modification of arylsilane reagents to allow arylation of 2,6-disubstituted 
substrates at room temperature. 
 
  
                                                     




Arylsilanes bearing ortho-substitution were previously thought to be unreactive in 
gold-catalysed arylation, as well as in related reactions.12,13 While this may be true for simple 
alkyl substituents, we have identified that incorporation of a suitable coordinating group to the 
substrate can allow the desired reaction to proceed. A range of different functional groups are 
effective in this regard, and the arylated products can typically be obtained in good yield. Even 
the arylation of a severely hindered 2,6-dibsubstituted arylsilane could be enabled by 
incorporation of a pendant ether. 
 In contrast to the previously reported mechanistic study, in which the nature of the arylsilane 
reagent was found to have little impact on the rate of reaction,14 the relative reactivity of these 
substrates covers a broad range. This is attributed to the importance of a key intermediate of 
the catalytic cycle, in which formation of a metallocycle is required to generate a reactive 
conformation for arylation (Scheme 3.20). Based on this proposed intermediate, it is apparent 
that structural or electronic changes to the substrate can have a profound effect on the overall 
reactivity.  
 
Scheme 3.20. Adapted catalytic cycle to include the proposed conformational requirement 
prior to C−H auration. 
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Of all the functional groups tested, short-chained methyl ethers proved most effective, 
resulting in reliably high yields and fast rates of arylation. The compatibility of other 
ether-containing functional groups has not been examined in detail, and it is appreciated that 
the identification of a more readily cleaved alternative would be more synthetically useful 
(e.g., a −MOM protected alcohol).  
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3.5. Future Work 
3.5.1. Sequential Arylation 
Sequential couplings, carried out by the same or a different catalyst species, are an attractive 
method to construct multiple bonds in one step, provided that selectivity can be effectively 
controlled (Scheme 3.21).15–17 Avoiding the need to isolate and purify an intermediate can be 
a significant benefit to the processing time and cost of a synthesis, particularly on large-scale.  
 
Scheme 3.21. Typical method for sequential coupling using different leaving groups. 
Most sequential methods derive chemoselectivity from the use of leaving groups that possess 
intrinsically different reactivity,xix such as the aryl (pseudo)halides in palladium catalysis.18,19 
However, it is also possible to differentiate between identical leaving groups based on steric 
and/or electronic discrimination. For example, Langer and co-workers described a 
palladium-catalysed coupling in which two triflates were sequentially cross-coupled due to 
electron-withdrawing effects (Scheme 3.22).20  
 
Scheme 3.22. Langer’s sequential Suzuki-Miyaura coupling of electronically differentiated 
aryl triflates. 
Arylsilane 153o, which contains two (identical) competing silyl groups was found to undergo 
selective coupling at one site due to the activating effect of ortho-substitution (Scheme 3.23).  
 
                                                     
xix The use of different silyl groups to allow sequential coupling under palladium catalysis has been 




Scheme 3.23. Selectivity for ortho-substituted TMS group in arylation. 
This highlighted the potential for ortho-substituted silanes to be used in sequential couplings, 
with regioselectivity dictated by the degree of neighbouring substitution of both silyl groups. 
Stepwise addition of two arene coupling partners could then provide the required control over 
both arylation events, resulting in the formation of a single product (Scheme 3.24). 
 
 
Scheme 3.24. Proposed method for sequential arylation with selectivity governed by the 
reactivity of the silyl groups. 
In addition to discrimination between the two silyl groups at the transmetalation step, the 
incompatibility of ortho-substitution on both coupling partners offers the possibility of 
selectivity at the C−H auration step of the catalytic cycle (Scheme 3.25). Intermediate 167 is 
unable to undergo reaction with sterically hindered arenes and so will selectively react with 
the less substituted substrate, even if it is less electronically activated. Only during the second 
coupling, in which the arylsilane has no neighbouring substituent, will the arylation with the 




Scheme 3.25. Chemoselectivity derived from the incompatibility of ortho-substituents on 
both coupling partners. 
Therefore, it should be possible to perform a sequential coupling with all components present 
from the outset, to generate a single product with good control over selectivity (Scheme 3.26). 
 





3.5.2. Phosphine Ligand Synthesis 
Buchwald phosphine ligands, used either in a free unprotected form or as palladacycle based 
pre-catalysts, enjoy a prominent status in modern day cross-coupling.21 Noteworthy 
applications feature state-of-the-art methodologies for Suzuki-Miyaura,22,23 and Negishi 
cross-coupling reactions,24–27 Buchwald-Hartwig amination,28–32 amidation,33,34 and the 
cyanation,35–37 hydroxylation,38 and aminocarbonylation39 of aryl halides (Figure 3.7). Most of 
the ligands share a common biaryl scaffold, with key features that can be modified to tailor 
the reactivity of the metal complex to different applications.     
 
Figure 3.7. Overview of some applications of biaryl phosphine ligands in palladium 
catalysis. 
The ligands are most commonly synthesised in a one-pot procedure, combining an aryl 
Grignard, in situ generated benzyne, and chlorophosphine to generate the biaryl phosphine in 
moderate yield (Scheme 3.27).40 The products exhibit surprising air stability, and can typically 
be purified by routine recrystallisation. However, one caveat to this method is the requirement 
to introduce the second aryl group as an organolithium or Grignard reagent, limiting the choice 
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of functionalities that can be incorporated. In addition, the bis-alkyl chlorophosphine reagents 
used are often pyrophoric, necessitating careful handling under an inert atmosphere. 
 
Scheme 3.27. Established route for the synthesis of biaryl phosphine ligands. 
Phosphine oxide containing arylsilane 153m has been demonstrated to be a competent 
coupling partner in the gold-catalysed arylation reaction of 2-bromothiophene (Scheme 3.28). 
The product of coupling, if reduced to the free phosphine, contains the same basic scaffold as 
the aforementioned Buchwald ligands, but differs in that it contains a heteroarene as the second 
aryl unit.  
 
Scheme 3.28. Arylation of silane 153m to form biarylphosphine oxide 154m. 
Based on the established substrate scope of the gold-catalysed coupling, this aromatic group 
could be varied to incorporate a range of sterically and electronically diverse heteroarenes 
(Scheme 3.29). These may constitute a class of hemi-labile ligands with diverse properties and 
potential applications, able to coordinate to metals either through the π-system, or the lone 




Scheme 3.29. Proposed synthetic route to access a range of diverse phosphine ligands from 
one common starting material. 
While modifications to the common biaryl scaffold have been extensively examined, the 
incorporation of (substituted) heteroarenes into the ligand structure is less well studied 
(especially for alkyl phosphines).41–44 This is perhaps due to the required linear synthetic route 
that prevents facile diversification. In contrast, synthesis of a small number of arylsilane 
precursors could allow for rapid generation of an entirely novel phosphine ligand library.  
 
 
3.5.3. Chiral Biaryls 
The selective synthesis of atropisomerically pure biaryl compounds is a significant challenge 
in modern transition metal catalysis. As a common structural motif in natural products,45 active 
pharmaceutical ingredients,46–48 and in chiral ligand structures,49 a mild and general method 
for their synthesis is highly sought after.  
 




The most commonly utilised method in the literature relies on an asymmetric Suzuki-Miyaura 
cross-coupling, in which chirality is either transferred from the substrate (Path A or B) or from 
the catalyst (Path C) to form a single atropisomer as the product (Scheme 3.30).52,53  
 
Scheme 3.30. Different strategies to perform asymmetric Suzuki-Miyaura couplings. 
Chiral sulfoxides are an established class of ligand used to effect a variety of transition 
metal-catalysed asymmetric transformations.54,55 They can be reliably synthesised in a method 
pioneered by Andersen and co-workers, in which a sulfinyl chloride is reacted with a chiral 
alcohol to produce diastereomeric sulfinate esters; these can then be separated by 
crystallisation or chromatography. Treatment of one diastereomer with an organometallic 
reagent results in alkylation with inversion of stereochemistry to yield an enantiomerically 
pure sulfoxide (Scheme 3.31).56–59 
 
Scheme 3.31. Andersens’s method of chiral sulfoxide synthesis using an alcohol auxiliary. 
Aryl iodides containing a chiral sulfoxide auxiliary have been utilised by Colobert, Fernández, 
Khiar, and their respective co-workers, to enable a diastereoselective Suzuki-Miyaura 
coupling (Scheme 3.32).60 The axially chiral products can be obtained in good yield and 




Scheme 3.32. Asymmetric Suzuki-Miyaura coupling using a chiral sulfoxide auxiliary. 
The fact that arylsilane 153j is a competent coupling partner in gold-catalysed direct arylation 
provides an opportunity for the development of a complementary diastereoselective biaryl 
synthesis (Scheme 3.33). A room temperature coupling offers the possibility to synthesise 
biaryls that are more prone to thermal racemisation. Following arylation, the sulfoxide 
directing group can be removed or modified via established methods of lithium-sulfoxide 
exchange (Scheme 3.34).61–65  
 
Scheme 3.33. Arylation of 153j, containing an ortho-sulfoxide group.  
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The effective recovery and reuse of transition metal catalysts represents a longstanding 
challenge throughout applied industrial chemistry.1 Not only does the ability (or inability) to 
recycle a catalyst on large-scale have significant financial implications, but often purification 
requirements stipulate that levels of trace metal contaminants must fall within certain levels. 
This is particularly pertinent in the pharmaceutical industry, where regulatory bodies demand 
very tight control over the quantity of metals allowed in final active pharmaceutical ingredients 
(APIs). As a late transition metal, gold is subject to fairly strict regulations; FDA oral permitted 
daily exposure limit (PDE) = 100 mg/day.2 Therefore, for a gold-catalysed reaction to be 
amenable to industrial scale-up, there must be a method in place to ensure that the catalyst is 
effectively purified from the final product. 
The most convenient methods used in process chemistry to remove metal contaminants are 
recrystallisation, aqueous washing, and distillation.3–5 These processes tend to work relatively 
well for systems in which the metal is unlikely to be strongly bound to the product (compounds 
without coordinating functional groups). Unfortunately, the very nature of pharmaceutical 
compounds dictates that they are typically rich in heteroatoms, and therefore these methods of 
purification are often unsuccessful. Alternatively, residual metals can often be adsorbed onto 
activated charcoal6 or functionalised solid supports.7–9 In this case, additional filtration and 
washing sequences are required, and it is generally not possible to recover the catalyst. 
The field of heterogeneous catalysis represents another practical alternative.10–15 However, 
while much easier to separate following reaction, solid supported catalysts are typically 
associated with reduced rates of reaction, poorer selectivity, and potential catalyst leaching 
(leading to reduced catalyst loadings in subsequent reactions).16 
Due to the propensity for weakly ligated gold(I) complexes to decompose in solution, an 
additional problem arises in oxidative gold catalysis when the external oxidant is fully 
consumed. It is known that gold(I) complexes readily disproportionate to form colloidal gold,17 
which cannot be easily recovered at the end of reaction, and may pose a risk of contamination 
to the reaction vessel. One possible solution to this problem would be to capture the gold 
catalyst as a stable complex, which can be easily isolated and recycled at the end of each 
reaction. If this isolated complex could also be used as a suitable pre-catalyst, then the active 
gold catalyst could simply be reintroduced to a fresh coupling reaction. Ideally, this would be 
facilitated by addition of an otherwise benign reagent (in catalytic quantities) able to promote 






Scheme 4.1. The concept of ‘Catch and Release’ catalysis. 
This sequence of ‘Catch and Release’ seeks to amalgamate the established benefits of 
homogeneous (reaction rate, selectivity) and heterogeneous (purification, recyclability) 
catalysis (Scheme 4.1).18 In order to offer a viable alternative to current methods, the ‘catch’ 
step must be capable of removing the catalyst in an almost quantitative yield, such that the 
product is sufficiently purified of metal contaminants following treatment. Equally, the 
‘release’ step must be as efficient as possible to avoid diminished catalyst loadings in the 
subsequent reaction(s).  
Similar systems have been previously reported for other transition metal-catalysed reactions, 
typically involving separation by manipulating solubility in biphasic solutions,19–21 or by 
taking advantage of reversible adsorption to a solid support.22–24 Care must be taken to quantify 
the exact amount of catalyst that is activated and recovered in these systems, as the partial 





4.2. Ortho-Substituted Arylsilanes as Traps 
The rapid rates of catalyst transmetalation, coupled with the unreactive nature of the resulting 
arylgold(III) species, highlighted the potential for ortho-substituted arylsilanes to be used as 
catalyst ‘traps’ in a Catch and Release protocol. While arylsilanes containing methyl, ethyl, 
and iso-propyl substituents at the 2-position (113, 132, and 133) had been found to slowly 
couple intermolecularly with 2-bromothiophene, larger ortho-substituents were shown to be 
completely unreactive under the original reaction conditions (see Chapter 2). Having already 
established the relative transmetalating ability of these substrates in the liquid phase, we sought 
to identify a method by which the catalyst could be released and reused (Scheme 4.2). 
 
Scheme 4.2. Proposed “Catch and Release” sequence using ortho-substituted arylsilanes. 
Fuchita and co-workers were able to demonstrate in stoichiometric studies that arylgold(III) 
species 185, can undergo coupling with terminal alkynes to form diphenylacetylene products 
186 (Scheme 4.3).26 In contrast to the arylation reaction, in which an ortho-ethyl group 
severely reduces the rate of reaction, the alkynylation proceeds under fairly mild conditions 
(50 °C, 5 hours) to afford the coupled product in high yield. The linear geometry of the 
incoming alkyne nucleophile perhaps mitigates the steric hinderance to complexation, 
allowing coordination to occur despite the presence of an ortho-substituent. We therefore 
hypothesised that the addition of small, auraphillic nucleophiles may facilitate the coupling of 
the hindered gold(III) complexes and simultaneously allow the gold catalyst to be released. 
 
Scheme 4.3. Fuchita’s stoichiometric alkynylation of arylgold(III) complex 185. 
Ideally, any hypothetical release reaction would take place under the conditions required for 
arylation, and in the presence of the various reaction components. Therefore, to test the 
compatibility of various additives that may promote catalyst release, a trapping experiment 
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analogous to those in Chapter 2 was carried out, and different additives added to the stalled 
reaction after a given time. Should an additive successfully react to release the catalyst, then 
the reaction would simply restart, and formation of additional product would be detected 
(Scheme 4.4). Additives were selected based on perceived compatibility with the reaction 
conditions, and as a result the use of reductants or organometallic reagents was excluded due 
to the requirement for the oxidative and acidic components of the reaction. 
 




Figure 4.1. Structures of additives used in the attempted release reaction. 
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Table 4.1. Screening of additives in the attempted release of gold(III) from complex 187. 
Entry Additive / Conditions Comment Entry Additive / Conditions Comment 
1 -  a 26 193 (0.5 eq) b 
2 Under sunlight  a 27 Entry 7 + 190 (0.5 eq) b 
3 In darkness  a 28 Entry 7 + 191 (0.5 eq) b 
4 151 (0.5 eq) b 29 Entry 7 + 192 (0.5 eq) b 
5 151 (1.0 eq) b 30 Entry 7 + 193 (0.5 eq) b 
6 151 (5.0 eq) b 31 TFA (1.0 eq) b,c 
7 AgSbF6 (0.25 eq) b 32 TFA (5.0 eq) b,c 
8 As above + 151 (1.0 eq) b 33 NBS (0.25 eq) b,d 
9 AgPF6 (0.25 eq) b 34 NBS (0.5 eq) b,d 
10 As above + 151 (1.0 eq) b 35 NBS (1.0 eq) b,d 
11 AgBF4 (0.25 eq) b 36 Selectfluor (0.25 eq) b 
12 As above + 151 (1.0 eq) b 37 Selectfluor (0.5 eq) b 
13 Cu(OAc)2.H2O (0.5 eq) b 38 Selectfluor (1.0 eq) b 
14 CuI (0.5 eq) b 39 HCl in Et2O (0.5 eq) b,c 
15 CuCl (1.0 eq) b 40 HCl in Et2O (1.0 eq) b,c 
16 KF (0.25 eq) b 41 HCl in Et2O (5.0 eq) b,c 
17 PPh3 (1.0 eq) b 42 194 (0.25 eq) b,d 
18 DMSO (1.0 eq) b 43 194 (0.5 eq) b,d 
19 DMSO (5.0 eq) b 44 BnOH (1.0 eq) b 
20 TFE (5.0 eq) b 45 PhEtOH (1.0 eq) b 
21 188 (0.5 eq) b 46 195 (0.5 eq) b 
22 189 (0.5 eq) b 47 Entry 7 + 196 (0.5 eq) b 
23 190 (0.5 eq) b    
24 191 (0.5 eq) b    
25 192 (0.5 eq) b    
[a] Reaction stalled at 23% conversion; [b] No additional product formed after addition of 
additive; [c] Protodesilylation observed; [d] Bromodesilylation observed. 
 
In the absence of any additive, other than the trap, the reaction reliably stalled at 23%, as 
confirmed by 1H NMR spectroscopy. As expected based on the earlier trapping experiments, 
addition of an arene coupling partner (even in significant excess) failed to promote the release 
reaction (Entries 4 to 6). Silver salts are often used as additives in gold catalysis, proposed to 
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activate complexes via halide abstraction (Scheme 4.5).27–30 In this case however, addition of 
a number of silver salts, either alone or in combination with 2-bromothiophene, failed to 
promote a successful release reaction (Entries 7 to 12).  
 
Scheme 4.5. Proposed activation of the trapped gold(III) complex by silver-mediated halide 
abstraction. 
A range of metal salts were tested in an attempt to promote C−X reductive elimination 
(X = OAc, F, Cl, I), but were typically insoluble and proved ineffective (Entries 13 to 16).31 
Vasapollo and co-workers reported that Gold(III) phosphine complex 198 was found to 
undergo C−Br reductive elimination to form bromostyrene 199 at room temperature 
(Scheme 4.6).32 Addition of triphenylphosphine though failed to promote the analogous 
reaction in this instance (Entry 17). 
 
Scheme 4.6. Observation that complex 198 undergoes C−Br reductive elimination. 
Addition of co-solvents that were known to accelerate the intermolecular arylation reaction 
did not facilitate the desired release reaction (Entries 18 to 20).33 In addition to the alkynylation 
reported by Fuchita and co-workers (Scheme 4.6), a select number of alkene insertion 
reactions at gold(III) have been reported in the recent literature.34–37 However, the addition of 
a variety of alkenes under these reaction conditions proved unsuccessful, and evidence of 
polymerisation was often detected (Entries 21 to 30). Incorporation of an alcohol to the 
additive, anticipated to aid coordination to the metal catalyst, had no noticeable effect (Entries 
42 to 47).  
Protodeauration, of alkyl,38 alkenyl,39 and aryl groups,38 is a key step in many gold(I) catalysed 
reactions, though it is comparatively less common for gold(III) complexes.40 Addition of acids 
to the arylation reaction mixture failed to promote release of the catalyst species, even in large 
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excess, and resulted in significant protodesilylation of the substrate (Entries 31, 32, and 39 to 
41). 
Wang and co-workers reported an electrophilic halogenation of arenes in the presence of a 
gold(III) catalyst using N-halosuccinimides (Scheme 4.7).41 The mechanism is not clear 
however, and may involve Lewis Acid activation of the succinimide reagent rather than C-H 
auration. When electrophilic halogenating reagents were used in the attempted release 
reaction, halogenation of the trap could not be detected and bromodesilylation of the substrate 
was instead observed (Entries 33 to 38). 
 
Scheme 4.7. Wang’s electrophilic halogenation of simple aromatics in the presence of a 
gold(III) catalyst.  
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4.3. Restricted Rotation Traps 
Inspired by the results in Chapter 3, in which tethered alcohols were found to effectively 
coordinate to the metal centre, we hypothesised that incorporation of an alcohol to the bridging 
methylene unit of cyclisation substrates might prevent the intramolecular arylation from taking 
place (Scheme 4.8). Strong binding through the alcohol would prevent π-complexation of the 
aryl group (on conformational grounds) and therefore prevent the cyclisation. Breaking the 
coordination (e.g., by increasing the temperature) would then allow the required 
π-complexation to occur and the cyclisation would proceed with expulsion of the catalyst.  
 
Scheme 4.8. Proposed mechanism of “Catch and Release” using restricted rotation. 
The attempted use of arylsilane 204 as catalyst trap in the cyclisation reaction of 128 resulted 
in a significant reduction in the rate of reaction (ordinarily complete in <1000 seconds), but 






Scheme 4.9. Attempted trapping experiment with 5 mol% 204. 
The sigmoidal appearance of the reaction profile can be rationalised as follows. Initial 
competition for the catalyst results in deceleration of the reaction rate, until the resting state of 
the catalyst has shifted from the (usual) pre-reductive elimination species to the ‘trapped’ 
complex. Slow cyclisation of the trap allows the catalyst to turnover and re-enter the cycle. 
This process repeats until all of the trap is fully consumed, resulting in a gradual acceleration 
in rate throughout the latter part of the reaction (as the concentration of available trap 
decreases). 
The release process can be greatly accelerated by increasing the reaction temperature by 15 °C, 
























Figure 4.2. Trapping by 204 and attempted release by increasing temperature to 315 K. 
However, in order to act as a viable trap in a Catch and Release protocol, the release reaction 
must be controlled such that it does not take place to any appreciable degree during the “Catch” 
step. We hypothesised that the reactivity of the trap in the catalyst-releasing cyclisation 
reaction could be modulated by either lengthening the linker between the arenes, or 
incorporating electron-withdrawing substituents on the tethered arene (Scheme 4.10).  
 
Scheme 4.10. Modification of catalyst trap in order to alter the rate of the release reaction. 
This resulted in a similar rate of catalyst capture, but with the rate of catalyst release decreasing 
as a function of the electron-withdrawing capability of the substituent on the arene 
(Figure 4.3). The -CF3 substituent was sufficiently electron-withdrawing to entirely prevent 
the release reaction from taking place under the ambient reaction conditions. The lengthened 
tether of 207 led to a slightly accelerated rate of catalyst trapping, but did not prevent the 
























Figure 4.3. Kinetic profile of catalyst trapping and release with compounds 204 to 207 at 
300 K. 
 
Figure 4.4. Trapping by 206 (CF3) at 300 K and attempted release by increasing temperature 
to 315 K. 
Attempted thermal release however, proved unsuccessful using the same increase in 
temperature as previously (Figure 4.4). The temperature was not increased further owing to 
concern over the stability of the in situ formed oxidant, and therefore future efforts would 


















































The development of a suitable method for catalyst recovery is an important, but presently 
unsolved problem in oxidative gold catalysis. It is particularly pertinent in reactions such as 
direct arylation, which operate under nominally “ligand-free” conditions, as the stability of the 
related gold(I) species are generally poor. As discussed in the body of this chapter, the recovery 
of the catalyst is an issue that must be addressed if the reaction is to be amenable to large-scale 
industrial synthesis.   
The rapid rates of transmetalation of ortho-substituted arylsilanes, coupled with the highly 
stable nature of the resulting gold(III) complexes, suggested that these reagents may be 
suitable catalyst “traps” for use in a Catch and Release protocol. While much was known about 
the kinetic behaviour of the “Catch” step (detailed in Chapter 2), the possibility of a “Release” 
reaction had not been investigated. Unfortunately, we have not yet been able to identify a 
suitable method through which to release the gold(III) species under catalytically relevant 
conditions. This can likely be attributed to the high kinetic stability of the trapped complex, in 
addition to compatibility issues between the various additives tested and the other reaction 
components. 
An alternative method, involving intramolecular arylation substrates that had been modified 
to prevent cyclisation, was more promising. The reactivity of these traps in the “Release” 
reaction could be modulated by controlling the electronic properties of the tethered arene. 
A -CF3 substituted trap was found to form a stable trapped complex at room temperature, 
offering the possibility of a thermally triggered release of the catalyst. In order to test the 
higher temperatures required to promote this reaction, an alternative, more thermally stable 
oxidant would be needed.  
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4.5. Future Work 
4.5.1. Protected Alcohols as Catalyst Traps 
The contrasting reactivity of simple alkyl-substituted arylsilanes compared to those 
incorporating a tethered alcohol appealed as a potential opportunity for a catch and release 
manifold. Design of a chemical switch that allows trapping as an alkyl-substituted substrate, 
but coupling as a tethered alcohol, would provide the necessary control to trap and release the 
catalyst at will. While short-chain protected alcohols could undergo efficient arylation under 
typical reaction conditions, longer tethers were accompanied by a significant drop in reactivity. 
For example, pivalyl-protected alcohol 208 was effectively unreactive in the attempted 
coupling with 2-bromothiophene (Scheme 4.11).  
 
Scheme 4.11. Unsuccessful coupling of pivaloyl-protected alcohol 208 in arylation. 
Identification of a protecting group that is tolerant of the reaction conditions, but can be 
selectively cleaved by addition of a suitable reagent, would allow facile interconversion 
between the trapped and reactive species (Scheme 4.12).   
 





Figure 4.13. Stability of protecting groups under relevant acidic conditions.   
While an acetate ester was slowly cleaved in the presence of CSA at room temperature, 
Piv- and THP-protected alcohols exhibited impressive stability, showcasing their potential as 
protecting groups to use in the Catch and Release sequence (Scheme 4.13). A successful 
release reaction would require the identification of a selective deprotection reaction to trigger 
controlled release of the free alcohol. To this end, photolabile protecting groups might offer a 



























4.5.2. Metallocycle Expansion 
As discussed in Chapter 2, (o-biphenyl)trimethylsilane 118 is known to undergo reaction with 
the active gold catalyst used in arylation to form the stable metallocycle 119 (Scheme 4.14).44 
The reductive elimination to form biphenylene, 120, does not occur at room temperature,xx 
presumably due to the high energetic barrier associated with  the introduction of such 
significant bond strain.45 As a result, the metallocycle is a stable, long-lived species, and has 
even been demonstrated to be a competent Lewis Acid catalyst for a multitude of 
transformations.46 
 
Scheme 4.14. Formation of stable metallocycle XX via sequential C-Si and C-H auration. 
While classical migratory insertion reactions at gold(III) are uncommon, this elementary step 
is currently the focus of much attention in the field.34 Development of a suitable insertion 
reaction in this case would result in a metallocycle ring expansion (Scheme 4.15). The 
energetic barrier to reductive elimination could be expected to be significantly lowered, 
perhaps allowing cyclisation to occur.  
  
Scheme 4.15. Release reaction enabled by a hypothetical (CO) migratory insertion. 
This sequence could allow a catch and release method to be developed, relying on the 
straightforward introduction of a gaseous reagent (e.g., carbon monoxide) to promote the 
release of an active gold species. 
  
                                                     
xx The (reverse) oxidative addition into the C-C bond of biphenylene has been demonstrated to be 
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5 Experimental  
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5.1 General Experimental Details 
5.1.1 Techniques 
Procedures that involve the use of air- and/or moisture-sensitive reagents were performed in 
anhydrous solvents, using standard inert-atmosphere techniques under an atmosphere of N2 
(unless otherwise stated). Where necessary, solvents were degassed following a 
freeze-pump-thaw sequence for a minimum of 3 cycles. Room temperature (rt) typically 
fluctuated between 18 – 25 °C depending on the season and time of day. Reaction temperatures 
were controlled using a Heidolph MR Hei-Standard stirrer hotplate equipped with Teflon 
coated thermocouple.  
 
5.1.2 Reagents and Solvents 
Reaction solvents tetrahydrofuran (THF) (unstabilised, HPLC grade; Sigma-Aldrich), diethyl 
ether (Et2O) (EtOH stabilised, HPLC grade; VWR), toluene (HPLC grade; Fisher), and 
dichloromethane (CH2Cl2) (unstabilised, HPLC grade; Fisher) were dried by percolation 
through columns packed with neutral alumina under a positive pressure of argon. Reaction 
solvents chloroform (CHCl3) (amylene stabilised, HPLC grade; Sigma-Aldrich) and   
chloroform-d (CDCl3) (99.8 atom % D; Sigma-Aldrich) were passed through a short plug of 
basic activated alumina (Al2O3; Brockman I) and held over 3 Å molecular sieves under N2, in 
the dark and used within one month. Trimethylsilyl chloride was distilled over calcium hydride 
(CaH2) prior to use and stored under an atmosphere of N2 at 0 °C. Other silyl chlorides were 
purchased and used as received unless otherwise stated. Gold(III) bromide (99%, 99.9% Au) 
was purchased from STREM chemicals and used as received. Unless otherwise stated, 
reagents were purchased from Sigma-Aldrich, Fluorochem, VWR, Apollo Scientific, Fisher 
Scientific, or Alpha Aesar, and used without additional purification.  
 
5.1.3 Chromatography 
Analytical thin-layer chromatography was performed on pre-coated aluminum-backed plates 
(Silica Gel 60 F254; Merck) or pre-coated glass-backed plates (Silica Gel 60 F254; Merck), 
and visualised under ultraviolet (UV) light (254 nm). Where appropriate, plates were treated 
with aqueous basic potassium permanganate, ethanolic phosphomolybdic acid, or vanillin 
stains. Preparative thin-layer chromatography (PTLC) was performed on pre-coated, 
analytical aluminium-backed plates (Silica Gel 60 F254; Merck) or glass-backed plates (Silica 
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Gel 60 F254; Merck). Flash column chromatography was performed using Geduran® Silica 
Gel 60 (40-63 µm; Merck).  
 
5.1.4 Analysis 
5.1.4.1 NMR Spectroscopy 
All NMR spectra were acquired using a Bruker Avance III+ 400 MHz spectrometer. 1H, 
13C{1H}, 19F, and 31P{1H} NMR spectra were acquired at 400, 100, 376, and 162 MHz 
respectively. Unless otherwise stated, NMR spectra were acquired at 300 K (27 °C). 1H and 
13C{1H} NMR spectra were referenced to residual and bulk solvent signals respectively; 
chemical shifts are reported in parts per million (ppm) relative to residual chloroform (CHCl3, 
δH 7.26 ppm; CDCl3, δC 77.16 ppm) or methanol (CH3OH, δH 3.31 ppm; CD3OD, δC 49.00 
ppm). 19F and 31P NMR spectra are reported in ppm relative to external standards. Coupling 
constants (J) were calculated using MestreNova v9.0 software and are reported to the nearest 
0.1 Hz. The following abbreviations (and their combinations) are used to denote signal 
multiplicities: s (singlet), d (doublet), t (triplet), q (quartet), p (pentet), m (multiplet), app 
(apparent) and br (broad). Quantitative 19F NMR were recorded using 1,3,5-trifluorobenzene 
as an internal standard (δF −107.48 ppm in CDCl3). 
 
5.1.4.2 IR Spectroscopy 
Infrared (IR) absorption spectra of neat compounds were recorded over the range 4000 – 400 
cm-1 using a Bruker Alpha FT-IR spectrometer equipped with a Bruker Platinum Quicksnap 
(diamond cell) attachment. Peaks are reported in cm-1 with relative intensities denoted by the 
following abbreviations (and their combinations): s (strong, 0–33% T), m (medium, 34–66% 
T), w (weak, 67–100% T), and br (broad).  
 
5.1.4.3 Mass Spectrometry 





5.1.4.4 Melting Points 
Melting points (mp) were determined using a Griffin capillary melting point apparatus using 
open 100 mm soda glass capillary tubes and are reported uncorrected. 
 
5.1.5 Kinetic Modelling and Simulations 






5.2 Reaction Monitoring 
5.2.1 Standard in situ NMR Reaction Monitoring Procedure  
The requisite arylsilane (0.10 mmol) was weighed into a 7 mL screw-capped vial. CDCl3 
(1 mL), MeOD-d4 (20 μL), thtAuBr3 (0.002 mmol, 2 mol%, from a 0.01 M stock solution), 
and the requisite arene (0.10 mmol) were added and the resulting solution transferred to a 
standard borosilicate NMR tube. The sample was injected into the spectrometer; locked, 
shimmed, and tuned, before a (t = 0) spectrum was acquired. Once the appearance of this initial 
spectrum was deemed suitable the sample was ejected from the spectrometer and the contents 
of the tube poured into a 7 mL screw-capped vial containing HCIB (58.8 mg, 0.13 mmol). The 
mixture was shaken until visibly homogenous (typically < 5 seconds) then returned to the 
NMR tube, and again injected into the spectrometer. Spectra were acquired at regular intervals 
as required depending on the rate of reaction. 
For 1H NMR experiments, CH2Br2 was typically employed as an internal standard. In some 
cases (as specified) a mixture of IBDA (41.9 mg, 0.13 mmol) and CSA (34.8 mg, 0.15 mmol) 
was used in place of HCIB. 
Note: The time of the first data point was measured (by stopwatch) from the point of mixing to 
the midpoint of the first NMR experiment. 
 
5.2.2 Standard Reaction Monitoring Procedure  
The requisite arylsilane (0.10 mmol) was weighed into a 7 mL screw-capped vial. CDCl3 
(1 mL), MeOD-d4 (20 μL), thtAuBr3 (0.002 mmol, 2 mol%, from a 0.01 M stock solution), 
and the requisite arene (0.10 mmol) were added and the resulting solution transferred to a 
standard borosilicate NMR tube. The sample was injected into the spectrometer and a spectrum 
acquired using the automation interface. The sample was ejected from the spectrometer and 
the contents of the tube poured into a 7 mL screw-capped vial containing HCIB (58.8 mg, 0.13 
mmol). The mixture was shaken until visibly homogenous (typically < 5 seconds) then 
returned to the NMR tube, and spectra acquired at regular intervals. The sample was ejected 
from the spectrometer between experiments, allowing for multiple reactions to be performed 
in parallel. The spectrometer was housed in a room in which the ambient temperature, and 
therefore reaction temperature, was controlled (at 294 K). 
Note: The time of the first data point was measured (by stopwatch) from the point of mixing to 




5.2.3 Sample Preparation for Trapping Experiments 
A 500 μL aliquot of Stock Solution A; containing the arylsilane substrate (0.10 mmol), 
MeOD-d4 (20 μL), CH2Br2 (0.10 mmol), and thtAuBr3 (0.002 mmol, 2 mol%) in CDCl3, was 
transferred to a 7 mL screw-capped vial. The arylsilane trap (X mol%) was added, by weight, 
from a 0.025 M stock solution in CDCl3 (Stock Solution B). The reaction volume was made 
up to 1 mL with additional CDCl3, added via syringe. This sample was then analysed according 
to the Standard in situ Reaction Monitoring Procedure. 
Stock solutions were prepared fresh and used within 12 hours to avoid ingress of moisture. 
Note: The exact concentration of arylsilane trap was calculated based on the mass of stock 




5.3 General Procedures 
5.3.1 Procedure A 
The requisite arylsilane (1.00 mmol) was weighed into a 30 mL screw-capped vial equipped 
with magnetic stirrer bar. CHCl3 (10 mL), MeOH (0.2 mL), thtAuBr3 (10.5 mg, 0.02 mmol, 
2 mol%), and the requisite arene (1.00 mmol) were added and stirring commenced. HCIB 
(588 mg, 1.30 mmol) was added in one portion, a screw cap fitted, and the reaction stirred at 
room temperature for the length of time indicated. The crude reaction mixture was then dry-
loaded on to silica and purified by column chromatography as described in each case. 
 
5.3.2 Procedure B 
The requisite arylsilane (0.50 mmol) was weighed into a 30 mL screw-capped vial equipped 
with magnetic stirrer bar. CHCl3 (5 mL), MeOH (0.1 mL), thtAuBr3 (5.3 mg, 0.01 mmol, 
2 mol%), and the requisite arene (0.50 mmol) were added and stirring commenced. HCIB 
(294 mg, 0.65 mmol) was added in one portion, a screw cap fitted, and the reaction stirred at 
room temperature for the length of time indicated. The crude reaction mixture was then dry-
loaded on to silica and purified by column chromatography as described in each case. 
 
5.3.3 Procedure C 
The requisite arylsilane (0.10 mmol) was weighed into a 7 mL screw-capped vial equipped 
with magnetic stirrer bar. CHCl3 (1 mL), MeOH (20 μL), thtAuBr3 (0.002 mmol, 2 mol%, 
from a stock solution), and the requisite arene (0.10 mmol) were added and stirring 
commenced. HCIB (58.8 mg, 0.13 mmol) was added in one portion, a screw cap fitted, and 
the reaction stirred at room temperature for 72 hours. The volatiles were removed under 
reduced pressure, and the residue purified by preparative TLC using the elution solvent 
indicated in each case.  
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5.4 Synthetic Procedures 
thtAuBr3,1 1-tert-butyl-2-iodobenzene,2 HPDMS-Cl,1 and HCIB,3 were synthesised according 
to literature procedures. 
 (2-Methylphenyl)trimethylsilane (113) and 2-(trimethylsilyl)phenol were prepared and 
characterised by Dr Liam Ball as previously reported.4,5 
 
5.4.1 Arylsilanes 




To a nitrogen filled, flame-dried Schlenk flask was added 1-bromo-3-chlorobenzene (3.26 g, 
17.0 mmol) along with dry THF (40 mL). The solution was cooled to −78 °C and 
n-butyllithium (2.38 M in hexanes, 8.00 mL, 19.0 mmol) was added dropwise over 15 minutes. 
The mixture was stirred at −78 °C for a further 60 mins, then 2-bromobenzaldehyde (2.50 mL, 
21.5 mmol) was added via syringe. The flask was removed from the cold bath and allowed to 
return to room temperature overnight. Water (25 mL) was added to quench any remaining 
organolithium species, and the aqueous layer extracted with Et2O (3 × 30 mL). The combined 
organic extracts were dried over MgSO4, concentrated under reduced pressure to afford a 
highly viscous, pale yellow oil (crude mass = 3.74 g). Triethylsilane (4.0 mL, 25.0 mmol) was 
added dropwise, then the mixture was cooled to 0 °C and trifluoroacetic acid (15 mL) was 
added dropwise. The resulting solution was stirred at this temperature for 1 hour, then stirred 
at room temperature overnight. The remaining trifluoroacetic acid was removed under a rapid 
stream of nitrogen, and the resulting oil purified by column chromatography (eluent: hexanes) 
to afford the title compound as a pale yellow oil (3.03 g, 63%). 
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1H NMR (400 MHz, CDCl3): δ 7.58 (dd, J = 7.9, 1.3 Hz, 1H), 7.31 – 7.04 (m, 7H), 4.10 (s, 
2H). 
13C NMR (100 MHz, CDCl3): δ 141.5, 139.5, 134.3, 133.0, 131.1, 129.7, 129.0, 128.2, 127.6, 
127.2, 126.5, 124.9, 41.4. 
νmax(neat)/cm-1: 2919 (w), 2817 (w), 1595 (w), 1573 (w), 1557 (w), 1539 (w), 1505 (w), 1471 
(m), 1429 (w), 1379 (w), 1190 (w), 1091 (w), 1078 (w), 1046 (w), 1024 (w), 976 (w), 932 (w), 
876 (w), 797 (w), 774 (m), 751 (m), 728 (w), 682 (w), 659 (w), 435 (w). 
1H and 13C NMR data are consistent with those reported in the literature.6 
 
[2-(3-Chlorobenzyl)phenyl]trimethylsilane (126) 
To a nitrogen filled, flame-dried Schlenk flask was added 1-bromo-2-(3-chlorobenzyl)benzene  
(3.03 g, 10.75 mmol) along with dry THF (25 mL). The solution was cooled to −78 °C and 
n-butyllithium (2.38 M in hexanes, 5.75 mL, 11.95 mmol) was added dropwise over 15 
minutes. The mixture was stirred at –78 °C for a further 60 mins, then trimethylsilylchloride 
(2.00 mL, 15.75 mmol) was added via syringe. The flask was removed from the cold bath and 
allowed to return to room temperature overnight. Water (30 mL) was added to quench any 
remaining organolithium species, and the aqueous layer extracted with Et2O (3 × 30 mL). The 
combined organic extracts were dried over MgSO4, concentrated under reduced pressure, and 
purified by column chromatography (eluent: hexanes) to afford the title compound as a clear, 
colourless oil (2.03 g, 69%). 
1H NMR (400 MHz, CDCl3): δ 7.57 (dd, J = 7.3, 1.5 Hz, 1H), 7.35 – 7.18 (m, 4H), 7.12 – 
7.09 (m, 1H), 7.04 – 6.96 (m, 2H), 4.16 (s, 2H), 0.33 (s, 9H). 
13C NMR (100 MHz, CDCl3): δ 145.3, 143.7, 139.1, 134.8, 134.4, 130.0, 129.7, 129.6, 129.3, 
127.4, 126.4, 125.9, 41.4, 0.5. 
νmax(neat)/cm-1: 2953 (w), 2896 (w), 1596 (w), 1573 (w), 1474 (w), 1429 (w), 1262 (w), 1249 
(m), 1186 (w), 1122 (w), 1092 (w), 1077 (w), 834 (s), 774 (m), 754 (m), 728 (m), 685 (m), 
622 (w), 565 (w), 437 (w). 






To an N2-purged, flame-dried 250 mL RBF was added bromobenzene (3.37 mL, 32.0 mmol) 
along with dry THF (80 mL). The solution was cooled to −78 °C and n-butyllithium (2.15 M 
in hexanes, 16.30 mL, 35.0 mmol) was added dropwise over 30 minutes. The mixture was 
stirred at −78 °C for a further 30 mins, then 2-bromobenzaldehyde (4.70 mL, 40.0 mmol) was 
added via syringe. The flask was removed from the cold bath and allowed to return to room 
temperature overnight. Water (40 mL) was added to quench any remaining organolithium 
species, and the aqueous layer extracted with Et2O (3 × 40 mL). The combined organic extracts 
were dried over MgSO4, concentrated under reduced pressure, and purified by column 
chromatography (eluent: 9:1 hexanes/EtOAc)to afford the title compound as a highly viscous, 
pale yellow oil (5.45 g, 65%). 
1H NMR (400 MHz, CDCl3): δ 7.59 (dd, J = 7.8, 1.8 Hz, 1H), 7.54 (dd, J = 8.0, 1.2 Hz, 1H), 
7.43 – 7.25 (m, 6H), 7.15 (ddd, J = 8.0, 7.4, 1.7 Hz, 1H), 6.20 (d, J = 3.8 Hz, 1H), 2.39 (d, J = 
3.9 Hz, 1H). 
13C NMR (100 MHz, CDCl3): δ 142.7, 142.3, 133.0, 129.3, 128.6, 128.6, 127.9, 127.9, 127.2, 
123.0, 74.9. 
νmax(neat)/cm-1: 3335 (br w), 1493 (w), 1465 (w), 1455 (w), 1436 (w), 1396 (w), 1182 (w), 
1012 (m), 748 (m), 719 (w), 697 (m), 681 (w), 643 (w), 619 (w), 600 (w), 562 (w). 
1H and 13C NMR data are consistent with those reported in the literature.6 
 
1-Benzyl-2-bromobenzene (214) 
Triethylsilane (4.48 mL, 28.0 mmol) was added dropwise to a 250 mL RBF containing 
(2-bromophenyl)(phenyl)methanol (3.70 g, 14.0 mmol) and CH2Cl2 (30 mL). The mixture was 
cooled to 0 °C and trifluoroacetic acid (4.3 mL) was added dropwise. The resulting solution 
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was stirred at this temperature for 3 hours, then allowed to return to room temperature. The 
trifluoroacetic acid was removed under a rapid stream of nitrogen, and the resulting oil purified 
by column chromatography (eluent: hexanes) to afford the title compound as a pale yellow oil 
(3.30 g, 95%). 
1H NMR (400 MHz, CDCl3): δ 7.57 (dd, J = 7.9, 1.3 Hz, 1H), 7.34 − 7.06 (m, 8H), 4.13 (s, 
2H). 
13C NMR (100 MHz, CDCl3): δ 140.5, 139.6, 133.0, 131.2, 129.1, 128.6, 128.6, 128.0, 127.6, 
126.4, 125.1, 41.9. 
νmax(neat)/cm-1: 1494 (w), 1473 (w), 1464 (w), 1453 (w), 1437 (m), 1073 (w), 1045 (w), 1024 
(m), 743 (m), 717 (m), 695 (m), 659 (w), 610 (w), 562 (w), 459 (w), 437 (w). 
1H and 13C NMR data are consistent with those reported in the literature.6 
 
[2-Benzylphenyl]trimethylsilane (128) 
To a nitrogen filled, flame-dried Schlenk flask was added 1-bromo-2-(benzyl)benzene  
(3.30 g, 13.35 mmol) along with dry THF (35 mL). The solution was cooled to −78 °C and 
n-butyllithium (2.15 M in hexanes, 8.37 mL, 18.0 mmol) was added dropwise over 15 minutes. 
The mixture was stirred at −78 °C for a further 60 mins, then trimethylsilylchloride (2.54 mL, 
20.0 mmol) was added via syringe. The flask was removed from the cold bath and allowed to 
return to room temperature overnight. Water (20 mL) was added to quench any remaining 
organolithium species, and the aqueous layer extracted with Et2O (3 × 20 mL). The combined 
organic extracts were dried over MgSO4, concentrated under reduced pressure, and purified 
by column chromatography (eluent: hexanes) to afford the title compound as a colourless oil 
(3.05 g, 95%). 
1H NMR (400 MHz, CDCl3): δ 7.58 (dd, J = 7.4, 1.6 Hz, 1H), 7.35 – 7.28 (m, 3H), 7.27 – 
7.20 (m, 2H), 7.16 – 7.11 (m, 2H), 7.06 – 7.02 (m, 1H), 4.20 (s, 2H), 0.35 (s, 9H). 
13C NMR (100 MHz, CDCl3): δ 146.4, 141.6, 139.0, 134.7, 130.0, 129.5, 129.3, 128.5, 126.1, 
125.6, 41.8, 0.5. 
νmax(neat)/cm-1: 3058 (w), 3026 (w), 2952 (w), 2897 (w), 1587 (w), 1494 (w), 1465 (w), 1452 
(w), 1435 (w), 1248 (m), 1122 (w), 1073 (w), 1030 (w), 833 (s), 743 (m), 725 (m), 696 (m), 
622 (w), 563 (w), 439 (w). 









To a nitrogen filled, flame-dried Schlenk flask was added 1-bromo-2-ethylbenzene 
(1.87 mL, 13.5 mmol) followed by dry THF (30 mL). The solution was cooled to −78 °C and 
n-butyllithium (2.15 M in hexanes, 7.0 mL, 15.0 mmol) was added dropwise over 15 minutes. 
The mixture was stirred at −78 °C for a further 60 mins, then trimethylsilylchloride (2.54 mL, 
20.0 mmol) added via syringe. The flask was removed from the cold bath and allowed to return 
to room temperature overnight (approximately 14 hours). Water (15 mL) was added to quench 
any remaining organolithium species, and the aqueous layer extracted with Et2O (3 × 20 mL). 
The combined organic extracts were dried over MgSO4, concentrated under reduced pressure, 
and purified by column chromatography (eluent: hexanes) to afford the title compound as a 
clear, colourless oil (2.28 g, 95%). 
1H (400 MHz, CDCl3): δ 7.48 (dd, J =7.4, 1.3 Hz, 1H), 7.34 (app. td, J = 7.5, 1.5 Hz, 1H), 
7.24 (m, 1H), 7.18 (app. td, J = 7.5, 1.3 Hz, 1H), 2.79 (q, J = 7.5 Hz, 2H), 1.27 (t, J = 7.5 Hz, 
3H), 0.35 (s, 9H). 
13C (100 MHz, CDCl3): δ 150.2, 138.0, 134.6, 129.5, 128.1, 125.1, 29.2, 16.6, 0.6. 
νmax(neat)/cm-1: 2962 (w), 2897 (w), 2873 (w), 1470 (w), 1453 (w), 1430 (w), 1248 (m), 1128 
(w), 1084 (w), 1061 (w), 833 (s), 794 (m), 751 (m), 726 (w), 687 (w), 673 (w), 621 (w), 569 
(w), 456 (w), 420 (w). 






To a nitrogen filled, flame-dried Schlenk flask was added 1-iodo-2-isopropylbenzene 
(0.81 mL, 5.0 mmol) followed by dry THF (10 mL). The solution was cooled to −78 °C and 
n-butyllithium (1.52 M in hexanes, 6.58 mL, 10.0 mmol) was added dropwise over 15 minutes. 
The mixture was stirred at −78 °C for a further 30 mins, then trimethylsilylchloride (1.91 mL, 
15.0 mmol) added via syringe. The flask was removed from the cold bath and allowed to return 
to room temperature overnight. Water (10 mL) was added to quench any remaining 
organolithium species, and the aqueous layer extracted with Et2O (3 × 20 mL). The combined 
organic extracts were dried over MgSO4, concentrated under reduced pressure, and purified 
by column chromatography (eluent: hexanes) to afford the title compound as a clear, colourless 
oil (0.39 g, 41%). 
1H (400 MHz, CDCl3): δ 7.46 (dd, J = 7.3, 1.4 Hz, 1H), 7.38 – 7.30 (m, 2H), 7.20 – 7.15 (m, 
1H), 3.17 (hept, J = 6.7 Hz, 1H), 1.27 (d, J = 6.9 Hz, 6H), 0.34 (s, 9H). 
13C (100 MHz, CDCl3): δ 155.2, 137.4, 134.4, 129.7, 125.3, 125.3, 33.9, 24.8, 0.6. 
νmax(neat)/cm-1: 2959 (w), 2868 (w), 1473 (w), 1458 (w), 1430 (w), 1248 (m), 1116 (w), 1068 
(w), 834 (s), 761 (m), 728 (m), 687 (w), 676 (w), 621 (w), 547 (w), 460 (w). 







n-Butyllithium (2.15 M in hexanes, 2.33 mL, 5.0 mmol) was added to a flame-dried Schlenk 
flask which had been evacuated and backfilled with nitrogen 4 times. The solution was cooled 
to −78 °C and diluted with dry THF (3.0 mL). In a separate flame-dried flask, 
2-tert-butyliodobenzene (0.65 g, 2.5 mmol) was dissolved in dry THF (2.5 mL) and then 
transferred dropwise by cannula to the solution of BuLi over approximately 20 minutes. 
Additional THF (approx. 1 mL) was used to transfer any residual iodoarene. The solution was 
stirred at −78 °C for 45 mins and then trimethylsilylchloride (1.90 mL, 15.0 mmol) was added 
in one portion. The mixture was allowed to return to room temperature overnight (approx. 14 
hours) and then quenched by cautious addition of H2O (10 mL). Additional Et2O (10 mL) was 
added and the two phases separated before the aqueous layer was extracted with Et2O (3 × 15 
mL). The combined organic extracts were dried over MgSO4 and concentrated in vaccuo. The 
crude oil was purified by column chromatography (eluent: hexanes) to afford the title 
compound as a clear, colourless oil (215 mg, 42%). 
Note: Attempts to synthesise the compound by addition of BuLi to the iodoarene resulted in 
consistent formation of material contaminated with 1-butyl-2-tert-butylbenzene which was 
inseparable from the desired compound by chromatography and fractional distillation. 
1H NMR (400 MHz, CDCl3): δ 7.74 (dd, J = 7.5, 1.6 Hz, 1H), 7.49 (dd, J = 8.0, 1.3 Hz, 1H), 
7.35 – 7.28 (m, 1H), 7.20 (app. td, J = 7.4, 1.3 Hz), 1.44 (s, 9H), 0.45 (s, 9H). 
13C NMR (100 MHz, CDCl3): δ 156.8, 137.9, 137.1, 128.7, 125.6, 124.9, 37.0, 33.0, 4.2. 
νmax(neat)/cm-1: 3287 (br, w), 2952 (w), 2895 (w), 1434 (w), 1407 (w), 1247 (m), 1200 (w), 
1125 (w), 1078 (w), 1010 (w), 834 (s), 743 (m), 728 (m), 687 (m), 622 (m), 604 (w), 460 (w), 
429 (w). 







To a nitrogen filled, flame-dried Schlenk flask was added 2-bromobiphenyl (1.0 mL, 
5.80 mmol) along with dry THF (15 mL). The solution was cooled to −78 °C and 
n-butyllithium (2.38 M in hexanes, 2.75 mL, 6.50 mmol) was added dropwise over 15 minutes. 
The mixture was stirred at −78 °C for a further 60 mins, then trimethylsilylchloride (0.90 mL, 
7.00 mmol) added via syringe. The flask was removed from the cold bath and allowed to return 
to room temperature overnight. Water (15 mL) was added to quench any remaining 
organolithium species, and the aqueous layer extracted with Et2O (3 × 20 mL). The combined 
organic extracts were dried over MgSO4, concentrated under reduced pressure, and purified 
by column chromatography (eluent: hexanes) to afford the title compound as a clear, colourless 
oil (0.98 g, 75%). 
1H NMR (400 MHz, CDCl3): δ 7.77 (m, 1H), 7.56 – 7.35 (m, 8H), 0.16 (s, 9H). 
13C NMR (100 MHz, CDCl3): δ 149.4, 144.6, 138.6, 134.8, 129.6, 129.5, 128.6, 127.8, 127.2, 
126.4, 0.7. 
νmax(neat)/cm
-1: 2952 (w), 1557 (w), 1540 (w), 1507 (w), 1463 (w), 1442 (w), 1425 (w), 1247 
(m), 1122 (w), 1087 (w), 1072 (w), 1008 (w), 834 (s), 750 (m), 728 (m), 701 (m), 622 (w), 
553 (w), 459(w). 







To a nitrogen filled, flame-dried Schlenk flask was added 1-bromo-2-cyclohexylbenzene (0.46 
mL, 2.5 mmol) along with dry THF (6 mL). The solution was cooled to −78 °C and 
n-butyllithium (2.15 M in hexanes, 2.3 mL, 5.0 mmol) was added dropwise over 15 minutes. 
The mixture was stirred at −78 °C for a further 60 mins, then trimethylsilylchloride (0.96 mL, 
7.5 mmol) added via syringe. The flask was removed from the cold bath and allowed to return 
to room temperature overnight. Water (10 mL) was added to quench any remaining 
organolithium species, and the aqueous layer extracted with Et2O (3 × 20 mL). The combined 
organic extracts were dried over MgSO4, concentrated under reduced pressure, and purified 
by column chromatography (eluent: hexanes) to afford the title compound as a clear, colourless 
oil (401 mg, 69%). 
1H NMR (400 MHz, CDCl3): δ 7.45 (ddd, J = 7.5, 1.6, 0.6 Hz, 1H), 7.34 (app. td, J = 7.4, 1.5 
Hz, 1H), 7.27 (m, 1H), 7.16 (app. td, J = 7.3, 1.4 Hz, 1H), 2.73 (tt, J = 11.7, 3.2 Hz, 1H), 1.92 
– 1.72 (m, 5H), 1.52 – 1.24 (m, 6H), 0.33 (s, 9H). 
13C NMR (100 MHz, CDCl3): δ 154.2, 137.7, 134.5, 129.5, 126.0, 125.3, 44.8, 35.0, 27.2, 
26.3, 0.6. 
νmax(neat)/cm-1: 2924 (m), 2850 (w), 1472 (w), 1447 (w), 1247 (m), 1115 (w), 1062 (w), 995 
(w), 833 (s), 756 (m), 727 (m), 688 (w), 620 (w), 539 (w), 459 (w). 







To a nitrogen filled, flame-dried Schlenk flask was added 1-bromo-2,6-dimethylbenzene 
(0.99 mL, 7.5 mmol) followed by dry, degassed THF (20 mL) and trimethylsilylchloride (3.79 
mL, 30.0 mmol). The solution was cooled to −78 °C and n-butyllithium (8.05 mL, 18.8 mmol, 
2.33 M in hexanes) was added dropwise over 30 minutes. The flask was allowed to gradually 
return to room temperature overnight (approximately 14 hours). Water (15 mL) was added to 
quench any remaining organolithium species, and the aqueous layer extracted with Et2O 
(3 × 20 mL). The combined organic extracts were dried over MgSO4, concentrated under 
reduced pressure, and purified by column chromatography (eluent: hexanes) to afford the title 
compound as a colourless oil (234 mg, 18%) along with an amount of recovered 
1-bromo-2,6-dimethylbenzene (530 mg, 38%). 
Note: Attempts to synthesise the compound by addition of BuLi to the bromoarene resulted in 
consistent formation of material contaminated with 2-butyl-1,3-dimethylbenzene which was 
inseparable from the desired compound by chromatography and fractional distillation. 
1H (400 MHz, CDCl3): δ 7.13 (t, J = 7.6 Hz, 1H), 6.97 (d, J = 7.6 Hz, 2H), 2.45 (s, 6H), 0.40 
(s, 9H). 
13C (100 MHz, CDCl3): δ 144.3, 136.9, 128.9, 128.2, 25.0, 3.7. 
νmax(neat)/cm-1: 2952 (w), 2898 (w), 1586 (w), 1443 (w), 1400 (w), 1377 (w), 1325 (w), 1250 
(m), 1130 (w), 1059 (w), 1026 (w), 835 (m), 765 (m), 714 (m), 680 (w), 638 (m). 







A 25 mL RBF fitted with a stirrer bar and rubber septum was flame-dried, then purged with 
N2 through an inlet needle. 2-Bromotoluene (0.60 mL, 5.0 mmol) and dry THF (12 mL) were 
added via syringe and the stirred solution cooled to −78 °C in an acetone-dry ice bath. BuLi 
(2.5 M, 2.4 mL, 6.0 mmol) was added dropwise over 10 minutes, then the solution stirred for 
an additional 30 minutes at −78 °C. Chloro(dimethyl)ethylsilane (0.75 mL, 7.0 mmol) was 
added in one portion, and the reaction mixture allowed to return to room temperature 
overnight. After 14 hours, H2O (10 mL) and Et2O (10 mL) were added, the layers separated, 
and the aqueous phase extracted with Et2O (3 × 10 mL). The combined organic extracts were 
dried over MgSO4, concentrated under reduced pressure, and purified by column 
chromatography (eluent: hexanes) to afford the title compound as a clear, colourless oil (0.60 
g, 68%). 
1H NMR (400 MHz, CDCl3): δ 7.46 (d, J = 7.0 Hz, 1H), 7.30 – 7.23 (m, 1H), 7.20 – 7.12 (m, 
2H), 2.46 (s, 3H), 1.00 – 0.93 (m, 3H), 0.87 – 0.78 (m, 2H), 0.32 (s, 6H). 
13C NMR (100 MHz, CDCl3): δ 143.8, 137.6, 134.8, 129.9, 129.2, 125.0, 23.2, 7.9, 7.7, -2.2. 
νmax(neat)/cm-1: 2953 (w), 2911 (w), 2873 (w), 1507 (w), 1471 (w), 1456 (w), 1435 (w), 1417 
(w), 1248 (m), 1127 (w), 1078 (w), 1008 (w), 957 (w), 817 (m), 798 (w), 773 (m), 739 (m), 
719 (w), 696 (m), 667 (w), 607 (w), 438 (w). 







A Schlenk tube equipped with magnetic stirrer bar was flame-dried, then evacuated and 
backfilled with N2 three times. 2-Bromotoluene (0.65 mL, 5.0 mmol) and THF (12 mL) were 
added sequentially via syringe, stirring commenced, and the temperature adjusted to –78 °C 
in an acetone-dry ice bath. n-Butyllithium (2.5 M in hexanes, 3 mL, 7.5 mmol) was added 
dropwise over approximately 15 mins, then the mixture stirred at –78 °C for a further 30 mins. 
Triethylsilyl chloride (1.65 mL, 10.0 mmol) was added in one portion and the reaction allowed 
to return to room temperature overnight. After 13 hours the reaction was quenched by the 
addition of H2O (10 mL) and extracted into Et2O (3 × 10 mL). The combined organic extracts 
were dried over MgSO4, and the solvent removed under reduced pressure. The residue was 
purified by column chromatography (eluent: hexanes) to afford the title compound as a clear, 
colourless oil (0.84 g, 81%). 
1H NMR (400 MHz, CDCl3): δ 7.47 – 7.42 (m, 1H), 7.31 – 7.23 (m, 1H), 7.20 – 7.12 (m, 
2H), 2.44 (s, 3H), 0.99 – 0.92 (m, 9H), 0.90 – 0.82 (m, 6H).  
13C NMR (100 MHz, CDCl3): δ 144.0, 135.6, 135.5, 129.9, 129.1, 124.9, 23.2, 7.7, 4.2. 
νmax(neat)/cm
-1: 2952 (m), 2909 (w), 2873 (w), 1456 (w), 1436 (w), 1417 (w), 1236 (w), 1127 
(w), 1077 (w), 1002 (m), 970 (w), 802 (w), 722 (m), 709 (m), 669 (w), 600 (w), 586 (w), 442 
(w), 419 (w). 







To a nitrogen filled, flame-dried, three-necked RBF (fitted with thermometer, suba seal, and 
connected to manifold) was added 1,2-dibromobenzene (1.20 mL, 10.0 mmol) along with dry 
THF (15 mL). The solution was cooled to –110 °C in an ethanol/liquid nitrogen bath and 
n-butyllithium (2.08 M in hexanes, 5.30 mL, 11.0 mmol) was added dropwise over 60 minutes. 
The mixture was stirred at –110 °C for a further 30 mins, then trimethylsilyltriflate (2.20 mL, 
12.0 mmol) was added slowly via syringe such that the temperature remained below –100 °C. 
The flask was allowed to slowly return to room temperature overnight. Water (10 mL) was 
added to quench any remaining organolithium species, and the aqueous layer extracted with 
Et2O (3 × 20 mL). The combined organic extracts were dried over MgSO4, concentrated under 
reduced pressure, and purified by column chromatography (eluent: hexanes) to afford the title 
compound as a colourless oil (1.88 g, 82%). 
Note: Effective control of the internal reaction temperature is crucial, with poor control 
resulting in significantly diminished product yields. 
1H NMR (400 MHz, CDCl3): δ 7.55 (dd, J = 7.8, 1.2 Hz, 1H), 7.46 (dd, J = 7.5, 1.9 Hz), 7.30 
(m, 1H), 7.22 (app. td, J = 7.5, 1.9 Hz), 0.42 (s, 9H). 
13C NMR (100 MHz, CDCl3): δ 141.1, 136.1, 132.7, 130.7, 130.6, 126.4, 0.6. 
νmax(neat)/cm-1: 3056 (w), 2953 (w), 2897 (w), 1578 (w), 1553 (w), 1450 (w), 1418 (w), 1406 
(w), 1248 (m), 1123 (m), 1103 (w), 1038 (w), 1019 (m), 836 (s), 743 (s), 708 (m), 690 (w), 
648 (w), 620 (w), 433 (w). 
1H and 13C NMR data are consistent with those reported in the literature.5 
 
1,2-Bis(trimethylsilyl)benzene (135) 
To a nitrogen filled, flame-dried Schlenk flask was added (2-bromophenyl)trimethylsilane 
(0.72 g, 3.1 mmol) along with dry, degassed THF (10 mL). The solution was cooled to −78 °C 
and n-butyllithium (2.33 M in hexanes, 1.50 mL, 3.5 mmol) was added dropwise over 15 
minutes. The mixture was stirred at −78 °C for a further 45 mins, then trimethylsilylchloride 
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(0.51 mL, 4.0 mmol) added via syringe in one portion. The flask was removed from the cold 
bath and allowed to return to room temperature overnight. H2O (10 mL) was added, the layers 
separated, and the aqueous phase extracted with Et2O (3 × 20 mL). The combined organic 
extracts were dried over MgSO4, concentrated under reduced pressure, and purified by column 
chromatography (eluent: hexanes) to afford the title compound as a clear, colourless oil (0.49 
g, 71%). 
1H NMR (400 MHz, CDCl3): δ 7.70 (dd, J = 5.6, 3.3 Hz, 2H), 7.35 (dd, J = 5.6, 3.3 Hz, 2H), 
0.40 (s, 18H). 
13C NMR (100 MHz, CDCl3): δ 146.1, 135.2, 127.8, 1.9.  
νmax(neat)/cm-1: 3044 (w), 2951 (w), 2898 (w), 1449 (w), 1410 (w), 1264 (w), 1247 (m), 1119 
(w), 1054 (w), 1039 (w), 831 (s), 753 (m), 735 (m), 682 (m), 658 (w), 620 (w), 439 (w). 





A 250 mL RBF fitted with a stirrer bar and rubber septum was flame-dried, then purged with 
N2 through an inlet needle. 4-Fluoro-2-methylbromobenzene (3.34 mL, 26.5 mmol) and dry 
THF (60 mL) were added via syringe and the stirred solution cooled to −78 °C in an 
acetone-dry ice bath. n-Butyllithium (2.5 M in hexanes, 12.0 mL, 30.0 mmol) was added 
dropwise over 30 minutes, then the solution stirred for an additional 45 minutes at −78 °C. 
Trimethylsilyl chloride (4.19 mL, 33.0 mmol) was added in one portion, and the reaction 
mixture allowed to return to room temperature overnight. After 14 hours, H2O (50 mL) and 
Et2O (50 mL) were added, the layers separated, and the aqueous phase extracted with Et2O (3 
× 50 mL). The combined organic extracts were dried over MgSO4, concentrated under reduced 
pressure, and purified by column chromatography (eluent: hexanes) to afford the title 
compound as a clear, colourless oil (4.59 g, 95%). 
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1H NMR (400 MHz, CDCl3): δ 7.45 – 7.36 (app t, J = 7.3 Hz, 1H), 6.92 – 6.84 (m, 2H), 2.46 
(s, 3H), 0.32 (s, 9H). 
13C NMR (100 MHz, CDCl3): δ 163.8 (d, J = 247.4 Hz), 146.4 (d, J = 7.1 Hz), 136.2 (d, J = 
7.6 Hz), 134.0 (d, J = 3.5 Hz), 116.8 (d, J = 19.3 Hz), 111.8 (d, J = 19.0 Hz), 23.1 (d, J = 2.0 
Hz), 0.0. 
19F NMR (375 MHz, CDCl3): δ −113.48 (m) 
νmax(neat)/cm-1: 2956 (w), 1578 (m), 1482 (w), 1248 (m), 1221 (m), 1068 (m), 949 (m), 834 
(s), 757 (m), 706 (w), 477 (w), 445 (w). 





To a nitrogen filled, flame-dried Schlenk flask was added (2-bromophenyl)trimethylsilane 
(0.72 g, 3.1 mmol) along with dry, degassed THF (10 mL). The solution was cooled to −78 °C 
and n-butyllithium (2.33 M in hexanes, 1.50 mL, 3.5 mmol) was added dropwise over 15 
minutes. The mixture was stirred at −78 °C for a further 45 mins, then HPDMSCl (0.91 mL, 
0.84 g, 3.75 mmol) added via syringe in one portion. The flask was removed from the cold 
bath and allowed to return to room temperature overnight (ca. 14 hours). The volatiles were 
removed under vacuum, then the remaining residue dissolved in methanol (10 mL) and K2CO3 
(1.24 g, 9.0 mmol) added. The mixture was stirred for 4 hours, by which time the reaction 
appeared complete by TLC (eluent: 3:1 hexanes/EtOAc). Water (25 mL) and EtOAc (30 mL) 
were added and the layers separated, then the aqueous phase extracted with EtOAc 
(3 × 30 mL). The combined organic extracts were washed with brine, dried over MgSO4, and 
concentrated in vacuo. The resulting oil was purified by column chromatography (eluent: 3:1 
hexanes/EtOAc) to afford the title compound as a pale yellow oil (241 mg, 29%). 
1H NMR (400 MHz, CDCl3): δ 7.66 (m, 2H), 7.32 (m, 2H), 3.60 (t, J = 6.8 Hz, 2H), 1.58 (m, 
2H), 0.83 (m, 2H), 0.38 (s, 6H), 0.37 (s, 9H). 
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13C NMR (100 MHz, CDCl3): δ 146.4, 144.8, 135.5, 135.5, 128.0, 127.9, 65.9, 27.6, 13.3, 
2.2, 0.2. 
νmax(neat)/cm-1: 3305 (br), 2948 (w), 1263 (w), 1247 (m), 1118 (w), 1053 (m), 1039 (w), 1011 
(w), 832 (m), 737 (m), 682 (m), 659 (w), 621 (w). 





To a nitrogen filled, flame-dried Schlenk flask was added 1-iodo-2-iso-propylbenzene (0.50 
mL, 3.1 mmol) along with dry, degassed THF (10 mL). The solution was cooled to −78 °C 
and n-butyllithium (2.33 M in hexanes, 1.50 mL, 3.5 mmol) was added dropwise over 15 
minutes. The mixture was stirred at −78 °C for a further 45 mins, then HPDMSCl (0.91 mL, 
0.84 g, 3.75 mmol) added via syringe in one portion. The flask was removed from the cold 
bath and allowed to return to room temperature overnight (ca. 14 hours). The volatiles were 
removed under vacuum, then the remaining residue dissolved in methanol (10 mL) and K2CO3 
(1.24 g, 9.0 mmol) added. The mixture was stirred for 4 hours, by which time the reaction 
appeared complete by TLC (eluent: 3:1 hexanes/EtOAc). Water (25 mL) and EtOAc (30 mL) 
were added and the layers separated, then the aqueous phase extracted with EtOAc (3 × 30 
mL). The combined organic extracts were washed with brine, dried over MgSO4, and 
concentrated in vacuo. The resulting oil was purified by column chromatography (eluent: 3:1 
hexanes/EtOAc) to afford the title compound as a pale yellow oil (105 mg, 14%). 
1H NMR (400 MHz, CDCl3): δ 7.42 (d, J = 7.4 Hz, 1H), 7.39 – 7.28 (m, 2H), 7.16 (app. td, 
J = 7.2, 1.5 Hz, 1H), 3.60 (t, J = 6.8 Hz, 2H), 3.11 (hept, J = 6.8 Hz, 1H), 1.65 – 1.50 (m, 2H), 
1.32 – 1.19 (m, 7H), 0.86 – 0.77 (m, 2H), 0.34 (s, 6H). 
13C NMR (100 MHz, CDCl3): δ 155.2, 135.8, 134.6, 129.6, 125.2, 125.2, 65.8, 33.8, 27.5, 
24.7, 12.3, −1.3. 
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νmax(neat)/cm-1: 3311 (br), 2960 (w), 2929 (w), 2868 (w), 1474 (w), 1458 (w), 1432 (w), 1415 
(w),1383 (w), 1362 (w), 1249 (w), 1117 (w), 1065 (w), 1052 (w), 1029 (w), 1011 (w), 863 
(w), 832 (m), 813 (m), 764 (m), 730 (m), 704 (w), 685 (w), 630 (w), 548 (w), 461 (w). 








Note: The NBS catalysed silylation reaction was based on a literature procedure.9 
2-Bromobenzyl alcohol (1.87 g, 10.0 mmol) was added to a flame-dried, N2-purged 100 mL 
RBF containing a magnetic stirrer bar, and fitted with a rubber septum and inlet needle. MeCN 
(25 mL) was added via syringe, followed by hexamethyldisilazane (HMDS, 1.47 mL, 7.0 
mmol). The resulting solution was stirred for 15 mins at room temperature, then N-
bromosuccinimide (NBS, 90 mg, 0.5 mmol) added in one portion. The temperature was 
adjusted to 50 °C and stirring maintained for a further 2 hours. The reaction mixture was then 
concentrated under reduced pressure, diluted with hexane (10 mL), and washed through a short 
plug of silica. The resulting solution was then concentrated in vacuo, and the crude oil 
transferred to a second flame-dried, N2-purged 100 mL RBF (again fitted with a septum and 
inlet needle). THF (20 mL) was added, and the solution cooled to −78 °C in an acetone-dry 
ice bath. n-Butyllithium (1.6 M in hexanes, 6.9 mL, 11.0 mmol) was added by syringe over 
approximately 15 minutes, and the solution allowed to return to room temperature overnight. 
After 14 hours, the mixture was quenched by the addition of H2O (10 mL) and extracted into 
Et2O (3 × 20 mL). The combined organic extracts were dried over MgSO4, concentrated in 
vacuo, and the resulting crude oil purified by column chromatography (eluent: 4:1 
hexanes/EtOAc) to afford the title compound as a viscous, colourless oil (1.44 g, 86%). 
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1H NMR (400 MHz, CDCl3): δ 7.54 (dd, J = 7.5, 1.2 Hz, 1H), 7.47 (ddd, J = 7.6, 1.3, 0.6 Hz, 
1H), 7.40 (app. td, J = 7.5, 1.5 Hz, 1H), 7.29 (app. td, J = 7.4, 1.4 Hz, 1H), 4.78 (d, J = 5.2 Hz, 
2H), 0.35 (s, 9H). 
13C NMR (100 MHz, CDCl3): δ 146.6, 138.6, 135.2, 130.0, 128.2, 127.5, 65.9, 0.8. 
νmax(neat)/cm-1: 3287 (w, br), 2952 (w), 2895 (w), 1434 (w), 1407 (w), 1247 (m), 1200 (m), 
1125 (w), 1078 (w), 1010 (w), 834 (s), 743 (m), 728 (m), 687 (m), 622 (m), 604 (w), 460 (w), 
429 (w). 





Note: The NBS catalysed silylation reaction was based on a literature procedure.9 
2-Bromophenethyl alcohol (5.0 g, 24.9 mmol) was added to a flame-dried, N2-purged 250 mL 
RBF equipped with a magnetic stirrer bar, and fitted with a rubber septum and inlet needle. 
MeCN (60 mL) was added via syringe, followed by hexamethyldisilazane (HMDS, 3.65 mL, 
17.4 mmol). The resulting solution was stirred for 10 mins at room temperature, then 
N-bromosuccinimide (NBS, 220 mg, 1.3 mmol, 5 mol%) added in one portion. The 
temperature was adjusted to 50 °C and stirring maintained for a further 2 hours. The reaction 
mixture was then concentrated under reduced pressure, diluted with hexane (30 mL), and 
washed through a short plug of silica. The resulting solution was then concentrated in vacuo, 
and the crude oil transferred to a second flame-dried, N2-purged, 250 mL RBF (again fitted 
with a septum and inlet needle). THF (40 mL) was added, and the solution cooled to −78 °C 
in an acetone-dry ice bath. n-Butyllithium (1.6 M in hexanes, 14.0 mL, 22.5 mmol) was added 
by syringe over approximately 15 minutes, and the solution stirred at this temperature for 1 
hour. Trimethylsilyl chloride (3.2 mL, 25.0 mmol) was then added via syringe and the reaction 
mixture allowed to return to room temperature overnight. After 14 hours, the mixture was 
quenched by the addition of H2O (20 mL), and extracted into Et2O (3 × 30 mL). The combined 
organic extracts were washed with HCl (0.1 M, 25 mL), then H2O (25 mL), dried over MgSO4, 
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concentrated in vacuo, and the resulting crude oil purified by column chromatography (eluent: 
9:1 hexanes/EtOAc) to afford the title compound as a viscous, colourless oil (3.14 g, 65%). 
1H NMR (400 MHz, CDCl3): δ 7.51 (dd, J = 7.5, 1.2 Hz, 1H), 7.33 (app. td, J = 7.5, 1.4 Hz, 
1H), 7.23 (m, 2H), 3.87 (m, 2H), 3.02 (t, J = 7.1 Hz, 2H), 1.41 (t, J = 5.7 Hz, 1H), 0.35 (s, 
9H). 
13C NMR (100 MHz, CDCl3): δ 143.9, 139.3, 135.1, 129.4, 129.2, 125.9, 64.3, 39.3, 0.7. 
νmax(neat)/cm-1: 3327 (br, w), 2952 (w), 2894 (w), 1471 (w), 1429 (w), 1248 (m), 1124 (w), 
1079 (w), 1040 (m), 833 (s), 751 (m), 726 (m), 687 (m), 621 (m), 579 (w), 456 (w), 422 (w). 




3-(2-Bromophenyl)propionic acid (216) 
Prepared according to the following modified literature procedure:12 
A 250 mL RBF equipped with a stirrer bar and rubber septum was flame-dried then evacuated 
and backfilled with N2 four times. 2,4,4-Trimethyl-2-oxazoline (4.5 mL, 35.0 mmol) and THF 
(100 mL) were added via syringe, and the stirred solution cooled to −78 °C in a dry ice-acetone 
bath. n-Butyllithium (2.15 M in hexanes, 16.3 mL, 35.0 mmol) was added dropwise over 30 
minutes, and the mixture stirred for a further 30 minutes at −78 °C. 2-Bromobenzyl bromide 
(8.7 g, 35.0 mmol) was added in one portion via syringe and the solution warmed to room 
temperature over 2 hours. H2O (5 mL) was added to quench any remaining organolithium 
reagent and the solvent removed under reduced pressure. Et2O (100 mL) was added and the 
mixture extracted with 10 % w/w HCl (5 × 75 mL). The aqueous extracts were combined and 
157 
 
the pH adjusted to ~11 with 40% w/w NaOH. The batch was split into two roughly equal 300 
mL portions, and both were extracted into Et2O (5 × 100 mL). The combined extracts were 
dried in vacuo, then the resulting oil dissolved in 10% w/w HCl (100 mL) and heated under 
reflux for 45 minutes. The cooled suspension was extracted into Et2O (5 × 40 mL), and the 
combined organic extracts washed with 10% w/w NaOH (5 × 40 mL). The aqueous washings 
were combined and acidified by cautious addition of HCl, then extracted into Et2O 
(5 × 50 mL). Removal of the solvent under reduced pressure and recrystallisation from hot 
CH2Cl2 afforded the title compound as a white, crystalline solid (3.44 g, 43%). 
1H NMR (400 MHz, CDCl3): δ 7.55 (dd, J = 8.0, 1.1 Hz, 1H), 7.30 – 7.21 (m, 2H), 7.12 – 
7.07 (m, 1H), 3.08 (t, J = 7.8 Hz, 2H), 2.72 (t, J = 7.7 Hz, 2H). 
13C NMR (100 MHz, CDCl3): δ 177.9, 139.5, 133.1, 130.6, 128.4, 127.8, 124.5, 33.8, 31.3. 
νmax(neat)/cm-1: 2904 (br), 1696 (m), 1470 (w), 1435 (m), 1406 (w), 1367 (w), 1317 (m), 1268 
(m), 1215 (m), 1023 (m), 949 (m), 928 (m), 783 (m), 749 (s), 700 (w), 686 (m), 652 (m), 575 
(w), 522 (w), 434 (m). 
mp: 98 – 100 °C (CH2Cl2); lit. 99 – 100 °C.12 
1H and 13C NMR data are consistent with those reported in the literature.13 
 
3-(2-Bromophenyl)propan-1-ol (217) 
A two-necked 250 mL RBF equipped with stirrer bar, condenser and rubber septum was 
flame-dried then purged with N2 through an inlet needle for 30 minutes. 
3-(2-Bromophenyl)propionic acid (5.0 g, 21.8 mmol) was added followed by dry THF 
(120 mL) and stirring commenced. The solution was cooled to 0 °C in an ice bath, and 
BH3·THF (1.0 M, 30.0 mL, 30.0 mmol) added by syringe over 30 minutes (Note: a significant 
amount of H2 gas was evolved). The cold bath was removed and the mixture refluxed for 1 
hour, then cooled to 0 °C and quenched by the careful addition of H2O (~10 mL). The volatiles 
were removed under reduced pressure and the remaining residue dissolved in Et2O (50 mL) 
then washed with saturated Na2CO3 (3 × 50 mL), dried over MgSO4, and concentrated to afford 
the title compound as a colourless, viscous oil without the need for additional purification 
(3.70g, 79%). 
1H NMR (400 MHz, CDCl3): 7.53 (d, J = 8.0 Hz, 1H), 7.27 – 7.20 (m, 2H), 7.10 – 7.05 (m, 
1H), 3.71 (t, J = 6.4 Hz, 2H), 2.87 – 2.81 (m, 2H), 1.95 – 1.85 (m, 2H), 1.58 (br s, 1H). 
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13C NMR (100 MHz, CDCl3): 141.2, 133.0, 130.6, 127.8, 127.6, 124.6, 62.3, 32.9, 32.5. 
νmax(neat)/cm
-1: 3308 (br w), 2936 (w), 2864 (w), 1471 (w), 1455 (w), 1436 (w), 1054 (m), 
1019 (m), 914 (w), 746 (m), 699 (m), 657 (w), 594 (w), 579 (w), 445 (w). 
1H and 13C NMR data are consistent with those reported in the literature.13 
 
3-(2-Trimethylsilylphenyl)propan-1-ol (153c) 
Note: The NBS catalysed silylation reaction was based on a literature procedure.9 
A 100 mL RBF equipped with stirrer bar and rubber septum was flame-dried then purged with 
N2 through an inlet needle. 3-(2-Bromophenyl)propanol (3.70 g, 17.2 mmol), MeCN (40 mL), 
and hexamethyldisilazane (HMDS, 2.54 mL, 12.1 mmol) were added via syringe (in that 
order) and stirring commenced. The reaction temperature was adjusted to 50 °C, then 
N-bromosuccinimide (NBS, 0.15 g, 0.9 mmol, 5 mol%) added in one portion. Stirring was 
maintained for 2 hours, then the solution allowed to return to room temperature over 30 
minutes. The solution was concentrated under reduced pressure, and the residue dissolved in 
hexane (25 mL) then passed through a short pad of silica. The resulting solution was then 
concentrated in vacuo, and the crude oil transferred to a second flame-dried, N2-purged, 
100 mL RBF (again fitted with rubber septum and inlet needle). THF (30 mL) was added, and 
the solution cooled to −78 °C in an acetone-dry ice bath. n-Butyllithium (1.6 M in hexanes, 
9.4 mL, 15.0 mmol) was added by syringe over approximately 15 minutes, and the solution 
stirred at this temperature for 1 hour. Trimethylsilyl chloride (2.2 mL, 17.5 mmol) was then 
added via syringe and the reaction mixture allowed to return to room temperature overnight. 
After 14 hours, the mixture was quenched by the addition of H2O (20 mL) and extracted into 
Et2O (3 × 30 mL). The combined organic extracts were washed with HCl (0.1 M, 25 mL), then 
H2O (25 mL), dried over MgSO4, concentrated in vacuo, and the resulting crude oil purified 
by column chromatography (eluent: 9:1 hexanes/EtOAc) to afford the title compound as a 
viscous, colourless oil (1.96 g, 75%). 
1H NMR (400 MHz, CDCl3): δ 7.49 (dd, J = 7.4, 1.4 Hz, 1H), 7.32 (app. td, J = 7.5, 1.5 Hz, 
1H), 7.25 – 7.16 (m, 2H), 3.80 – 3.72 (m, 2H), 2.85 – 2.78 (m, 2H), 1.95 – 1.86 (m, 2H), 1.36 
(br s, 1H), 0.34 (s 9H). 




νmax(neat)/cm-1: 3314 (br w), 2951 (w), 2896 (w), 2869 (w), 1471 (w), 1433 (w), 1260 (w), 
1248 (m), 1124 (w), 1057 (w), 834 (s), 751 (m), 726 (m), 687 (w), 621 (w), 471 (w), 455 (w). 





A 250 mL three-necked RBF equipped with magnetic stirrer bar and fitted with a low 
temperature thermometer and rubber septum was flame-dried, then purged with N2 through an 
inlet needle. 1-(2-Bromophenyl)propanone (2.24 mL, 15.0 mmol) and dry Et2O (150 mL) were 
added by syringe and stirring commenced. The solution was cooled to −15 °C in an ice-salt 
bath, then MeMgBr (3.0 M in Et2O, 7.5 mL, 22.5 mmol) was added dropwise over 
approximately 30 minutes (ensuring that the internal temperature did not exceed −10 °C). The 
solution was warmed slightly to 0 °C and stirred for a further 3 hours. The reaction mixture 
was then poured into a mixture of ice (approx. 100 g) and sat. NH4Cl (50 mL). The resulting 
biphasic solution was transferred to a separating funnel, and the aqueous layer extracted with 
EtOAc (3 × 100 mL). The combined organic extracts were dried over MgSO4, concentrated in 
vacuo, and the residue purified by column chromatography (eluent: 4:1 hexanes/EtOAc) to 
afford the title compound as a clear, colourless oil (2.74 g, 80%). 
1H NMR (400 MHz, CDCl3): 7.60 (dd, J = 8.0, 1.3 Hz, 1H), 7.38 (dd, J = 7.6, 1.8 Hz, 1H), 
7.32 – 7.24 (m, 1H), 7.12 (ddd, J = 8.0, 7.3, 1.8 Hz, 1H), 3.04 (s, 2H), 1.52 (br s, 1H), 1.31 (s, 
6H). 
13C NMR (100 MHz, CDCl3): 137.8, 133.2, 132.5, 128.2, 127.2, 126.1, 72.0, 48.1, 29.6. 
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νmax(neat)/cm-1: 3393 (br w), 2970 (w), 2924 (w), 1469 (w), 1436 (w), 1375 (w), 1205 (w), 
1137 (m), 1099 (w), 1024 (m), 970 (w), 902 (w), 771 (m), 743 (w), 659 (w), 612 (w), 530 (w). 
1H and 13C NMR data are consistent with those reported in the literature.14 
 
1-(2-(Trimethylsilyl)phenyl)-2-methyl-propan-2-ol (153p) 
Note: The NBS catalysed silylation reaction was based on a literature procedure.9 
1-(2-bromophenyl)-2-methyl-propan-2-ol (2.70 g, 11.8 mmol) was added to a flame-dried, 
N2-purged, 100 mL RBF containing a magnetic stirrer bar, and fitted with a rubber septum and 
inlet needle. MeCN (30 mL) was added via syringe, followed by hexamethyldisilazane 
(HMDS, 1.74 mL, 8.3 mmol). The resulting solution was stirred for 15 mins at room 
temperature, then N-bromosuccinimide (NBS, 105 mg, 0.6 mmol) added in one portion. The 
temperature was adjusted to 50 °C and stirring maintained for a further 3 hours. The reaction 
mixture was then concentrated under reduced pressure, diluted with hexane (10 mL), and 
washed through a short plug of silica. The resulting solution was then concentrated in vacuo, 
and the crude oil transferred to a second flame-dried, N2-purged, 100 mL RBF (again fitted 
with a septum and inlet needle). THF (40 mL) was added, and the solution cooled to −78 °C 
in an acetone-dry ice bath. n-Butyllithium (2.3 M in hexanes, 5.2 mL, 12.0 mmol) was added 
by syringe over approximately 15 minutes, and the solution stirred at −78 °C for 1 hour. 
Trimethylsilyl chloride (1.63 mL, 15.0 mmol) was added via syringe and the resulting solution 
allowed to return to room temperature overnight. After 14 hours, the mixture was quenched 
by the addition of H2O (20 mL), and extracted into Et2O (3 × 30 mL). The combined organic 
extracts were washed with HCl (10% w/w, 30 mL), then brine (25 mL) dried over MgSO4, 
concentrated in vacuo, and the resulting crude oil purified by column chromatography (eluent: 
9:1 hexanes/EtOAc) to afford the title compound as a viscous, pale yellow oil (0.87 g, 33%). 
1H NMR (400 MHz, CDCl3): δ 7.53 (ddd, J = 7.5, 1.6, 0.6 Hz, 1H), 7.40 (ddd, J = 7.7, 1.4, 
0.6 Hz, 1H), 7.31 (app. td, J = 7.6, 1.6 Hz, 1H), 7.23 (app. td, J = 7.3, 1.4 Hz, 1H), 2.95 (s, 
2H), 1.27 (s, 1H), 1.26 (s, 6H), 0.34 (s, 9H). 
13C NMR (100 MHz, CDCl3): δ 143.6, 140.5, 135.3, 130.6, 128.8, 125.9, 71.3, 48.3, 30.1, 
1.5. 
νmax(neat)/cm-1: 2964 (w), 1247 (m), 1131 (w), 834 (s), 755 (w), 738 (m), 682 (w), 622 (w). 






Methyl 3-(2-bromophenyl)-2,2-dimethylpropanoate (219) 
A 250 mL RBF equipped with magnetic stirrer and rubber septum was flame-dried and purged 
under a stream of N2 through an inlet needle. THF (75 mL) then LDA (2.0 M in THF, 27.5 mL, 
55.0 mmol) were added via syringe and stirring commenced. The solution was cooled to –
78 °C in an acetone-dry ice bath, then methyl isobutyrate (6.02 mL, 52.5 mmol) added 
dropwise over approximately 15 minutes. The mixture was stirred at –78 °C for 1 hour, then 
2-bromobenzyl bromide (7.31 mL, 55.0 mmol) added in one portion. The mixture was allowed 
to return to room temperature overnight. After 16 hours the reaction was quenched by addition 
of H2O (50 mL) and extracted into Et2O (3 × 50 mL). The combined organic extracts were 
washed with brine (50 mL), dried over MgSO4, and concentrated under reduced pressure. The 
crude oil was purified by column chromatography (eluent: 100:0 → 80:20 hexane/EtOAc) to 
afford the title compound as a pale yellow oil that crystallised to a waxy solid on standing for 
a number of days (12.69 g, 89%). 
1H NMR (400 MHz, CDCl3): 7.54 (dd, J = 8.0, 1.3 Hz, 1H), 7.20 (app. td, J = 7.5, 1.3 Hz, 
1H), 7.13 (app. td, J = 7.7, 1.9 Hz, 1H), 7.06 (dd, J = 7.7, 1.8 Hz, 1H), 3.69 (s, 3H), 3.12 (s, 
2H), 1.24 (s, 6H). 
13C NMR (100 MHz, CDCl3): 178.0, 137.9, 133.2, 131.5, 128.2, 127.2, 126.2, 52.0, 44.4, 
44.4, 25.1. 
νmax(neat)/cm-1: 2986 (w), 2967 (w), 2943 (w), 2873 (w), 1726 (s), 1468 (m), 1433 (m), 1390 
(m), 1370 (w), 1324 (m), 1279 (m), 1188 (m), 1177 (m), 1131 (s), 1103 (m), 1050 (w), 1019 
162 
 
(m), 992 (m), 962 (m), 942 (w), 902 (w), 860 (w), 807 (w), 770 (w), 747 (s), 717 (w), 661 (m), 
601 (w), 592 (w), 453 (w). 
HRMS: Calcd. for C12H15O279Br: 270.0250 [M]+; found (EI+): 270.0242 
 
3-(2-Bromophenyl)-2,2-dimethylpropan-1-ol (220) 
A 250 mL RBF equipped with magnetic stirrer and rubber septum was flame-dried and purged 
with a stream of N2 through an inlet needle. Methyl 
3-(2-bromophenyl)2,2-dimethylpropanoate (4.88 g, 18.0 mmol) was added followed by 
CH2Cl2 (35 mL) and stirring commenced. Once the solid had fully dissolved, the temperature 
was adjusted to 0 °C in an ice-water bath. DIBAL (1.0 M in hexanes, 40.5 mL, 40.5 mmol) 
was added dropwise over 30 minutes, and the resulting mixture allowed to stir at 0 °C for 4 
hours. The reaction was carefully quenched by addition of MeOH (5 mL) then a saturated 
solution of Rochelle’s Salt (50 mL) and Et2O (50 mL) added sequentially. The mixture was 
stirred rapidly for 1 hour, then the layers separated and the organic layer washed with sat. 
NH4Cl (2 × 50 mL) and brine (2 × 50 mL). The solvent was removed under reduced pressure 
to afford the title compound as a pale yellow oil without the need for additional purification 
(4.75 g, quant.). 
1H NMR (400 MHz, CDCl3): 7.55 (dd, J = 8.0, 1.3 Hz, 1H), 7.30 – 7.19 (m, 2H), 7.06 (ddd, 
J = 8.0, 7.1, 2.0 Hz, 1H), 3.37 (d, J = 6.1 Hz, 2H), 2.83 (s, 2H), 0.95 (s, 6H). 
13C NMR (100 MHz, CDCl3): 138.7, 133.1, 132.7, 127.8, 127.0, 126.1, 71.2, 42.8, 37.9, 24.3. 
νmax(neat)/cm-1: 3359 (br w), 2955 (w), 2928 (w), 2868 (w), 1468 (m), 1434 (w), 1384 (w), 
1364 (w), 1026 (m), 986 (m), 766 (w), 742 (m), 707 (w), 659 (m), 610 (w). 
HRMS: Calcd. for C11H15O79Br: 242.0301 [M]+; found (EI+): 242.0311 
 
2,2-Dimethyl-3-[2-(trimethylsilyl)phenyl]propan-1-ol (153q) 
Note: The NBS catalysed silylation reaction was based on a literature procedure.9 
A 100 mL RBF equipped with stirrer bar and rubber septum was flame-dried then purged with 
N2 through an inlet needle. 3-(2-Bromophenyl)-2,2-dimethylpropan-1-ol (4.75 g, 19.5 mmol), 
MeCN (50 mL), and hexamethyldisilazane (HMDS, 2.93 mL, 14.0 mmol) were added via 
syringe (in that order) and stirring commenced. The reaction temperature was adjusted to 
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50 °C, then N-bromosuccinimide (NBS, 0.18 g, 1.0 mmol, 5 mol%) added in one portion. 
Stirring was maintained for 2 hours, then the solution allowed to return to room temperature 
over 30 minutes. The solution was concentrated under reduced pressure, and the residue 
dissolved in hexane (25 mL) then passed through a short pad of silica. The resulting solution 
was then concentrated in vacuo, and the crude oil transferred to a second flame-dried, 
N2-purged, 250 mL RBF (again fitted with rubber septum and inlet needle). THF (50 mL) was 
added, and the solution cooled to −78 °C in an acetone-dry ice bath. n-Butyllithium (2.5 M in 
hexanes, 10 mL, 25.0 mmol) was added by syringe over approximately 15 minutes, and the 
solution stirred at this temperature for 1 hour. Trimethylsilyl chloride (3.5 mL, 27.5 mmol) 
was then added via syringe and the reaction mixture allowed to return to room temperature 
overnight. After 18 hours, the mixture was quenched by the addition of H2O (20 mL) and 
extracted into Et2O (3 × 30 mL). The combined organic extracts were washed with HCl 
(10% w/w, 40 mL), then H2O (40 mL), dried over MgSO4, concentrated in vacuo, and the 
resulting oil purified by column chromatography (eluent: 4:1 hexanes/EtOAc) to yield the title 
compound as a viscous, colourless oil (3.24 g, 70%). 
1H NMR (400 MHz, CDCl3): δ 7.57 – 7.51 (m, 1H), 7.34 – 7.26 (m, 2H), 7.25 – 7.17 (m, 
1H), 3.45 (s, 2H), 2.81 (s, 2H), 0.93 (s, 6H), 0.37 (s, 9H). 
13C NMR (100 MHz, CDCl3): δ 145.1, 140.1, 135.2, 130.3, 128.5, 125.4, 72.1, 43.3, 37.1, 
24.7, 1.8. 
νmax(neat)/cm-1: 3332 (br), 2952 (w), 2897 (w), 2869 (w), 1470 (w), 1433 (w), 1261 (w), 1248 
(m), 1112 (w), 1037 (m), 834 (m), 774 (w), 756 (w), 737 (m), 683 (w), 622 (w). 





A 250 mL three-necked RBF equipped with magnetic stirrer bar and fitted with a low 
temperature thermometer and rubber septum was flame-dried, then purged with N2 through an 
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inlet needle. Methyl 3-(2-bromophenyl)-2,2-dimethylpropanoate (4.88 g, 18.0 mmol) and dry 
Et2O (150 mL) were added by syringe and stirring commenced. The solution was cooled to 
−15 °C in an ice-salt bath, then MeMgBr (3.0 M in Et2O, 13.3 mL, 40.0 mmol) was added 
dropwise over approximately 30 minutes (ensuring that the internal temperature did not exceed 
−10 °C). The solution was warmed slightly to 0 °C and stirred for a further 4 hours. Crude 1H 
NMR indicated incomplete consumption of the starting material, so the crude reaction mixture 
was re-subjected to the reaction conditions and further MeMgBr (3.0 M in Et2O, 9.3 mL, 
27.9 mmol) added. After stirring at room temperature for a further 4 hours, the reaction 
mixture was poured into a mixture of ice (approx. 100 g) and sat. NH4Cl (50 mL). The resulting 
biphasic solution was transferred to a separating funnel, and the aqueous layer extracted with 
EtOAc (3 × 100 mL). The combined organic extracts were dried over MgSO4, concentrated in 
vacuo, and the residue purified by column chromatography (eluent: 19:1 hexanes/EtOAc) to 
afford the title compound as a clear, colourless oil (4.10 g, 84%). 
1H NMR (400 MHz, CDCl3): 7.58 – 7.52 (m, 1H), 7.25 – 7.19 (m, 2H), 7.06 (m, 1H), 2.94 
(s, 2H), 1.33 (s, 6H), 0.91 (s, 6H). 
13C NMR (100 MHz, CDCl3): 139.6, 133.2, 132.9, 127.7, 126.9, 126.7, 75.9, 42.8, 40.9, 25.7, 
21.5. 
νmax(neat)/cm-1: 3439 (br, w), 2971 (w), 2876 (w), 1468 (m), 1436 (w), 1368 (w), 1163 (w), 
1115 (w), 1085 (w), 1047 (w), 1023 (m), 942 (w), 873 (w), 750 (m), 732 (w), 659 (w). 
HRMS: Calcd. for C13H19O79BrNa: 293.0512 [M+Na]+; found (ESI+): 293.0525 
 
2,3,3-Trimethyl-4-[2-(trimethylsilyl)phenyl]butan-2-ol (153r) 
Note: The iodine-catalysed silylation reaction used is based on a literature procedure.15 
A 100 mL RBF equipped with stirrer bar and rubber septum was flame-dried then purged with 
N2 through an inlet needle. 4-(2-Bromophenyl)-2,3,3-trimethylbutan-2-ol (4.00 g, 14.7 mmol), 
CH2Cl2 (20 mL), and hexamethyldisilazane (HMDS, 2.16 mL, 10.3 mmol) were added via 
syringe (in that order) and stirring commenced. A single crystal of iodine was added, then 
stirring was maintained at room temperature for 15 minutes. Solid Na2S2O3 (approx. 3 g) was 
added and the reaction mixture stirred for a further 30 minutes, then passed through a short 
pad of silica. The resulting solution was then concentrated in vacuo, and the crude oil 
transferred to a second flame-dried, N2-purged, 150 mL RBF (again fitted with rubber septum 
and inlet needle). THF (40 mL) was added, and the solution cooled to −78 °C in an acetone-
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dry ice bath. n-Butyllithium (2.5 M in hexanes, 8.0 mL, 20.0 mmol) was added by syringe 
over approximately 15 minutes, and the solution stirred at this temperature for 30 minutes. 
Trimethylsilyl chloride (2.8 mL, 27.5 mmol) was then added via syringe and the reaction 
mixture allowed to return to room temperature overnight. The mixture was quenched by the 
addition of H2O (20 mL) and extracted into Et2O (3 × 30 mL). The combined organic extracts 
were washed with HCl (0.1 M, 30 mL), then H2O (40 mL), dried over MgSO4, concentrated 
in vacuo, and the resulting oil purified by column chromatography (eluent: 4:1 
hexanes/EtOAc) to afford the title compound as a viscous, colourless oil (1.15 g, 30%). 
1H NMR (400 MHz, CDCl3): δ 7.57 – 7.49 (m, 1H), 7.29 – 7.17 (m, 3H), 2.91 (s, 2H), 1.32 
(s, 6H), 0.87 (s, 6H), 0.36 (s, 9H). 
13C NMR (100 MHz, CDCl3): δ 145.7, 140.8, 135.3, 131.3, 127.9, 125.2, 76.1, 42.0, 40.9, 
26.0, 22.1, 1.8. 
νmax(neat)/cm-1: 3478 (br), 2971 (w), 1469 (w), 1367 (w), 1261 (w), 1247 (m), 1116 (w), 871 
(w), 834 (m), 754 (m), 732 (m), 684 (w), 623 (w). 





2-Bromobenzyl alcohol (1.29 g, 6.9 mmol) was added to a flame-dried, N2-purged, 100 mL 
RBF containing a magnetic stirrer bar, and fitted with a rubber septum and inlet needle. CH2Cl2 
(20 mL) was added via syringe, followed by triethylsilyl chloride (1.74 mL, 10.4 mmol) and 
imidazole (0.70 g, 10.4 mmol). The resulting solution was stirred for 15 hours at room 
temperature. The reaction mixture was then concentrated under reduced pressure, diluted with 
hexane (10 mL), and washed through a short plug of silica. The resulting solution was then 
concentrated in vacuo, and the crude oil transferred to a second flame-dried, N2-purged, 100 
mL RBF (again fitted with a septum and inlet needle). THF (20 mL) was added, and the 
solution cooled to −78 °C in an acetone-dry ice bath. n-Butyllithium (1.6 M in hexanes, 
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6.5 mL, 10.4 mmol) was added by syringe over approximately 15 minutes, and the solution 
allowed to return to room temperature overnight. After 14 hours, the mixture was quenched 
by the addition of H2O (10 mL), and extracted into Et2O (3 × 20 mL). The combined organic 
extracts were dried over MgSO4, concentrated in vacuo, and the resulting crude oil purified by 
column chromatography (eluent: 9:1 hexanes/EtOAc) to afford the title compound as a pale 
yellow oil (0.82 g, 53%). 
1H NMR (400 MHz, CDCl3): δ 7.52 – 7.47 (m, 2H), 7.40 (app. td, J = 7.5, 1.4 Hz, 1H), 7.28 
(app. td, J = 7.5, 1.4 Hz, 1H), 4.74 (s, 2H), 0.99 – 0.92 (m, 9H), 0.91 – 0.82 (m, 6H). 
13C NMR (100 MHz, CDCl3): δ 146.8, 135.8, 135.1, 129.5, 127.9, 127.0, 65.6, 7.7, 4.5. 
νmax(neat)/cm-1: 3307 (br w), 2952 (m), 2908 (w), 2873 (m), 1456 (w), 1435 (w), 1418 (w), 
1235 (w), 1124 (w), 1077 (w), 1002 (m), 713 (m), 672 (m), 606 (w), 582 (w). 





2-Bromobenzyl alcohol (0.94 g, 5.0 mmol) was added to a flame-dried 25 mL RBF equipped 
with stirrer bar, and purged with N2 via an inlet needle. Anhydrous DMF (7.5 mL) was added 
via syringe and stirring commenced. The temperature was adjusted to 0 °C with an external 
ice bath, then NaH (60% w/w dispersion in mineral oil, 240 mg, 6.0 mmol) added portion-wise 
over approximately 15 minutes. Following addition, the reaction mixture was stirred for a 
further 30 minutes at 0 °C, then methyl iodide (1.57 mL, 25.0 mmol) added in one portion via 
syringe. The reaction mixture was allowed to return to room temperature and stirred for a 
further 2 hours. The reaction was quenched by addition of a saturated NH4Cl solution (10 mL), 
then extracted into Et2O (3 × 30 mL). The combined organic extracts were washed with NaOH 
(3.0 M, 30 mL) then brine (30 mL), dried over MgSO4, and concentrated under reduced 
pressure. The residue was purified by column chromatography (eluent: 9:1 hexanes/EtOAc) 
to afford the title compound as a colourless oil (0.98 g, 97%). 
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1H NMR (400 MHz, CDCl3): δ 7.54 (dd, J = 7.9, 1.2 Hz, 1H), 7.49 – 7.44 (m, 1H), 7.32 (app. 
td, J = 7.5, 1.3 Hz, 1H), 7.19 – 7.11 (m, 1H), 4.53 (s, 2H), 3.47 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ 137.7, 132.7, 129.1, 129.0, 127.5, 122.9, 74.1, 58.7. 
νmax(neat)/cm-1: 2927 (w), 2822 (w), 1470 (w), 1456 (w), 1436 (m), 1379 (w), 1362 (w), 1195 
(w), 1120 (m), 1095 (m), 1044 (w), 1026 (m), 974 (w), 943 (w), 924 (w), 748 (s), 668 (w), 633 
(w), 605 (w). 
1H and 13C NMR data are consistent with those reported in the literature.13 
 
[2-(Methoxymethyl)phenyl]trimethylsilane (153e) 
To a nitrogen filled, flame-dried Schlenk flask was added 
1-Bromo-2-(methoxymethyl)benzene (0.95 g, 4.7 mmol) along with dry THF (12 mL). The 
solution was cooled to −78 °C and n-butyllithium (2.5 M in hexanes, 2.0 mL, 5.0 mmol) was 
added dropwise over 15 minutes. The mixture was stirred at −78 °C for a further 30 mins, then 
trimethylsilylchloride (0.90 mL, 7.0 mmol) added via syringe. The flask was removed from 
the cold bath and allowed to return to room temperature overnight. Water (10 mL) was added 
to quench any remaining organolithium species, and the aqueous layer extracted with Et2O 
(3 × 20 mL). The combined organic extracts were dried over MgSO4, concentrated under 
reduced pressure, and purified by column chromatography (eluent: 19:1 hexanes/EtOAc) to 
afford the title compound as a clear, colourless oil (0.37 g, 41%). 
1H NMR (400 MHz, CDCl3): δ 7.55 (dd, J = 7.3, 1.4 Hz, 1H), 7.44 – 7.34 (m, 2H), 7.28 (app. 
td, J = 7.3, 1.7 Hz, 1H), 4.54 (s, 2H), 3.41 (s, 3H), 0.34 (s, 9H). 
13C NMR (100 MHz, CDCl3): δ 143.7, 138.7, 134.8, 129.3, 128.5, 127.1, 75.1, 58.1, 0.4. 
νmax(neat)/cm-1: 2953 (w), 2924 (w), 2894 (w), 1456 (w), 1435 (w), 1246 (m), 1192 (w), 1126 
(w), 1096 (m), 1075 (w), 834 (s), 746 (m), 726 (m), 686 (w), 622 (w). 







A 250 mL RBF equipped with stirrer bar and rubber septum was flame-dried, then purged with 
N2 through an inlet needle. 2-(2-Bromophenyl)ethanol (5.0 g, 24.9 mmol) was added via 
syringe followed by anhydrous DMF (70 mL), and stirring commenced. The solution was 
cooled to 0 °C in an ice bath, then NaH (60% w/w dispersion in mineral oil, 1.32 g, 33.0 mmol) 
was added portion-wise (Note: A significant amount of H2 gas was evolved). Following 
addition, the reaction mixture was stirred for 1 hour at 0 °C before methyl iodide (2.8 mL, 
45.0 mmol) was added via syringe in one portion. The mixture was allowed to return to room 
temperature overnight. After 11 hours, the reaction was quenched by addition of a saturated 
NH4Cl solution (40 mL), then extracted into Et2O (3 × 40 mL). The combined organic extracts 
were washed with NaOH (3.0 M, 30 mL) then brine (30 mL), dried over MgSO4, and 
concentrated under reduced pressure. The residue was purified by column chromatography 
(eluent: 19:1 hexanes/EtOAc) to afford the title compound as a colourless oil (4.95 g, 92%). 
1H NMR (400 MHz, CDCl3): δ 7.51 (dd, J = 8.0, 1.2 Hz, 1H), 7.30 – 7.17 (m, 2H), 7.05 (ddd, 
J = 8.0, 7.0, 2.1 Hz, 1H), 3.60 (t, J = 7.1 Hz, 2H), 3.35 (s, 3H), 3.02 (t, J = 7.1 Hz, 2H). 
13C NMR (100 MHz, CDCl3): δ 138.3, 132.9, 131.2, 128.1, 127.5, 124.8, 71.9, 58.8, 36.5. 
νmax(neat)/cm-1: 2925 (w), 2871 (w), 2823 (w), 1471 (m), 1456 (w), 1438 (w), 1378 (w), 1179 
(w), 1110 (m), 1036 (w), 1022 (m), 968 (w), 748 (m), 719 (w), 657 (w). 
1H and 13C NMR data are consistent with those reported in the literature.13 
 
[2-(2-Methoxyethyl)phenyl]trimethylsilane (153f) 
A 150 mL RBF fitted with stirrer bar and rubber septum was flame-dried, then purged with N2 
via an inlet needle. 2-(2-Bromophenyl)ethyl methyl ether (4.70 g, 21.9 mmol) and THF 
(60 mL) were added via syringe, stirring commenced, and the temperature adjusted to −78 °C 
with an external acetone-dry ice bath. n-Butyllithium (2.3 M in hexanes, 10.9 mL, 25.0 mmol) 
was added dropwise over 20 minutes. The solution was stirred for a further 45 minutes at 
−78 °C, then trimethylsilyl chloride (3.81 mL, 30.0 mmol) added via syringe in one portion. 
The reaction mixture was allowed to return to room temperature overnight. After 14 hours, the 
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reaction was quenched by addition of H2O (50 mL) and extracted into Et2O (3 × 50 mL). The 
combined organic extracts were dried over MgSO4, concentrated in vacuo, and the residue 
purified by column chromatography (eluent: 19:1 hexanes/EtOAc) to afford the title 
compound as a colourless oil (4.21 g, 92%). 
1H NMR (400 MHz, CDCl3): δ 7.49 (dd, J = 7.4, 1.6 Hz, 1H), 7.32 (app. td, J = 7.4, 1.5 Hz, 
1H), 7.26 – 7.17 (m, 2H), 3.60 – 3.55 (m, 2H), 3.39 (s, 3H), 3.06 – 3.00 (m, 2H), 0.35 (s, 9H). 
13C NMR (100 MHz, CDCl3): δ 144.2, 138.9, 134.8, 129.3, 129.2, 125.7, 74.3, 58.9, 36.5, 
0.5. 
νmax(neat)/cm-1: 2953 (w), 2925 (w), 2893 (w), 2873 (w), 1472 (w), 1456 (w), 1435 (w), 1248 
(m), 1199 (w), 1113 (m), 1080 (w), 968 (w), 834 (s), 753 (m), 727 (m), 688 (w), 622 (w). 





A 50 mL RBF equipped with stirrer bar and rubber septum was flame-dried, then purged with 
N2 through an inlet needle. Neopentyl alcohol (0.35 g, 5.0 mmol) was added followed by 
anhydrous DMF (15 mL), and stirring commenced. The solution was cooled to 0 °C in an ice 
bath, then NaH (60% w/w dispersion in mineral oil, 0.40 g, 10.0 mmol) was added 
portion-wise (Note: A significant amount of H2 gas evolved). Following addition, the reaction 
mixture was stirred for 2 hours at 0 °C before 2-bromobenzyl bromide (1.36 mL, 10.0 mmol) 
was added via syringe in one portion. The mixture was allowed to return to room temperature 
overnight. After 14 hours, the reaction was quenched by addition of H2O (20 mL), then 
extracted into Et2O (3 × 40 mL). The combined organic extracts were washed with NaOH (3.0 
M, 30 mL) then brine (30 mL), dried over MgSO4, and concentrated under reduced pressure. 
The residue was purified by column chromatography (eluent: hexanes) to afford the title 
compound as a colourless oil (0.75 g, 58%). 
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1H NMR (400 MHz, CDCl3): δ 7.52 (m, 2H), 7.32 (app. td, J = 7.5, 1.3 Hz, 1H), 7.16 – 7.10 
(m, 1H), 4.56 (s, 2H), 3.22 (s, 2H), 0.97 (s, 9H). 
13C NMR (100 MHz, CDCl3): δ 138.6, 132.4, 128.7, 128.6, 127.4, 122.3, 81.6, 72.6, 32.4, 
27.0. 
νmax(neat)/cm-1: 2953 (w), 2900 (w), 2865 (w), 1472 (w), 1456 (w), 1438 (w), 1384 (w), 1361 
(w), 1352 (w), 1220 (w), 1122 (m), 1101 (m), 1044 (w), 1026 (m), 999 (w), 747 (m), 673 (w), 
609 (w). 
HRMS: Calcd. for C12H17O79BrSi: 256.0457 [M]+; found (EI+): 256.0442 
 
 {2-[(2,2-Dimethylpropoxy)methyl]phenyl}trimethylsilane (153g) 
A 50 mL RBF fitted with stirrer bar and rubber septum was flame-dried, then purged with N2 
via an inlet needle. 1-Bromo-2-[(2,2-dimethylpropoxy)methyl]benzene (0.75 g, 2.9 mmol) and 
THF (10 mL) were added via syringe, stirring commenced, and the temperature adjusted to 
−78 °C with an external acetone-dry ice bath. n-Butyllithium (2.5 M in hexanes, 1.3 mL, 3.3 
mmol) was added dropwise over 10 minutes. The solution was stirred for a further 15 minutes 
at −78 °C, then trimethylsilyl chloride (0.51 mL, 4.0 mmol) added via syringe in one portion. 
The reaction mixture was allowed to return to room temperature overnight. After 14 hours, the 
reaction was quenched by addition of H2O (10 mL) and extracted into Et2O (3 × 20 mL). The 
combined organic extracts were dried over MgSO4, concentrated in vacuo, and the residue 
purified by column chromatography (eluent: 19:1 hexanes/EtOAc) to afford the title 
compound as a colourless oil (0.64 g, 88%). 
1H NMR (400 MHz, CDCl3): δ 7.55 – 7.48 (m, 2H), 7.38 (app. td, J = 7.6, 1.5 Hz, 1H), 7.27 
(app. td, J = 7.3, 1.3 Hz, 1H), 4.60 (s, 2H), 3.17 (s, 2H), 0.96 (s, 9H), 0.34 (s, 9H). 
13C NMR (100 MHz, CDCl3): δ 144.6, 137.9, 134.4, 129.3, 127.9, 126.7, 81.4, 73.5, 32.3, 
27.1, 0.4. 
νmax(neat)/cm-1: 2953 (w), 2899 (w), 2866 (w), 1473 (w), 1456 (w), 1362 (w), 1248 (m), 1127 
(w), 1093 (m), 1076 (m), 1047 (w), 835 (s), 744 (m), 727 (m), 687 (w), 621 (w), 419 (w). 






2-(Trimethylsilyl)benzoic acid (225) 
2-(Trimethylsilyl)benzyl alcohol (2.20 g, 12.2 mmol), acetone (45 mL), and H2O (8 mL) were 
added to a 150 mL RBF equipped with magnetic stirrer bar, and stirring commenced. KMnO4 
(4.82 g, 30.5 mmol) was added in one portion (Note: Significant exotherm observed and 
reaction temperature reached approximately 30 °C) and the reaction stirred for 3 hours. The 
reaction mixture was concentrated under reduced pressure then sat. Na2SO3 (20 mL) was 
added to the residue. The resulting slurry was filtered through a pad of celite (washed 
copiously with H2O and CH2Cl2) then transferred to a separating funnel and acidified to pH 4 
with HCl (10% w/w). The aqueous layer was extracted with CH2Cl2 (3 × 100 mL) and the 
combined organic extracts dried over MgSO4, and concentrated to a white solid of sufficient 
purity (2.08 g, 88%).  
1H NMR (CDCl3): δ 8.20 (dd, J = 7.8, 1.2 Hz, 1H), 7.75 (dd, J = 7.5, 1.2 Hz, 1H), 7.58 (app. 
td, J = 7.4, 1.3 Hz, 1H), 7.49 (app. td, J = 7.7, 1.3 Hz), 0.37 (s, 9H). 
13C NMR (CDCl3): δ 173.8, 143.9, 135.7, 134.2, 132.4, 131.0, 128.9, 0.4. 
νmax(neat)/cm-1: 2952 (w), 2892 (w), 2657 (w), 2530 (w), 1682 (s), 1561 (m), 1478 (w), 1469 
(w), 1411 (m), 1293 (m), 1269 (m), 1260 (m), 1241 (s), 1146 (m), 1117 (m), 917 (w), 840 (s), 
807 (m), 753 (w), 730 (s), 682 (m), 652 (m), 621 (m), 555 (m), 482 (m), 422 (w). 
HRMS calcd. For C10H14O2Si: 217.0655 [M+Na]+; found (ESI+): 217.0668. 
mp: 93 – 95 °C (CH2Cl2); lit. 94 – 95 °C.16 
1H and 13C NMR data are consistent with those reported in the literature.16 
 
Methyl 2-(trimethylsilyl)benzoate (153h) 
2-(Trimethylsilyl)benzoic acid (194 mg, 1.0 mmol), K2CO3 (414 mg, 3.0 mmol) and acetone 
(5mL) were added to a 25 mL RBF fitted with condenser and magnetic stirrer bar. MeI 
(0.31 mL, 5.0 mmol) was added, stirring commenced, and the reaction mixture heated at reflux 
for 3 hours. After cooling to room temperature, the solvent was removed under reduced 
pressure, and the residue suspended between H2O (10 mL) and EtOAc (10 mL). The layers 
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were separated and the aqueous phase extracted with EtOAc (3 × 15 mL). The combined 
organic extracts were dried over MgSO4, concentrated in vacuo, and purified by column 
chromatography (eluent: 9:1 hexanes/EtOAc) to afford the title compound as a clear, 
colourless oil (190 mg, 91%). 
1H NMR (400 MHz, CDCl3): δ 8.01 (dd, J = 7.7, 1.3 Hz, 1H), 7.69 (dd, J = 7.5, 1.3 Hz, 1H), 
7.50 (app. td, J = 7.4, 1.4 Hz, 1H), 7.43 (app. td, J = 7.5, 1.4 Hz, 1H), 3.91 (s, 3H), 0.32 (s, 
9H). 
13C NMR (100 MHz, CDCl3): δ 168.9, 142.6, 135.8, 135.6, 131.5, 130.1, 128.9, 52.1, 0.4. 
νmax(neat)/cm-1: 2950 (w), 1722 (s), 1433 (w), 1271 (m), 1252 (m), 1191 (w), 1136 (m), 1111 
(m), 1066 (m), 838 (s), 734 (m), 710 (w), 694 (w), 681 (w), 621 (w). 
HRMS calcd. For C11H17O2Si: 209.0992 [M+H]+; found (ESI+): 209.1022 
 
 
[2-(Trimethylsilyl)phenyl]methyl 2,2-dimethylpropanoate (153i) 
A 25 mL RBF fitted with magnetic stirrer bar and rubber septum was flame-dried and purged 
with N2. 2-(Trimethylsilyl)benzyl alcohol (180 mg, 1.0 mmol) was added followed by CH2Cl2 
(2.5 mL) and stirring commenced. Pivaloyl chloride (0.18 mL, 1.5 mmol) and triethylamine 
(0.21 mL, 1.5 mmol) were added via syringe. The reaction was stirred overnight, then 
dry-loaded onto celite and purified by column chromatography (eluent: 9:1 hexanes/EtOAc) 
to afford the title compound as a clear, colourless oil (261 mg, 99%). 
1H NMR (400 MHz, CDCl3): δ 7.54 (d, J = 7.5 Hz, 1H), 7.42 – 7.34 (m, 2H), 7.32 – 7.27 (m, 
1H), 5.21 (s, 2H), 1.24 (s, 9H), 0.36 (s, 9H). 
13C NMR (100 MHz, CDCl3): δ 178.4, 141.7, 139.1, 134.7, 129.5, 128.8, 127.5, 66.4, 39.0, 
27.4, 0.4. 
νmax(neat)/cm-1: 2958 (w), 2904 (w), 1727 (m), 1479 (w), 1461 (w), 1396 (w), 1279 (m), 1263 
(w), 1250 (m), 1206 (w), 1141 (m), 1078 (w), 1032 (w), 963 (w), 942 (w), 836 (s), 756 (m), 
744 (m), 727 (m), 689 (w), 622 (w). 







A 150 mL RBF fitted with stirrer bar and rubber septum was flame-dried, then purged with N2 
via an inlet needle. 1-Bromo-2-(methylsulfanyl)benzene (5.0 g, 24.6 mmol) and THF (75 mL) 
were added via syringe, stirring commenced, and the temperature adjusted to −78 °C with an 
external acetone-dry ice bath. n-Butyllithium (2.5 M in hexanes, 12.0 mL, 30.0 mmol) was 
added dropwise over 20 minutes. The solution was stirred for a further 45 minutes at −78 °C, 
then trimethylsilyl chloride (4.44 mL, 35.0 mmol) added via syringe in one portion. The 
reaction mixture was allowed to return to room temperature overnight. After 12 hours, the 
reaction was quenched by addition of H2O (50 mL) and extracted into Et2O (3 × 50 mL). The 
combined organic extracts were dried over MgSO4, concentrated in vacuo, and the residue 
purified by column chromatography (eluent: 19:1 hexanes/EtOAc) to afford the title 
compound as a colourless oil (4.59 g, 95%). 
1H NMR (400 MHz, CDCl3): δ 7.48 – 7.41 (m, 1H), 7.38 – 7.22 (m, 2H), 7.16 (ddd, J = 7.3, 
5.7, 2.7 Hz, 1H), 2.49 (s, 3H), 0.39 (s, 9H). 
13C NMR (100 MHz, CDCl3): δ 145.0, 140.3, 134.8, 129.9, 127.7, 125.0, 18.1, 0.0. 
νmax(neat)/cm-1: 2952 (w), 2920 (w), 1574 (w), 1557 (w), 1421 (m), 1246 (m), 1126 (w), 1107 
(w), 1048 (w), 966 (w), 835 (s), 743 (m), 715 (m), 689 (w), 659 (w), 620 (w), 454 (w), 436 
(w). 
1H and 13C NMR data are consistent with those reported in the literature.17 
 
(2-Methanesulfinylphenyl)trimethylsilane (153j) 
A 100 mL RBF fitted with stirrer bar and rubber septum was flame-dried, then purged with N2 
via an inlet needle. Trimethyl[2-(methylsulfanyl)phenyl]silane (1.96 g, 10.0 mmol) and 
CH2Cl2 (30 mL) were added via syringe and the stirred solution cooled to 0 °C. 
meta-Chloroperoxybenzoic acid (mCPBA, ~77% w/w, 2.47 g, 11.0 mmol) was added 
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portion-wise over approximately 15 minutes, then the reaction mixture allowed to return to 
room temperature and stirred for a further 3 hours. The reaction was quenched by addition of 
sat. Na2S2O3 (25 mL) and extracted into EtOAc (3 × 30 mL). The combined organic extracts 
were dried over MgSO4 and concentrated under reduced pressure. The resulting residue was 
purified by column chromatography (eluent 1:1 hexanes/EtOAc) to afford the title compound 
as a clear, colourless oil (1.72 g, 81%). 
1H NMR (400 MHz, CDCl3): δ 8.13 (ddd, J = 7.9, 1.2, 0.6 Hz, 1H), 7.62 (ddd, J = 7.9, 7.2, 
1.5 Hz, 1H), 7.55 (ddd, J = 7.4, 1.5, 0.5 Hz, 1H), 7.47 (app. td, J = 7.4, 1.2 Hz, 1H), 2.68 (s, 
3H), 0.38 (s, 9H). 
13C NMR (100 MHz, CDCl3): δ 152.7, 138.0, 134.7, 131.0, 130.8, 123.4, 44.4, 0.9. 
νmax(neat)/cm
-1: 2954 (w), 1456 (w), 1417 (w), 1249 (m), 1106 (w), 1060 (m), 1033 (m), 950 
(w), 836 (s), 754 (m), 716 (m), 690 (w), 676 (w), 658 (w), 621 (w), 495 (w), 451 (w). 





A 100 mL RBF fitted with stirrer bar and rubber septum was flame-dried, then purged with N2 
via an inlet needle. Trimethyl[2-(methylsulfanyl)phenyl]silane (1.96 g, 10.0 mmol) and 
CH2Cl2 (30 mL) were added via syringe and stirring commenced. meta-Chloroperoxybenzoic 
acid (mCPBA, ~77% w/w, 2.47 g, 11.0 mmol) was added portion-wise over approximately 15 
minutes and stirred for a further 5 hours at room temperature. The reaction was quenched by 
addition of sat. Na2S2O3 (25 mL) and extracted into EtOAc (3 × 30 mL). The combined organic 
extracts were dried over MgSO4 and concentrated under reduced pressure. The resulting 
residue was purified by column chromatography (eluent 3:1 hexanes/EtOAc) to afford the title 




1H NMR (400 MHz, CDCl3): δ 8.09 – 8.02 (m, 1H), 7.83 – 7.79 (m, 1H), 7.64 – 7.53 (m, 
2H), 3.01 (s, 3H), 0.44 (s, 9H). 
13C NMR (100 MHz, CDCl3): δ 146.0, 140.5, 136.9, 132.7, 130.0, 129.5, 45.2, 1.3. 
νmax(neat)/cm-1: 2949 (w), 2897 (w), 1455 (w), 1416 (w), 1300 (m), 1281 (m), 1240 (m), 1165 
(w), 1145 (m), 1120 (m), 1102 (m), 1046 (w), 951 (m), 836 (s), 782 (m), 745 (s), 723 (m), 711 
(m), 681 (m), 657 (m), 621 (m), 543 (s), 529 (s), 475 (m), 453 (m), 430 (w). 
HRMS calcd. For C10H16O2SSiNa: 251.0532 [M+Na]+; found (ESI+): 251.0534 




A 100 mL RBF fitted with stirrer bar and rubber septum was flame-dried, then purged with N2 
through an inlet needle. p-Toluenesulfonyl chloride (5.0 g, 26.2 mmol) was added, followed 
by dry CH2Cl2 (25 mL), and stirring commenced. The mixture was cooled to 0 °C in an ice 
bath, then diethylamine (8.1 mL, 78.6 mmol) added dropwise over 15 minutes. The cold bath 
was removed and the reaction mixture stirred at room temperature for 14 hours. A saturated 
solution of NH4Cl (25 mL) was added and the aqueous phase extracted with EtOAc (3 × 25 
mL). The combined organic extracts were dried over MgSO4, concentrated under reduced 
pressure, and recrystallised from hot EtOH to produce the title compound as white crystalline 
needles (4.57 g, 77%). 
1H NMR (400 MHz, CDCl3): δ 7.70 (m, 2H), 7.32 – 7.27 (m, 2H), 3.23 (q, J = 7.1 Hz, 4H), 
2.42 (s, 3H), 1.13 (t, J = 7.1 Hz, 6H). 
13C NMR (100 MHz, CDCl3): δ 143.0, 137.5, 129.7, 127.1, 42.1, 21.6, 14.3. 
νmax(neat)/cm-1: 2991 (w), 2974 (w), 2935 (w), 1597 (w), 1493 (w), 1465 (w), 1456 (w), 1374 
(w), 1354 (w), 1329 (m), 1305 (w), 1291 (w), 1199 (m), 1171 (w), 1154 (s), 1087 (m), 1071 
(w), 1040 (w), 1012 (m), 927 (m), 814 (m), 797 (w), 777 (m), 711 (m), 696 (m), 642 (m), 558 
(m), 543 (s), 430 (w). 
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mp: 61 – 64 °C (EtOH); lit. 58 – 59 °C.18 
1H and 13C NMR data are consistent with those reported in the literature.18 
 
N,N-Diethyl-4-methyl-2-(trimethylsilyl)benzenesulfonamide (153l) 
A 100 mL RBF fitted with stirrer bar and rubber septum was flame-dried, then purged with N2 
through an inlet needle. N,N-Diethyl-4-methylbenzenesulfonamide (1.14 g, 5.0 mmol) was 
added, followed by dry THF (50 mL) and stirring commenced. The reaction mixture was 
cooled to −78 °C in an acetone-dry ice bath then n-butyllithium (2.5 M, 2.4 mL, 6.0 mmol) 
added dropwise via syringe over 10 minutes. The solution was stirred at −78 °C for 45 minutes 
then trimethylsilyl chloride (1.01 mL, 8.0 mmol) added in one portion. The reaction mixture 
was allowed to return to room temperature overnight. After 12 hours, the reaction was 
quenched by the addition of H2O (40 mL) and the aqueous phase extracted with EtOAc (3 × 
50 mL). The combined organic extracts were dried over MgSO4, concentrated in vacuo, and 
purified by column chromatography (eluent: 1:1 CH2Cl2/hexanes) to afford the title compound 
as a colourless oil (1.26 g, 84%). 
1H NMR (400 MHz, CDCl3): δ 7.62 – 7.54 (m, 2H), 7.29 – 7.25 (m, 1H), 3.33 (q, J = 7.1 Hz, 
4H), 2.42 (s, 3H), 1.19 (t, J = 7.1 Hz, 6H), 0.43 (s, 9H). 
13C NMR (100 MHz, CDCl3): δ 143.6, 141.4, 140.4, 137.3, 130.0, 127.2, 42.0, 21.7, 14.5, 
1.3. 
νmax(neat)/cm-1: 2977 (w), 2950 (w), 2926 (w), 2894 (w), 1456 (w), 1446 (w), 1417 (w), 1380 
(w), 1248 (m), 1130 (w), 1091 (m), 1056 (w), 926 (w), 837 (s), 790 (m), 761 (m), 724 (m), 
680 (w), 643 (w), 622 (w). 







A 250 mL RBF equipped with magnetic stirrer and rubber septum was flame-dried, then 
purged under a stream of N2 through an inlet needle. Triphenylphosphine oxide (2.78 g, 10.0 
mmol) was added followed by THF (90 mL) and stirring commenced. The temperature was 
adjusted to –78 °C with an acetone-dry ice bath and LDA (2.0 M in THF, 7.5 mL, 15.0 mmol) 
added dropwise over 15 minutes. The resulting mixture was stirred for 1 hour at –78 °C, then 
trimethylsilyl chloride (1.9 mL, 15.0 mmol) added in one portion. The stirred solution was 
allowed to return to room temperature overnight. After 16 hours the reaction was quenched by 
the addition of H2O (50 mL), then extracted into EtOAc (3 × 50 mL), and the combined organic 
extracts dried over MgSO4 then concentrated under reduced pressure. The residue was purified 
by column chromatography (eluent: 65:35 hexanes/EtOAc) to afford the title compound as a 
white solid (2.29 g, 65%). 
1H NMR (400 MHz, CDCl3): δ 7.89 – 7.83 (m, 1H), 7.60 – 7.39 (m, 11H), 7.29 (app. tdd, J 
= 7.5, 2.9, 1.3 Hz, 1H), 7.18 (dddd, J = 13.8, 7.7, 1.3, 0.6 Hz, 1H), 0.33 (s, 9H). 
13C NMR (100 MHz, CDCl3): δ 146.6 (d, J = 15.2 Hz), 137.1 (d, J = 106.0 Hz), 136.6 (d, 
J = 15.0 Hz), 134.5 (d, J = 100.7 Hz), 133.5 (d, J = 15.7 Hz), 132.2 (d, J = 9.7 Hz), 131.5 (d, 
J = 2.9 Hz), 130.5 (d, J = 2.9 Hz), 128.3 (d, J = 12.2 Hz), 127.6 (d, J = 13.3 Hz), 1.6 (s).  
31P NMR (162 MHz, CDCl3): δ 32.3 
νmax(neat)/cm-1: 3430 (w), 2945 (w), 1435 (m), 1242 (m), 1179 (m), 1116 (m), 1100 (m), 1054 
(w), 842 (s), 750 (m), 727 (s), 695 (m), 660 (m), 623 (w), 540 (s), 504 (m), 473 (m), 456 (m), 
441 (w). 
HRMS: Calcd. for C21H24OPSi: 351.1329 [M+H]+; found (ESI+): 351.1333 






2-(Trimethylsilyl)phenyl N,N-diethylcarbamate (153n) 
2-(Trimethylsilyl)phenol (1.11 g, 6.7 mmol), K2CO3 (1.38 g, 10.0 mmol) and MeCN (13.5 
mL) were added to a 50 mL RBF containing a magnetic stirrer bar and stirring commenced. 
Diethylcarbamoyl chloride (1.26 mL, 10.0 mmol) was added, then a condenser fitted to the 
flask and the reaction mixture heated at reflux for 3.5 hours. Once the reaction had cooled to 
room temperature, H2O (10 mL) was added, and the aqueous layer extracted with Et2O 
(3 × 10 mL). The combined organic extracts were dried over MgSO4 and concentrated under 
reduced pressure. The residue was purified by column chromatography (eluent: 100:0 → 80:20 
hexanes/EtOAc) to afford the title comound as a clear, colourless oil (0.89 g, 49%). 
1H NMR (400 MHz, CDCl3): δ 7.46 (dd, J = 7.3, 1.8 Hz, 1H), 7.37 (ddd, J = 8.1, 7.3, 1.8 Hz, 
1H), 7.18 (app. td, J = 7.4, 1.1 Hz, 1H), 7.04 (dd, J = 8.1, 1.0 Hz, 1H), 3.49 (q, J = 7.1 Hz, 
2H), 3.40 (q, J = 7.1 Hz, 2H), 1.26 (t, J = 7.1 Hz, 3H), 1.20 (t, J = 7.1 Hz, 3H), 0.28 (s, 9H). 
13C NMR (100 MHz, CDCl3): δ 156.5, 154.6, 135.0, 131.7, 130.5, 124.9, 122.4, 42.1, 41.7, 
14.4, 13.5, –0.7. 
νmax(neat)/cm-1: 2971 (w), 1714 (s), 1593 (w), 1541 (w), 1507 (w), 1468 (w), 1457 (w), 1411 
(m), 1379 (w), 1350 (w), 1315 (w), 1273 (m), 1257 (m), 1225 (w), 1187 (s), 1151 (s), 1125 
(m), 1098 (w), 1077 (m), 1042 (w), 960 (w), 937 (w), 836 (s), 786 (w), 747 (m), 715 (m), 691 
(w), 620 (w), 451 (w). 







A 150 mL RBF equipped with stirrer bar and rubber septum was flame-dried, then purged with 
N2 through an inlet needle. (2,5-Dibromophenyl)methanol (5.0 g, 18.8 mmol) was added 
followed by anhydrous DMF (60 mL), and stirring commenced. The solution was cooled to 0 
°C in an ice bath, then NaH (60% w/w dispersion in mineral oil, 1.60 g, 40.0 mmol) was added 
portion-wise. Following addition, the reaction mixture was stirred for 45 minutes at 0 °C, then 
methyl iodide (2.8 mL, 45.0 mmol) added via syringe in one portion. The mixture was allowed 
to return to room temperature and stirred for a further 3 hours. The reaction was quenched by 
addition of H2O (10 mL), then extracted into Et2O (3 × 50 mL). The combined organic extracts 
were washed with NaOH (3.0 M, 30 mL) then brine (30 mL), dried over MgSO4, and 
concentrated under reduced pressure to afford the title compound as a clear, colourless oil 
without the need for additional purification (5.10 g, 97%). 
1H NMR (400 MHz, CDCl3): δ 7.62 (m, 1H), 7.38 (d, J = 8.4 Hz, 1H), 7.29 – 7.24 (m, 1H), 
4.47 (s, 2H), 3.48 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ 139.9, 133.9, 131.9, 131.7, 121.7, 120.9, 73.4, 58.9. 
νmax(neat)/cm-1: 2922 (w), 2852 (w), 2819 (w), 1557 (w), 1540 (w), 1456 (m), 1387 (w), 1375 
(m), 1254 (w), 1198 (m), 1109 (m), 1082 (m), 1057 (w), 1024 (m), 975 (w), 928 (w), 882 (w), 
865 (w), 806 (m), 528 (w), 434 (w), 419 (w). 
HRMS: Calcd. for C8H8O79Br2: 277.8936 [M]+; found (EI+): 277.8944 
 
[3-(Methoxymethyl)-4-(trimethylsilyl)phenyl]trimethylsilane (153o) 
A 150 mL RBF fitted with stirrer bar and rubber septum was flame-dried, then purged with N2 
via an inlet needle. 1,4-Dibromo-2-(methoxymethyl)benzene (5.10 g, 18.2 mmol) and THF 
(50 mL) were added via syringe, stirring commenced, and the temperature adjusted to −78 °C 
with an external acetone-dry ice bath. n-Butyllithium (2.5 M in hexanes, 18.0 mL, 45.0 mmol) 
was added dropwise over 30 minutes. The solution was stirred for a further 45 minutes at 
−78 °C, then trimethylsilyl chloride (7.6 mL, 60.0 mmol) added via syringe in one portion. 
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The reaction mixture was allowed to return to room temperature overnight. The reaction was 
quenched by addition of H2O (30 mL) and extracted into Et2O (3 × 40 mL). The combined 
organic extracts were dried over MgSO4, concentrated in vacuo, and the residue purified by 
column chromatography (eluent: 19:1 hexanes/EtOAc) to afford the title compound as a clear, 
colourless oil that crystallised to a waxy solid on standing (1.70 g, 35%). 
1H NMR (400 MHz, CDCl3): δ 7.57 – 7.52 (m, 2H), 7.47 – 7.43 (dd, J = 7.1, 1.3 Hz, 1H), 
4.54 (s, 2H), 3.42 (s, 3H), 0.34 (s, 9H), 0.28 (s, 9H). 
13C NMR (100 MHz, CDCl3): δ 142.6, 141.6, 139.4, 134.2, 133.5, 132.2, 75.4, 58.2, 0.4, -1.0. 
νmax(neat)/cm-1: 2955 (w), 2928 (w), 2896 (w), 1456 (w), 1378 (w), 1244 (m), 1199 (m), 1144 
(m), 1121 (m), 1107 (m), 978 (w), 902 (w), 831 (s), 813 (s), 747 (s), 688 (m), 637 (m), 619 
(m), 543 (w), 480 (w), 428 (m), 




Tert-butyl 2-(trimethylsilyl)phenyl carbonate (153t) 
2-(Trimethylsilyl)phenol (1.66 g, 10.0 mmol) was added to a 100 mL RBF equipped with 
stirrer bar, followed by CH2Cl2 (30 mL), di-tert-butyldicarbonate (2.62 g, 12.0 mmol), and 
dimethylaminopyridine (DMAP, 1.47 g, 12.0 mmol). The reaction mixture was stirred at room 
temperature overnight, then dry-loaded onto silica and purified by column chromatography 
(eluent: 100:0 → 80:20 hexanes/EtOAc) to afford the title compound as a clear, colourless oil 
(1.65 g, 62%). 
1H NMR (400 MHz, CDCl3): δ 7.46 (dd, J = 7.4, 1.8 Hz, 1H), 7.39 (ddd, J = 8.1, 7.4, 1.8 Hz, 
1H), 7.21 (app. td, J = 7.4, 1.1 Hz, 1H), 7.11 (dd, J = 8.1, 1.0 Hz, 1H), 1.55 (s, 9H), 0.30 (s, 
9H). 




νmax(neat)/cm-1: 2979 (w), 1755 (s), 1717 (w), 1595 (w), 1541 (w), 1507 (w), 1472 (w), 1457 
(w), 1436 (w), 1395 (w), 1369 (w), 1273 (m), 1246 (s), 1202 (w), 1141 (s), 1081 (m), 1048 
(w), 1015 (w), 892 (w), 838 (m), 783 (m), 753 (m), 732 (m), 710 (w), 693 (w), 676 (w), 621 
(w), 603 (w), 453(w). 




A 250 mL RBF equipped with magnetic stirrer bar and rubber septum was flame-dried then 
purged with N2 via an inlet needle. 2-Bromoacetophenone (4.0 mL, 29.8 mmol) was added by 
syringe followed by dry Et2O (300 mL), and stirring commenced. The solution was cooled to 
−10 °C in an ice-salt bath, then MeMgBr (3.0 M in Et2O, 15.9 mL, 47.7 mmol) added dropwise 
over 30 minutes. The reaction was allowed to return to room temperature overnight, then 
poured onto ice (100 g) and sat. NH4Cl (100 mL) added. The mixture was transferred to a 
separating funnel and the aqueous phase extracted with additional Et2O (3 x 200 mL). The 
combined organic extracts were dried over MgSO4, concentrated under reduced pressure, and 
the residue purified by column chromatography (eluent: 100:0 → 80:20 hexanes/EtOAc) to 
afford the title compound as a clear, colourless oil (1.15 g, 18%). 
1H NMR (400 MHz, CDCl3): δ 7.67 (dd, J = 7.9, 1.7 Hz, 1H), 7.58 (dd, J = 7.9, 1.4 Hz, 1H), 
7.30 (ddd, J = 7.9, 7.3, 1.4 Hz, 1H), 7.10 (ddd, J = 7.9, 7.3, 1.7 Hz, 1H), 1.76 (s, 6H). 
13C NMR (100 MHz, CDCl3): δ 146.2, 135.2, 128.7, 127.7, 127.4, 120.6, 73.7, 29.7. 
νmax(neat)/cm-1: 3402 (br w), 2971 (w), 2929 (w), 1463 (w), 1424 (w), 1363 (w), 1336 (w), 
1266 (w), 1230 (w), 1170 (m), 1138 (w), 1097 (w), 1047 (w), 1017 (m), 951 (m), 856 (w), 754 
(m), 724 (m), 651 (w), 564 (w). 





Note: The NBS catalysed silylation reaction was based on a literature procedure.9 
2-(2-Bromophenyl)propan-2-ol (1.12 g, 5.2 mmol) was added to a flame-dried, N2-purged, 
100 mL RBF containing a magnetic stirrer bar, and fitted with a rubber septum and inlet 
needle. MeCN (15 mL) was added via syringe, followed by hexamethyldisilazane (HMDS, 
0.77 mL, 3.7 mmol). The resulting solution was stirred for 15 mins at room temperature, then 
N-bromosuccinimide (NBS, 46 mg, 0.25 mmol) added in one portion. The temperature was 
adjusted to 50 °C and stirring maintained for a further 2 hours. The reaction mixture was then 
concentrated under reduced pressure, diluted with hexane (5 mL), and washed through a short 
plug of silica. The resulting solution was then concentrated in vacuo, and the crude oil 
transferred to a second flame-dried, N2-purged, 100 mL RBF (again fitted with a septum and 
inlet needle). THF (15 mL) was added, and the solution cooled to −78 °C in an acetone-dry 
ice bath. BuLi (2.3 M in hexane, 2.4 mL, 5.5 mmol) was added by syringe over approximately 
15 minutes, and the solution allowed to return to room temperature overnight. After 16 hours, 
the mixture was quenched by the addition of H2O (10 mL), and extracted into Et2O 
(3 × 20 mL). The combined organic extracts were dried over MgSO4, concentrated in vacuo, 
and the resulting crude oil purified by column chromatography (eluent: 9:1 hexanes/EtOAc) 
to afford the title compound as a clear, colourless oil (0.65 g, 60%). 
1H NMR (400 MHz, CDCl3): δ 7.74 – 7.65 (m, 1H), 7.37 – 7.29 (m, 1H), 7.26 – 7.17 (m, 
2H), 1.64 (s, 1H), 1.61 (s, 6H), 0.34 (s, 9H). 
13C NMR (100 MHz, CDCl3): δ 155.0, 136.4, 136.0, 128.9, 125.9, 125.2, 75.0, 33.4, 3.5.  
νmax(neat)/cm-1: 2948 (w), 2898 (w), 1362 (w), 1243 (m), 1180 (w), 1115 (m), 1099 (w), 1064 
(w), 958 (w), 836 (m), 764 (m), 731 (m), 667 (m), 622 (w), 561 (w), 470 (w). 







Prepared according to the following modified literature procedure:22 
A Schlenk tube equipped with magnetic stirrer bar was flame-dried, then evacuated and 
backfilled with N2 three times. 4,4-Dimethyl-2-phenyl-4,5-dihydrooxazole (1.05 g, 6 mmol) 
and Et2O (6 mL) were added sequentially via syringe and stirring commenced. The 
temperature was adjusted to 0 °C in an ice-water bath, then n-butyllithium (2.5 M in hexanes, 
2.4 mL, 6.0 mmol) added dropwise over approximately 10 mins. The reaction mixture was 
stirred at 0 °C for 1 hour, then trimethylsilyl chloride (0.76 mL, 6.0 mmol) added dropwise 
via syringe. The resulting solution was allowed to return to room temperature overnight. After 
14 hours, the reaction mixture was quenched by addition of H2O (10 mL). Additional Et2O (10 
mL) was added, the layers separated, and the aqueous phase further extracted with Et2O (3 × 
10 mL). The combined organic extracts were dried over MgSO4 and concentrated under 
reduced pressure. The residue was purified by column chromatography (eluent: 100:0 → 80:20 
hexanes/EtOAc) to afford the title compound as a clear, colourless oil (1.05 g, 71%). 
1H NMR (400 MHz, CDCl3): δ 7.91 – 7.87 (m, 1H), 7.65 – 7.60 (m, 1H), 7.39 (app. pd, J = 
7.4, 1.6 Hz, 2H), 4.10 (s, 2H), 1.39 (s, 6H), 0.32 (s, 9H). 
13C NMR (100 MHz, CDCl3): δ 163.6, 140.2, 135.2, 133.8, 129.7, 129.5, 128.7, 79.1, 67.8, 
28.5, 0.7.  
νmax(neat)/cm-1: 2964 (w), 2892 (w), 1653 (m), 1457 (w), 1363 (w), 1349 (w), 1307 (w), 1242 
(m), 1188 (w), 1128 (w), 1092 (m), 1057 (w), 1038 (m), 991 (w), 967 (w), 837 (s), 779 (w), 
750 (w), 729 (m), 688 (m), 656 (m), 618 (w), 470 (w). 







A 25 mL RBF equipped with magnetic stirrer bar and rubber septum was flame-dried, then 
purged with a stream of N2 through an inlet needle. 3-[2-(Trimethylsilyl)phenyl]propan-1-ol 
(1.11 g, 5.4 mmol) and DMF (7.5 mL) were added and stirring commenced. The temperature 
was adjusted to 0 °C with an ice-water bath, then NaH (60% w/w dispersion in mineral oil, 
0.40 g, 10.0 mmol) was added portionwise with concurrent evolution of H2 gas. The reaction 
mixture was stirred at 0 °C for 45 mins, then methyl iodide (1.67 mL, 26.7 mmol) added in 
one portion and the reaction allowed to return to room temperature. After 14 hours, the reaction 
was cooled to 0 °C and carefully quenched by the slow addition of MeOH (2 mL) then H2O 
(10 mL). Et2O (20 mL) was added, the layers separated, and the aqueous phase extracted with 
additional Et2O (3 × 15 mL). The combined organic extracts were washed with H2O (20 mL) 
then brine (2 × 20 mL), dried over MgSO4, and concentrated under reduced pressure (Note: 
~2 mL Et3N was added to the distillate to quench any remaining methyl iodide). The residue 
was purified by column chromatography (eluent: 9:1 hexanes/EtOAc) to afford the title 
compound as a clear, colourless oil (0.91 g, 77%).  
1H NMR (400 MHz, CDCl3): δ 7.51 – 7.45 (m, 1H), 7.35 – 7.28 (m, 1H), 7.25 – 7.15 (m, 
2H), 3.46 (app. td, J = 6.4, 1.0 Hz, 2H), 3.37 (d, J = 1.0 Hz, 3H), 2.84 – 2.75 (m, 2H), 1.95 – 
1.85 (m, 2H), 0.34 (s, 9H). 
13C NMR (100 MHz, CDCl3): δ 148.0, 138.3, 134.7, 129.4, 128.7, 125.3, 72.6, 58.8, 32.8, 
32.4, 0.6. 
νmax(neat)/cm-1: 2952 (w), 2894 (w), 2869 (w), 1472 (w), 1456 (w), 1435 (w), 1385 (w), 1261 
(w), 1248 (m), 1117 (m), 1084 (w), 834 (s), 752 (m), 727 (m), 687 (w), 622 (w), 455 (w), 419 
(w). 






3-[2-(Trimethylsilyl)phenyl]propyl 2,2-dimethylpropanoate (153x) 
A 25 mL RBF fitted with magnetic stirrer bar and rubber septum was flame-dried and purged 
with N2. 3-[2-(Trimethylsilyl)phenyl]propan-1-ol (208 mg, 1.0 mmol) was added followed by 
CH2Cl2 (2.5 mL) and stirring commenced. PivCl (0.18 mL, 1.5 mmol) and Et3N (0.21 mL, 
1.5 mmol) were added via syringe. The reaction was stirred overnight, then dry-loaded onto 
celite and purified by column chromatography (eluent: 9:1 hexanes/EtOAc) to afford the title 
compound as a clear, colourless oil (273 mg, 93%). 
1H NMR (400 MHz, CDCl3): δ 7.48 (dd, J = 7.5, 1.3 Hz, 1H), 7.32 (app. td, J = 7.5, 1.5 Hz, 
1H), 7.23 – 7.12 (m, 2H), 4.16 (t, J = 6.5 Hz), 2.81 (m, 2H), 1.96 (m, 2H), 1.22 (s, 9H), 0.34 
(s, 9H). 
13C NMR (100 MHz, CDCl3): δ 178.8, 147.3, 138.3, 134.8, 129.5, 128.7, 125.5, 64.5, 39.0, 
32.9, 31.5, 27.4, 0.6. 
νmax(neat)/cm-1: 2956 (w), 1727 (m), 1282 (m), 1262 (w), 1249 (m), 1149 (m), 1127 (w), 1087 
(w), 835 (m), 753 (m), 727 (m), 688 (w), 622 (w). 




2-Bromo-3-methylbenzoic acid (10.0 g, 46.5 mmol) was added to a 1 L round-bottomed flask 
followed by dry THF (200 mL) and stirring commenced. The temperature was adjusted to 
0 °C, then BH3•THF (1.0 M in THF, 70 mL, 70 mmol) was added dropwise (Note: significant 
amount of H2 gas evolved). The solution was allowed to stir at room temperature overnight. 
H2O (approx. 10 mL) was added cautiously, and after the gas evolution had ceased, sat. 
Na2CO3 (100 mL) was added and the reaction mixture extracted into EtOAc (3 × 100 mL). 
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The combined organic extracts were dried over MgSO4 and concentrated in vacuo to yield a 
pale yellow solid. Recrystallisation from refluxing hexane afforded the title compound as a 
white crystalline solid (5.88 g, 63%). 
1H NMR (400 MHz, CDCl3): δ 7.28 (m, 1H), 7.25 – 7.15 (m, 2H), 4.75 (s, 2H), 2.42 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ 140.2, 138.6, 130.2, 127.3, 126.4, 125.3, 65.8, 23.5. 
νmax(neat)/cm-1: 3248 (m, br), 2917 (w), 2856 (w), 1452 (m), 1407 (m), 1372 (m), 1349 (m), 
1240 (m), 1168 (w), 1056 (s), 1025 (m), 988 (m), 900 (w), 769 (m), 759 (m), 695 (w), 644 
(m), 618 (m, br), 531 (w). 
HRMS calcd. For C8H9O79Br: 199.9831 [M]+; found (EI+): 199.9838 
mp: 88 – 91 °C (hexane) 
 
[3-Methyl-2-(trimethylsilyl)phenyl]methanol (155a) 
A 50 mL RBF equipped with stirrer bar and rubber septum was flame-dried then purged with 
N2 through an inlet needle. (2-Bromo-3-methylphenyl)methanol (1.00 g, 5.0 mmol), CH2Cl2 
(10 mL), and hexamethyldisilazane (HMDS, 0.73 mL, 3.5 mmol) were added via syringe (in 
that order) and stirring commenced. A single crystal of iodine was added, then stirring was 
maintained at room temperature for 15 minutes. Solid Na2S2O3 (approx. 3 g) was added and 
the reaction mixture stirred for a further 30 minutes, then passed through a short pad of silica. 
The resulting solution was then concentrated in vacuo, and the crude oil transferred to a second 
flame-dried, N2-purged, round-bottomed flask (again fitted with rubber septum and inlet 
needle). THF (20 mL) was added, and the solution cooled to −78 °C in an acetone-dry ice bath. 
n-Butyllithium (2.5 M in hexanes, 2.4 mL, 6.0 mmol) was added by syringe over 
approximately 15 minutes, and the solution allowed to return to room temperature overnight. 
The mixture was quenched by the addition of H2O (10 mL) and extracted into EtOAc 
(3 × 20 mL). The combined organic extracts were dried over MgSO4, concentrated in vacuo, 
and the resulting oil purified by column chromatography (eluent: 9:1 hexanes/EtOAc) to afford 
the title compound as a pale yellow oil (0.75 g, 77%). 
1H NMR (400 MHz, CDCl3): δ 7.30 – 7.24 (m, 2H), 7.15 – 7.08 (m, 1H), 4.76 (s, 2H), 2.51 
(s, 3H), 0.45 (s, 9H). 
13C NMR (100 MHz, CDCl3): δ 147.0, 144.8, 137.2, 130.4, 129.2, 126.4, 66.2, 24.8, 3.4. 
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νmax(neat)/cm-1: 3307 (w, br), 2952 (w), 2897 (w), 1557 (w), 1540 (w), 1520 (w), 1507 (w), 
1472 (w), 1456 (w), 1445 (w), 1417 (w), 1377 (w), 1249 (m), 1129 (w), 1056 (w), 1018 (w), 
835 (s), 792 (m), 760 (m), 725 (m), 679 (w), 642 (w), 619 (w). 




[3-Methyl-2-(trimethylsilyl)phenyl]methyl 2,2-dimethylpropanoate (155b) 
A 25 mL RBF fitted with magnetic stirrer bar and rubber septum was flame-dried and purged 
with N2. [3-Methyl-2-(trimethylsilyl)phenyl]methanol (388 mg, 2.0 mmol) was added 
followed by CH2Cl2 (5 mL) and stirring commenced. PivCl (0.36 mL, 3.0 mmol) and Et3N 
(0.42 mL, 3.0 mmol) were added via syringe. The reaction was stirred overnight, then dry-
loaded onto celite and purified by column chromatography (eluent: 19:1 hexanes/EtOAc) to 
afford the title compound as a clear, colourless oil (362 mg, 65%). 
1H NMR (400 MHz, CDCl3): δ 7.28 – 7.17 (m, 2H), 7.12 (dd, J = 7.4, 1.6 Hz, 1H), 5.17 (s, 
2H), 2.50 (s, 3H), 1.22 (s, 9H), 0.43 (s, 9H).  
13C NMR (100 MHz, CDCl3): δ 178.4, 144.5, 141.9, 137.7, 130.7, 129.1, 127.5, 67.3, 38.9, 
27.4, 24.8, 3.3. 
νmax(neat)/cm-1: 2971 (w), 2904 (w), 1726 (m), 1698 (w), 1683 (w), 1558 (w), 1540 (w), 1507 
(w), 1478 (w), 1456 (w), 1447 (w), 1417 (w), 1396 (w), 1363 (w), 1280 (w), 1251 (m), 1142 
(s), 1057 (w), 1032 (w), 957 (w), 940 (w), 838 (m), 783 (m), 768 (m), 725 (w), 681 (w), 645 
(w). 






[3-Methyl-2-(trimethylsilyl)phenyl]methyl acetate (155c) 
A 25 mL RBF fitted with magnetic stirrer bar and rubber septum was flame-dried and purged 
with N2. [3-Methyl-2-(trimethylsilyl)phenyl]methanol (180 mg, 0.9 mmol) was added 
followed by CH2Cl2 (2.5 mL) and stirring commenced. Acetic anhydride (0.15 mL, 1.6 mmol) 
and triethylamine (0.23 mL, 1.6 mmol) were added via syringe, then 4-dimethylaminopyridine 
(DMAP, 12.2 mg, 10 mol%) added in one portion. After 14 hours, the reaction mixture was 
dry-loaded onto celite and purified by column chromatography (eluent: 9:1 hexanes/EtOAc) 
to afford the title compound as a clear, colourless oil (175 mg, 80%). 
1H NMR (400 MHz, CDCl3): δ 7.28 – 7.22 (m, 1H), 7.21 – 7.17 (m, 1H), 7.15 – 7.11 (m, 
1H), 5.17 (s, 2H), 2.50 (s, 3H), 2.09 (s, 3H), 0.42 (s, 9H). 
13C NMR (100 MHz, CDCl3): δ 170.9, 144.8, 141.5, 138.1, 131.0, 129.1, 128.0, 67.7, 24.8, 
21.3, 3.2. 
νmax(neat)/cm-1: 2954 (w), 1736 (s), 1698 (w), 1472 (w), 1455 (w), 1447 (w), 1417 (w), 1376 
(w), 1360 (w), 1230 (s), 1132 (w), 1023 (m), 966 (w), 836 (s), 785 (m), 765 (m), 724 (m), 681 
(m), 657 (w), 633 (w), 606 (w). 





(2-Bromo-3-methylphenyl)methanol (1.40 g, 7.0 mmol) was added to a flame-dried, 
N2-purged, round-bottomed flask containing a magnetic stirrer bar, and fitted with a rubber 
septum and inlet needle. CH2Cl2 (20 mL) was added via syringe, followed by triethylsilyl 
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chloride (1.77 mL, 10.5 mmol) and imidazole (0.71 g, 10.5 mmol). The resulting solution was 
stirred for 15 hours at room temperature. The reaction mixture was then concentrated under 
reduced pressure, diluted with hexane (10 mL), and washed through a short plug of silica. The 
resulting solution was then concentrated in vacuo, and the crude oil transferred to a second 
flame-dried, N2-purged, round-bottomed flask (again fitted with a septum and inlet needle). 
THF (20 mL) was added, and the solution cooled to −78 °C in an acetone-dry ice bath. 
n-Butyllithium (2.5 M in hexanes, 4.2 mL, 10.5 mmol) was added by syringe over 
approximately 15 minutes, and the solution allowed to return to room temperature overnight. 
After 14 hours, the mixture was quenched by the addition of H2O (20 mL) and extracted into 
Et2O (3 × 20 mL). The combined organic extracts were dried over MgSO4, concentrated in 
vacuo, and the resulting crude oil purified by column chromatography (eluent: 9:1 
hexanes/EtOAc) to afford the title compound as a pale yellow oil (1.07 g, 65%). 
1H NMR (400 MHz, CDCl3): δ 7.30 – 7.22 (m, 2H), 7.12 – 7.06 (m, 1H), 4.72 (d, J = 5.6 Hz, 
2H), 2.49 (s, 3H), 1.43 (br t, J = 5.7 Hz, 1H), 0.96 (app. s, 15H). 
13C NMR (100 MHz, CDCl3): δ 147.8, 145.2, 134.7, 130.3, 129.0, 126.3, 66.1, 24.6, 8.0, 6.2. 
νmax(neat)/cm-1: 3307 (br w), 2952 (m), 2907 (w), 2873 (w), 1456 (w), 1445 (w), 1417 (w), 
1396 (w), 1376 (w), 1237 (w), 1055 (w), 999 (m), 792 (w), 766 (w), 725 (m), 694 (m), 677 
(m), 601 (w). 





A 150 mL RBF equipped with stirrer bar and rubber septum was flame-dried, then purged with 
N2 through an inlet needle. (2-Bromo-3-methylphenyl)methanol (2.01 g, 10.0 mmol) was 
added via syringe followed by anhydrous DMF (30 mL), and stirring commenced. The 
solution was cooled to 0 °C in an ice bath, then NaH (60% w/w dispersion in mineral oil, 0.80 
g, 20.0 mmol) was added portion-wise. Following addition, the reaction mixture was stirred 
for 45 minutes at 0 °C, then methyl iodide (1.87 mL, 30.0 mmol) added via syringe in one 
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portion. The mixture was allowed to return to room temperature and stirred for a further 3 
hours. The reaction was quenched by addition of H2O (10 mL), then extracted into Et2O 
(3 × 50 mL). The combined organic extracts were washed with NaOH (3.0 M, 30 mL) then 
brine (30 mL), dried over MgSO4, and concentrated under reduced pressure to afford the title 
compound as a clear, colourless oil without the need for additional purification (1.81 g, 84%). 
1H NMR (400 MHz, CDCl3): 7.32 – 7.27 (m, 1H), 7.25 – 7.15 (m, 2H), 4.54 (s, 2H), 3.48 
(s, 3H), 2.42 (s, 3H). 
13C NMR (100 MHz, CDCl3): 138.5, 138.1, 129.9, 127.1, 126.4, 125.3, 74.7, 58.8, 23.6. 
νmax(neat)/cm-1: 2922 (w), 2853 (w), 2818 (w), 1683 (w), 1557 (w), 1540 (w), 1507 (w), 
1455 (w), 1417 (w), 1379 (w), 1365 (w), 1195 (w), 1114 (m), 1098 (m), 1026 (m), 979 (w), 
955 (w), 936 (w), 906 (w), 891 (w), 771 (m), 720 (w), 702 (w), 656 (w). 
HRMS: Calcd. for C9H11O79Br: 213.9988 [M]+; found (EI+): 213.9978 
 
[2-(Methoxymethyl)-6-methylphenyl]trimethylsilane (155e) 
A 150 mL RBF fitted with stirrer bar and rubber septum was flame-dried, then purged with N2 
via an inlet needle. 2-Bromo-1-(methoxymethyl)-3-methylbenzene (1.81 g, 8.4 mmol) and 
THF (20 mL) were added via syringe, stirring commenced, and the temperature adjusted to 
−78 °C with an external acetone-dry ice bath. n-Butyllithium (2.3 M in hexanes, 4.35 mL, 10.0 
mmol) was added dropwise over 20 minutes. The solution was stirred for a further 45 minutes 
at −78 °C, then trimethylsilyl chloride (1.52 mL, 12.0 mmol) added via syringe in one portion. 
The reaction mixture was allowed to return to room temperature overnight. The reaction was 
quenched by addition of H2O (10 mL) and extracted into Et2O (3 × 20 mL). The combined 
organic extracts were dried over MgSO4, concentrated in vacuo, and the residue purified by 
column chromatography (eluent: 100:0 → 90:10 hexanes/EtOAc) to afford the title compound 
as a clear, colourless oil (1.70 g, 97%). 
1H NMR (400 MHz, CDCl3): δ 7.25 – 7.16 (m, 2H), 7.11 – 7.06 (m, 1H), 4.49 (s, 2H), 3.34 
(s, 3H), 2.49 (s, 3H), 0.41 (s, 9H). 




νmax(neat)/cm-1: 2977 (w), 2950 (w), 2926 (w), 2894 (w), 1456 (w), 1446 (w), 1417 (w), 
1380 (w), 1248 (m), 1190 (w), 1130 (w), 1091 (m), 1056 (w), 926 (w), 837 (m), 790 (m), 
761 (m), 724 (m), 680 (w), 643 (w), 622 (w). 
HRMS: Calcd. for C12H20OSi: 208.1278 [M]+; found (EI+): 208.1262 
 
 




Analytical sample prepared according to General Procedure C (PTLC eluent: hexanes). 
1H NMR (400 MHz, CDCl3): δ 7.38 – 7.31 (m, 1H), 7.29 – 7.18 (m, 3H), 7.04 (d, J = 3.8 Hz, 
1H), 6.81 (d, J = 3.8 Hz, 1H), 2.42 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ 144.9, 136.3, 133.5, 131.0, 130.4, 130.1, 128.4, 126.8, 126.2, 
111.7, 21.1. 
νmax(neat)/cm-1: 1507 (m), 1486 (m), 1455 (w), 1429 (w), 1378 (w), 1204 (w), 976 (m), 936 
(w), 798 (m), 754 (s), 733 (w), 720 (m), 679 (w), 450 (w), 422 (w). 




Analytical sample prepared according to General Procedure C (PTLC eluent: hexanes). 
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1H NMR (400 MHz, CDCl3): δ 7.35 – 7.28 (m, 3H), 7.24 – 7.18 (m, 1H), 7.03 (d, J = 3.7 Hz, 
1H), 6.77 (d, J = 3.7 Hz, 1H), 2.74 (q, J = 7.5 Hz, 2H), 1.19 (t, J = 7.6 Hz, 3H). 
13C NMR (100 MHz, CDCl3): δ 144.7, 142.8, 133.0, 131.0, 130.0, 129.2, 128.8, 126.8, 125.9, 
111.6, 26.6, 15.9. 
νmax(neat)/cm-1: 2964 (w), 2928 (w), 2870 (w), 1558 (w), 1541 (w), 1507 (w), 1484 (w), 1447 
(w), 1430 (w), 1373 (w), 1202 (w), 1054 (w), 978 (m), 937 (w), 796 (m), 755 (m), 733 (w), 
675 (w). 




Analytical sample prepared according to General Procedure C (PTLC eluent: hexanes). 
1H NMR (400 MHz, CDCl3): δ 7.41 – 7.33 (m, 2H), 7.30 – 7.27 (m, 1H), 7.22 – 7.16 (m, 
1H), 7.03 (d, J = 3.7 Hz, 1H), 6.73 (d, J = 3.7 Hz, 1H), 3.27 (hept, J = 6.9 Hz, 1H), 1.21 (d, J 
= 6.9 Hz, 6H). 
13C NMR (100 MHz, CDCl3): δ 147.9, 144.7, 132.3, 131.2, 129.9, 129.1, 127.0, 126.0, 125.6, 
111.6, 29.7, 24.5. 
νmax(neat)/cm-1: 2960 (w), 2924 (w), 1557 (w), 1540 (w), 1507 (w), 1483 (w), 1456 (w), 1446 
(w), 1431 (w), 1362 (w), 1205 (w), 1088 (w), 1054 (w), 1032 (w), 977 (m), 938 (w), 796 (m), 
757 (m), 731 (w), 676 (w), 503 (w), 464 (w). 






Prepared according to General Procedure A (reaction time: 16 hours). The residue was purified 
by column chromatography (eluent: 3:1 hexanes/EtOAc) to afford the title compound as a pale 
yellow oil (161 mg, 60%). 
1H NMR (400 MHz, CDCl3): δ 7.57 – 7.51 (m, 1H), 7.43 – 7.31 (m, 3H), 7.06 (d, J = 3.8 Hz, 
1H), 6.95 (d, J = 3.8 Hz, 1H), 4.73 (s, 2H), 1.70 (br s, 1H). 
13C NMR (100 MHz, CDCl3): δ 143.3, 138.6, 133.1, 130.8, 130.4, 129.2, 128.8, 128.2, 127.5, 
112.4, 63.5. 
νmax(neat)/cm-1: 3294 (br w), 3060 (w), 2921 (w), 2883 (w), 1480 (w), 1449 (w), 1431 (m), 
1310 (w), 1193 (w), 1161 (w), 1096 (w), 1028 (w), 999 (m), 977 (m), 938 (w), 798 (w), 755 
(s), 688 (m), 633 (w), 590 (w), 575 (w), 530 (w), 516 (m), 504 (m), 441 (w), 420 (w). 




Prepared according to General Procedure A (reaction time: 12 hours). The residue was purified 
by column chromatography (eluent: 80:20 hexanes/EtOAc) to afford the title compound as a 
yellow oil (152 mg, 54%). 
1H NMR (400 MHz, CDCl3): δ 7.36 – 7.32 (m, 3H), 7.29 – 7.23 (m, 1H), 7.03 (d, J = 3.8 Hz, 
1H), 6.80 (d, J = 3.8 Hz, 1H), 3.79 (t, J = 6.9 Hz, 2H), 3.00 (t, J = 6.9 Hz, 2H), 1.40 (br s, 1H). 
13C NMR (100 MHz, CDCl3): δ 144.2, 137.1, 133.9, 131.5, 130.4, 130.1, 128.8, 127.2, 126.7, 
112.0, 63.5, 36.6. 
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νmax(neat)/cm-1: 3306 (br w), 2931 (w), 2873 (w), 1483 (w), 1447 (w), 1431 (m), 1198 (w), 
1040 (m), 977 (m), 938 (w), 797 (m), 755 (s), 683 (w), 587 (w), 575 (w), 516 (w), 489 (w). 




Prepared according to General Procedure A (reaction time: 16 hours). The residue was purified 
by column chromatography (eluent: 3:1 hexanes/EtOAc) to afford the title compound as a 
viscous, pale yellow oil (237 mg, 80%). 
1H NMR (400 MHz, CDCl3): δ 7.34 – 7.28 (m, 3H), 7.25 – 7.20 (m, 1H), 7.03 (d, J = 3.7 
Hz, 1H), 6.78 (d, J = 3.7 Hz, 1H), 3.62 (t, J = 6.8 Hz, 2H), 2.86 – 2.77 (m, 2H), 1.85 – 1.76 
(m, 2H), 1.31 (br s, 1H). 
13C NMR (100 MHz, CDCl3): δ 144.5, 140.5, 133.2, 131.3, 130.1, 129.9, 128.8, 126.9, 
126.2, 111.8, 62.5, 34.4, 29.8. 
νmax(neat)/cm-1: 3308 (br w), 2932 (w), 2866 (w), 1483 (w), 1447 (w), 1431 (w), 1200 (w), 
1161 (w), 1054 (m), 977 (m), 940 (w), 796 (m), 755 (m), 681 (w), 575 (w), 516 (w), 420 (w). 




Analytical sample prepared according to General Procedure C (PTLC eluent: 3:1 
hexanes/EtOAc). 
1H NMR (400 MHz, CDCl3): δ 7.47 – 7.41 (m, 1H), 7.39 – 7.32 (m, 2H), 7.32 – 7.26 (m, 
1H), 7.04 (d, J = 3.7 Hz, 1H), 6.84 (d, J = 3.7 Hz, 1H), 3.04 (s, 2H), 1.15 (s, 6H). 
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13C NMR (100 MHz, CDCl3): δ 145.3, 136.7, 134.7, 131.9, 131.7, 130.1, 128.3, 127.5, 
126.8, 112.0, 71.7, 45.4, 29.7. 
νmax(neat)/cm-1: 3339 (w, br), 2977 (w), 2964 (w), 2919 (w), 2849 (w), 1487 (w), 1472 (w), 
1457 (w), 1446 (m), 1420 (w), 1377 (w), 1362 (m), 1316 (w), 1229 (w), 1197 (w), 1155 (m), 
1142 (m), 1131 (m), 974 (m), 894 (m), 831 (w), 806 (m), 773 (w), 759 (s), 722 (w), 682 (m), 
618 (w), 591 (w), 521 (w), 493 (w). 




Analytical sample prepared according to General Procedure C (PTLC eluent: 4:1 
hexanes/EtOAc). 
1H NMR (400 MHz, CDCl3): δ 7.37 – 7.17 (m, 4H), 7.05 (d, J = 3.8 Hz, 1H), 6.80 (d, J = 
3.7 Hz, 1H), 3.21 (s, 2H), 2.90 (s, 2H), 0.77 (s, 6H). 
13C NMR (100 MHz, CDCl3): δ 145.6, 137.5, 134.3, 132.3, 131.5, 129.9, 127.8, 127.2, 
126.3, 111.7, 71.1, 40.0, 37.6, 24.2. 
νmax(neat)/cm-1: 3335 (w, br), 2955 (w), 2922 (w), 2867 (w), 1472 (w), 1457 (w), 1446 (w), 
1430 (w), 1387 (w), 1363 (w), 1201 (w), 1037 (m), 977 (m), 940 (w), 797 (w), 759 (m), 723 
(w), 684 (w), 670 (w), 594 (w). 






Analytical sample prepared according to General Procedure C (PTLC eluent: 4:1 
hexanes/EtOAc). 
1H NMR (400 MHz, CDCl3): δ 7.35 – 7.23 (m, 4H), 7.03 (d, J = 3.7 Hz, 1H), 6.80 (d, J = 
3.7 Hz, 1H), 3.03 (s, 2H), 1.19 (s, 6H), 0.70 (s, 6H). 
13C NMR (100 MHz, CDCl3): δ 146.0, 138.6, 135.0, 132.8, 131.6, 129.9, 127.7, 127.3, 
126.3, 111.6, 75.7, 42.6, 37.7, 25.5, 21.6. 
νmax(neat)/cm-1: 2971 (w), 1472 (w), 1456 (w), 1447 (w), 1431 (w), 1374 (w), 1264 (w), 
1200 (w), 1163 (w), 1129 (w), 1109 (w), 1079 (w), 978 (m), 940 (w), 872 (w), 799 (w), 759 
(m), 737 (m), 704 (w), 687 (w), 504 (w). 




Prepared according to General Procedure B (reaction time: 1 hour). The residue was purified 
by column chromatography (eluent: 9:1 hexanes/EtOAc) to afford the title compound as a 
clear, colourless oil (127 mg, 90%). 
1H NMR (400 MHz, CDCl3): δ 7.55 – 7.51 (m, 1H), 7.45 – 7.34 (m, 3H), 7.08 (d, J = 3.8 Hz, 
1H), 6.95 (d, J = 3.8 Hz, 1H), 4.46 (s, 2H), 3.43 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ 143.5, 135.8, 133.7, 130.7, 130.3, 130.2, 128.5, 128.3, 127.5, 
112.4, 72.9, 58.2. 
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νmax(neat)/cm-1: 2921 (w), 2869 (w), 2819 (w), 1484 (w), 1448 (w), 1430 (w), 1380 (w), 1191 
(w), 1117 (w), 1090 (m), 978 (m), 960 (w), 938 (w), 907 (w), 840 (w), 798 (m), 757 (m), 684 
(w), 616 (w), 590 (w), 516 (w), 487 (w), 443 (w), 418 (w). 




Prepared according to General Procedure A (reaction time: 10 hours). The residue was purified 
by column chromatography (eluent: 9:1 hexanes/EtOAc) to afford the title compound as a 
clear, colourless oil (282 mg, 95%). 
1H NMR (400 MHz, CDCl3): δ 7.36 – 7.29 (m, 3H), 7.27 – 7.21 (m, 1H), 7.03 (d, J = 3.7 Hz, 
1H), 6.80 (d, J = 3.7 Hz, 1H), 3.54 (t, J = 7.2 Hz, 2H), 3.31 (s, 3H), 3.00 (t, J = 7.2 Hz, 2H). 
13C NMR (100 MHz, CDCl3): δ 144.3, 137.5, 133.7, 131.2, 130.3, 130.1, 128.7, 127.1, 126.5, 
111.8, 73.3, 58.8, 33.6. 
νmax(neat)/cm-1: 2922 (w), 2869 (w), 2823 (w), 2805 (w), 1485 (w), 1448 (w), 1431 (w), 1381 
(w), 1197 (w), 1110 (m), 1054 (w), 997 (w), 977 (m), 938 (w), 797 (m), 757 (m), 679 (w), 586 
(w), 517 (w), 495 (w). 






Prepared according to General Procedure B (reaction time: 12 hours). The residue was purified 
by column chromatography (eluent: 19:1 hexanes/EtOAc) to afford the title compound as a 
clear, colourless oil (154 mg, 91%). 
1H NMR (400 MHz, CDCl3): δ 7.58 – 7.51 (m, 1H), 7.41 – 7.29 (m, 3H), 7.04 (d, J = 3.8 Hz, 
1H), 6.92 (d, J = 3.8 Hz, 1H), 4.50 (s, 2H), 3.13 (s, 2H), 0.94 (s, 9H). 
13C NMR (100 MHz, CDCl3): δ 143.7, 136.7, 133.3, 130.5, 130.3, 129.8, 128.4, 127.9, 127.5, 
112.2, 81.2, 71.5, 32.3, 27.0. 
νmax(neat)/cm-1: 2952 (w), 2899 (w), 2864 (w), 1476 (w), 1450 (w), 1431 (w), 1384 (w), 1361 
(w), 1200 (w), 1122 (w), 1086 (m), 1046 (w), 978 (m), 940 (w), 797 (m), 757 (m), 734 (w), 
682 (w). 
HRMS: Calcd. for C16H19O79BrS: 338.0335 [M]+; found (EI+): 338.0320 
 
 
Methyl 2-(5-bromothiophen-2-yl)benzoate (154h) 
Prepared according to General Procedure B (reaction time: 16 hours). The residue was purified 
by column chromatography (eluent: 9:1 hexanes/EtOAc) to afford the title compound as a pale 
yellow oil (76 mg, 51%). 
1H NMR (400 MHz, CDCl3): δ 7.77 – 7.72 (m, 1H), 7.53 – 7.47 (m, 1H), 7.45 – 7.38 (m, 
2H), 7.01 (d, J = 3.8 Hz, 1H), 6.78 (d, J = 3.8 Hz, 1H), 3.77 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ 168.7, 143.7, 133.5, 131.6, 131.4, 131.3, 130.2, 129.9, 
128.3, 126.8, 112.5, 52.5. 
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νmax(neat)/cm-1: 1718 (s), 1683 (w), 1595 (w), 1484 (w), 1447 (w), 1429 (m), 1289 (m), 
1252 (m), 1189 (w), 1124 (m), 1086 (m), 1058 (w), 1044 (w), 978 (m), 963 (w), 942 (w), 
824 (w), 796 (m), 757 (m), 713 (w), 704 (w), 658 (w). 
HRMS: Calcd. for C12H9O279BrS: 295.9501 [M]+; found (EI+): 295.9503 
 
 
[2-(5-Bromothiophen-2-yl)phenyl]methyl 2,2-dimethylpropanoate (154i) 
Prepared according to General Procedure B (reaction time: 16 hours). The residue was purified 
by column chromatography (eluent: 19:1 hexanes/EtOAc) to afford the title compound as a 
clear, colourless oil (146 mg, 83%). 
1H NMR (400 MHz, CDCl3): δ 7.53 – 7.48 (m, 1H), 7.45 – 7.36 (m, 3H), 7.06 (d, J = 3.8 
Hz, 1H), 6.87 (d, J = 3.8 Hz, 1H), 5.17 (d, J = 0.5 Hz, 2H), 1.23 (s, 9H). 
13C NMR (100 MHz, CDCl3): δ 178.3, 143.1, 134.3, 133.8, 130.9, 130.3, 130.1, 128.7, 
128.6, 127.4, 112.6, 64.5, 39.0, 27.3. 
νmax(neat)/cm-1: 2969 (w), 1725 (m), 1698 (w), 1683 (w), 1540 (w), 1478 (w), 1455 (w), 
1431 (w), 1396 (w), 1363 (w), 1277 (m), 1203 (w), 1139 (s), 1032 (w), 978 (m), 939 (w), 
798 (w), 758 (m), 682 (w). 






Prepared according to General Procedure A (reaction time: 16 hours). The residue was purified 
by column chromatography (eluent: 1:1 hexanes/EtOAc) to afford the title compound as a 
clear, colourless oil (226 mg, 75%). 
1H NMR (400 MHz, CDCl3): δ 8.12 (ddd, J = 7.9, 1.4, 0.4 Hz, 1H), 7.62 (ddd, J = 7.9, 7.4, 
1.3 Hz, 1H), 7.51 (app. td, J = 7.5, 1.4 Hz, 1H), 7.40 (ddd, J = 7.6, 1.3, 0.4 Hz, 1H), 7.07 (d, J 
= 3.8 Hz, 1H), 6.93 (d, J = 3.8 Hz, 1H), 2.54 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ 144.7, 140.3, 131.0, 130.9, 130.9, 130.8, 129.9, 128.2, 124.1, 
114.1, 42.3. 
νmax(neat)/cm-1: 1468 (m), 1436 (w), 1425 (w), 1250 (w), 1200 (w), 1070 (m), 1038 (m), 977 
(m), 951 (w), 939 (m), 841 (w), 800 (w), 761 (m), 734 (w), 711 (w), 673 (w), 660 (w), 514 
(w), 489 (w), 472 (w), 419 (w). 




Prepared according to General Procedure A (reaction time: 16 hours). The residue was purified 
by column chromatography (eluent: 3:1 hexanes/EtOAc) to afford the title compound as a 
white solid (272 mg, 86%). 
1H NMR (400 MHz, CDCl3): δ 8.25 (dd, J = 8.0, 1.5 Hz, 1H), 7.64 (app. td, J = 7.5, 1.6 Hz, 
1H), 7.58 (app. td, J = 7.7, 1.5 Hz, 1H), 7.50 (dd, J = 7.5, 1.5 Hz, 1H), 7.23 (d, J = 3.8 Hz, 
1H), 7.09 (d, J = 3.9 Hz, 1H), 2.81 (s, 3H). 
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13C NMR (100 MHz, CDCl3): δ 140.0, 139.5, 133.8, 133.3, 132.8, 131.3, 130.6, 129.2, 129.1, 
114.4, 42.7. 
νmax(neat)/cm-1: 2922 (w), 1466 (w), 1439 (w), 1426 (w), 1297 (s), 1248 (m), 1199 (w), 1169 
(w), 1144 (s), 1125 (m), 1068 (m), 1058 (m), 1040 (w), 970 (m), 953 (m), 938 (m), 885 (w), 
811 (m), 778 (m), 761 (s), 732 (m), 663 (m), 591 (w), 537 (s), 510 (s), 465 (m), 421 (m). 
HRMS: Calcd. for C11H9O279BrS2: 315.9222 [M]+; found (EI+): 315.9237 




Prepared according to General Procedure A (reaction time: 16 hours). The residue was purified 
by column chromatography (eluent: 4:1 hexanes/EtOAc) to afford the title compound as an 
orange oil that crystallised on standing overnight (307 mg, 79%). 
1H NMR (400 MHz, CDCl3): δ 7.98 (d, J = 8.1 Hz, 1H), 7.30 – 7.19 (m, 2H), 7.08 (d, J = 3.8 
Hz, 1H), 7.02 (d, J = 3.8 Hz, 1H), 2.98 (q, J = 7.1 Hz, 4H), 2.41 (s, 3H), 1.00 (t, J = 7.1 Hz, 
6H). 
13C NMR (100 MHz, CDCl3): δ 142.9, 141.0, 137.1, 134.8, 132.6, 130.7, 130.0, 129.9, 129.2, 
112.8, 41.0, 21.3, 14.0. 
νmax(neat)/cm-1: 2972 (w), 2932 (w), 2869 (w), 1601 (w), 1569 (w), 1458 (w), 1437 (w), 1386 
(w), 1360 (w), 1320 (m), 1266 (w), 1203 (m), 1180 (w), 1163 (m), 1135 (m), 1099 (w), 1075 
(m), 1058 (w), 1017 (m), 986 (w), 958 (w), 944 (m), 889 (w), 837 (m), 807 (m), 789 (m), 778 
(m), 740 (w), 709 (m), 678 (m), 646 (m), 632 (w), 599 (m), 568 (w), 546 (m), 503 (m), 465 
(w), 437 (w), 420 (w). 
HRMS: Calcd. for C15H18O2N79BrS2: 386.9957 [M]+; found (EI+): 386.9951 






Prepared according to General Procedure B (reaction time: 16 hours). The residue was purified 
by column chromatography (eluent: 1:1 hexanes/EtOAc) to afford the title compound as a 
white solid (175 mg, 80%). 
1H NMR (400 MHz, CDCl3): δ 7.67 – 7.29 (m, 14H), 7.19 (d, J = 3.8 Hz, 1H), 6.69 (d, J = 
3.9 Hz, 1H). 
13C NMR (100 MHz, CDCl3): δ 142.5 (d, J = 4.9 Hz), 138.6 (d, J = 7.7 Hz), 134.6 (d, J = 
11.9 Hz), 132.8 (d, J = 101.7 Hz), 132.6 (d, J = 9.2 Hz), 132.4 (d, J = 101.3 Hz), 131.9 (d, J = 
1.2 Hz), 131.6 (d, J = 9.4 Hz), 131.4 (d, J = 2.7 Hz), 131.0 (s), 129.7 (s), 128.3 (d, J = 12.2 
Hz), 127.6 (d, J = 12.3 Hz), 113.4 (s). 
νmax(neat)/cm-1: 3076 (w), 3055 (w), 2923 (w), 1586 (w), 1562 (w), 1467 (w), 1436 (m), 1320 
(w), 1303 (w), 1261 (w), 1188 (m), 1135 (w), 1103 (m), 1068 (w), 1027 (w), 999 (w), 977 
(m), 938 (m), 885 (w), 822 (m), 774 (m), 753 (w), 717 (s), 693 (s), 665 (m), 632 (w), 534 (s), 
507 (m), 490 (m), 456 (m). 
HRMS: Calcd. for C22H16O79BrPS: 437.9837 [M]+; found (EI+): 437.9838 
mp: 150 − 153 °C (hexanes/EtOAc) 
 
 
2-(5-Bromothiophen-2-yl)phenyl N,N-diethylcarbamate (154n) 
Prepared according to General Procedure A (reaction time: 16 hours). The residue was purified 
by column chromatography (eluent: 17:1 hexanes/EtOAc) to afford the title compound as a 
pale yellow oil (255 mg, 72%). 
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1H NMR (400 MHz, CDCl3): δ 7.54 (dd, J = 7.8, 1.7 Hz, 1H), 7.32 (ddd, J = 8.1, 7.4, 1.7 Hz, 
1H), 7.23 (app. td, J = 7.6, 1.4 Hz, 1H), 7.15 (dd, J = 8.1, 1.3 Hz, 1H), 7.04 – 7.01 (m, 2H), 
3.50 (q, J = 7.1 Hz, 2H), 3.38 (q, J = 7.1 Hz, 2H) 1.29 – 1.13 (m, 6H). 
13C NMR (100 MHz, CDCl3): δ 153.8, 148.0, 140.3, 129.9, 129.2, 129.0, 127.1, 126.1, 125.9, 
123.8, 112.7, 42.3, 41.9, 14.3, 13.4. 
νmax(neat)/cm-1: 2972 (w), 2932 (w), 1714 (s), 1562 (w), 1506 (w), 1487 (w), 1472 (w), 1456 
(w), 1416 (m), 1379 (w), 1365 (w), 1349 (w), 1315 (w), 1266 (m), 1236 (w), 1194 (m), 1147 
(m), 1101 (m), 1075 (w), 1036 (w), 980 (m), 958 (m), 933 (m), 821 (w), 787 (m), 749 (m), 
679 (w), 447 (w). 




Prepared according to General Procedure A (reaction time: 10 hours). The residue was purified 
by column chromatography (eluent: 95:5 → 90:10 hexanes/EtOAc) to afford the title 
compound as a clear, colourless oil (259 mg, 73%). 
Regioselectivity was confirmed by additional 2D NMR experiments. 
1H NMR (400 MHz, CDCl3): δ 7.63 (dd, J = 1.3, 0.5 Hz, 1H), 7.50 (dd, J = 7.6, 1.3 Hz, 1H), 
7.39 (dd, J = 7.5, 0.5 Hz, 1H), 7.05 (d, J = 3.8 Hz, 1H), 6.95 (d, J = 3.8 Hz, 1H), 4.43 (s, 2H), 
3.42 (s, 3H), 0.30 (s, 9H). 
13C NMR (100 MHz, CDCl3): δ 143.7, 141.1, 135.4, 134.6, 134.3, 133.4, 130.4, 129.9, 127.6, 
112.5, 73.2, 58.2, -1.0. 
νmax(neat)/cm-1: 2953 (w), 2921 (w), 2890 (w), 1557 (w), 1540 (w), 1506 (w), 1487 (w), 1472 
(w), 1456 (w), 1434 (w), 1418 (w), 1386 (w), 1371 (w), 1247 (m), 1191 (w), 1112 (w), 1089 
(m), 978 (m), 947 (w), 881 (m), 826 (s), 797 (m), 753 (m), 694 (w), 654 (w), 623 (w), 596 (w), 
553 (w), 508 (w), 472 (w). 
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Prepared according to General Procedure B (reaction time: 6 hours). The residue was purified 
by column chromatography (eluent: 19:1 hexanes/EtOAc) to afford the title compound as a 
pale yellow solid (138 mg, 76%). 
1H NMR (400 MHz, CDCl3): δ 7.53 – 7.48 (m, 1H), 7.42 – 7.33 (m, 3H), 7.01 (s, 1H), 4.42 
(s, 2H), 3.42 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ 143.3, 135.9, 133.0, 130.4, 129.7, 129.0, 128.5, 114.0, 111.4, 
72.8, 58.1. 
νmax(neat)/cm-1: 2975 (w), 2917 (w), 2889 (w), 2823 (w), 2805 (w), 1525 (w), 1474 (m), 1459 
(w), 1447 (m), 1380 (m), 1315 (m), 1203 (w), 1186 (m), 1142 (w), 1084 (s), 1045 (m), 997 
(m), 953 (m), 936 (m), 835 (m), 815 (m), 754 (s), 744 (s), 692 (m), 619 (w), 590 (m), 510 (w), 
499 (w), 451 (w), 418 (w). 
HRMS: Calcd. for C12H10O79Br2S: 359.8814 [M]+; found (EI+): 359.8813 







Prepared according to General Procedure B (reaction time: 12 hours). The residue was purified 
by column chromatography (eluent: 100:0 → 95:5 hexanes/EtOAc) to afford the title 
compound as a clear, colourless oil (150 mg, 83%). 
1H NMR (400 MHz, CDCl3): δ 7.56 (ddd, J = 7.7, 1.4, 0.7 Hz, 1H), 7.46 (app. td, J = 7.5, 1.5 
Hz, 1H), 7.35 (app. td, J = 7.5, 1.5 Hz, 1H), 7.29 (ddd, J = 7.7, 1.5, 0.5 Hz, 1H), 7.03 (s, 1H), 
4.38 (s, 2H), 3.34 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ 138.5, 138.3, 132.4, 131.6, 130.6, 129.8, 128.5, 127.6, 112.6, 
109.7, 72.1, 58.5. 
νmax(neat)/cm-1: 2921 (w), 2885 (w), 2819 (w), 1480 (w), 1450 (m), 1434 (w), 1378 (w), 1363 
(w), 1301 (w), 1194 (w), 1116 (m), 1092 (m), 1044 (w), 981 (m), 943 (w), 921 (w), 874 (w), 
816 (m), 756 (m), 725 (w), 693 (w), 654 (w), 629 (w), 607 (w), 523 (w), 444 (w). 




Prepared according to General Procedure B (reaction time: 24 hours). The residue was purified 
by column chromatography (eluent: 19:1 hexanes/EtOAc) to afford the title compound as a 
clear, colourless oil (87 mg, 77%). 
1H NMR (400 MHz, CDCl3): δ 7.56 – 7.50 (m, 1H), 7.39 – 7.27 (m, 3H), 7.21 – 7.09 (m, 
3H), 4.36 (s, 2H), 3.35 (s, 3H), 2.35 – 2.29 (m, 6H). 
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13C NMR (100 MHz, CDCl3): δ 142.0, 138.5, 136.4, 135.6, 130.7, 130.1, 129.5, 129.1, 127.7, 
127.3, 126.8, 72.7, 58.2, 20.0, 19.6. 
νmax(neat)/cm-1: 2920 (w), 1558 (w), 1541 (w), 1507 (w), 1480 (w), 1447 (w), 1419 (w), 1395 
(w), 1380 (w), 1338 (w), 1321 (w), 1195 (w), 1114 (w), 1085 (m), 1021 (w), 987 (w), 946 (w), 
889 (w), 827 (w), 763 (m), 720 (w), 638 (w), 601 (w), 554 (w). 




Prepared according to General Procedure B (reaction time: 36 hours). The residue was purified 
by column chromatography (eluent: 19:1 hexanes/EtOAc) to afford the title compound as a 
clear, colourless oil (35 mg, 31%). 
1H NMR (400 MHz, CDCl3): δ 7.57 – 7.51 (m, 1H), 7.37 (app. td, J = 7.5, 1.5 Hz, 1H), 7.31 
(app. td, J = 7.4, 1.6 Hz, 1H), 7.19 – 7.05 (m, 3H), 6.97 – 6.92 (m, 1H), 4.17 (s, 2H), 3.26 (s, 
3H), 2.34 (s, 3H), 2.01 (s, 3H). 
13C NMR (100 MHz, CDCl3): δ 141.0, 140.2, 136.2, 134.9, 132.9, 130.3, 129.8, 129.6, 128.2, 
127.9, 127.4, 127.3, 72.3, 58.4, 21.1, 19.6. 
νmax(neat)/cm-1: 2919 (w), 2863 (w), 2819 (w), 1480 (w), 1447 (w), 1378 (w), 1192 (w), 1114 
(w), 1093 (m), 1046 (w), 971 (w), 944 (w), 923 (w), 887 (w), 810 (m), 772 (m), 744 (m), 634 
(w), 611 (w), 468 (w). 







Prepared according to General Procedure B (reaction time: 16 hours). The residue was purified 
by column chromatography (eluent: 19:1 hexanes/EtOAc) to afford the title compound as a 
clear, colourless oil (208 mg, 69%). 
Note: Purity estimated to be approximately 90% by 1H NMR, containing impurities arising 
from protodesilylation and bromodesilylation of the arylsilane. 
1H NMR (400 MHz, CDCl3): δ 7.40 – 7.27 (m, 2H), 7.23 – 7.18 (m, 1H), 7.06 (d, J = 3.6 Hz, 
1H), 6.63 (d, J = 3.6 Hz, 1H), 4.25 (s, 2H), 3.31 (s, 3H), 2.19 (s, 2H). 
13C NMR (100 MHz, CDCl3): δ 141.5, 138.6, 138.6, 132.3, 130.0, 129.4, 129.0, 127.7, 125.8, 
112.0, 72.6, 58.4, 20.7. 
νmax(neat)/cm-1: 2920 (w), 2887 (w), 2817 (w), 1463 (m), 1446 (m), 1420 (w), 1378 (w), 1222 
(w), 1190 (m), 1166 (w), 1091 (m), 1052 (w), 1019 (w), 975 (m), 955 (w), 936 (w), 912 (w), 
896 (w), 794 (m), 777 (m), 728 (w), 673 (w), 635 (w), 606 (w), 517 (w). 
HRMS: Calcd. for C13H13O79BrS: 295.9865 [M]+; found (EI+): 295.9853 
 
 




(2-Bromophenyl)(phenyl)methanol (1.32 g, 5.0 mmol) was added to a flame-dried, N2-purged, 
100 mL RBF containing a magnetic stirrer bar, and fitted with a rubber septum and inlet 
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needle. MeCN (12.5 mL) was added via syringe, followed by hexamethyldisilazane (HMDS, 
0.73 mL, 3.5 mmol). The resulting solution was stirred for 15 mins at room temperature, then 
N-bromosuccinimide (NBS, 45 mg, 0.25 mmol) added in one portion. The temperature was 
adjusted to 50 °C and stirring maintained for a further 2 hours. The reaction mixture was then 
concentrated under reduced pressure, diluted with hexane (5 mL), and washed through a short 
plug of silica. The resulting solution was then concentrated in vacuo, and the crude oil 
transferred to a second flame-dried, N2-purged, 100 mL RBF (again fitted with a septum and 
inlet needle). THF (6 mL) was added, and the solution cooled to −78 °C in an acetone-dry ice 
bath. n-Butyllithium (2.15 M in hexanes, 1.4 mL, 3.0 mmol) was added by syringe over 
approximately 10 minutes, and the solution allowed to return to room temperature overnight. 
The mixture was quenched by the addition of H2O (10 mL) and extracted into Et2O 
(3 × 20 mL). The combined organic extracts were dried over MgSO4, concentrated in vacuo, 
and the resulting solid purified by column chromatography (eluent: 9:1 hexane/EtOAc) to 
afford the title compound as a pale yellow solid (0.51 g, 40%). 
1H NMR (400 MHz, CDCl3): δ 7.57 (ddd, J = 7.3, 1.7, 0.6 Hz, 1H), 7.37 – 7.21 (m, 8H), 6.15 
(d, J = 4.0 Hz, 1H), 2.06 (d, J = 4.1 Hz, 1H), 0.39 (s, 9H). 
13C NMR (100 MHz, CDCl3): δ 149.5, 143.8, 139.0, 134.6, 130.0, 128.3, 128.2, 127.4, 127.3, 
126.7, 74.8, 0.9. 
νmax(neat)/cm-1: 3382 (br), 3057 (w), 3028 (w), 2954 (w), 2895 (w), 1493 (w), 1447 (w), 1434 
(w), 1399 (w), 1314 (w), 1295 (w), 1261 (w), 1247 (m), 1187 (w), 1124 (m), 1079 (w), 1068 
(w), 1034 (m), 1020 (m), 879 (w), 833 (s), 768 (m), 752 (m), 730 (s), 698 (s), 651 (m), 620 
(m), 606 (m), 561 (w), 473 (w), 462 (m), 422 (w). 
HRMS: Calcd. for C16H20OSi: 256.1278 [M]+; found (EI+): 256.1281 







To a nitrogen filled, flame-dried 100 mL RBF was added 1-bromo-3-chlorobenzene (2.0 mL, 
17.0 mmol) along with dry THF (40 mL). The solution was cooled to −78 °C and n-
butyllithium (2.33 M in hexanes, 8.15 mL, 19.0 mmol) was added dropwise over 30 minutes. 
The mixture was stirred at −78 °C for a further 30 mins, then 2-bromobenzaldehyde (2.50 mL, 
21.5 mmol) was added via syringe. The flask was removed from the cold bath and allowed to 
return to room temperature overnight. Water (20 mL) was added to quench any remaining 
organolithium species, and the aqueous layer extracted with Et2O (3 × 40 mL). The combined 
organic extracts were dried over MgSO4 and concentrated under reduced pressure to leave a 
viscous yellow oil (crude mass = 3.95 g). MeCN (30 mL) was added, followed by 
hexamethyldisilazane (HMDS, 1.95 mL, 9.3 mmol). The resulting solution was stirred for 15 
mins at room temperature, then N-bromosuccinimide (NBS, 125 mg, 0.7 mmol) added in one 
portion. The temperature was adjusted to 50 °C and stirring maintained for a further 2 hours. 
The reaction mixture was then concentrated under reduced pressure, diluted with hexane 
(10 mL), and washed through a short plug of silica. The resulting solution was then 
concentrated in vacuo, and the crude oil transferred to a flame-dried, N2-purged, 100 mL RBF. 
THF (15 mL) was added, and the solution cooled to −78 °C. n-Butyllithium (1.6 M in hexanes, 
5.94 mL, 9.5 mmol) was added by syringe over approximately 15 minutes, and the solution 
allowed to return to room temperature overnight. The mixture was quenched by the addition 
of H2O (10 mL) and extracted into Et2O (3 × 20 mL). The combined organic extracts were 
dried over MgSO4, concentrated under reduced pressure, and the resulting crude solid purified 
by column chromatography (eluent: 9:1 hexanes/EtOAc) to afford the title compound as a pale 
yellow solid (2.06 g, 42%). 
1H NMR (400 MHz, CDCl3): δ 7.59 (dd, J = 7.2, 1.5 Hz, 1H), 7.44 – 7.23 (m, 5H), 7.21 – 
7.14 (m, 2H), 6.11 (d, J = 3.9 Hz, 1H), 2.11 (d, J = 4.0 Hz, 1H), 0.41 (s, 9H). 
13C NMR (100 MHz, CDCl3): δ 148.9, 145.9, 139.1, 134.7, 134.4, 130.2, 129.6, 128.2, 127.7, 
127.4, 126.8, 124.9, 74.2, 0.9. 
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νmax(neat)/cm-1: 3242 (br), 3062 (w), 2953 (w), 2895 (w), 1595 (w), 1573 (w), 1472 (w), 1425 
(m), 1405 (w), 1304 (w), 1247 (m), 1185 (m), 1124 (m), 1096 (w), 1070 (w), 1032 (m), 887 
(w), 875 (w), 835 (m), 778 (m), 769 (m), 721 (m), 686 (m), 651 (m), 622 (m), 607 (m), 573 
(w), 473 (w), 430 (w), 417 (w). 
HRMS: Calcd. for C16H19O35ClSi: 290.0888 [M]+; found (EI+): 290.0902 





To a flame-dried Schlenk flask (under an atmosphere of N2) was added 
1-bromo-3-(trifluoromethyl)benzene (2.8 mL, 20.0 mmol) along with dry THF (50 mL). The 
solution was cooled to −78 °C and n-butyllithium (2.33 M in hexanes, 8.58 mL, 20.0 mmol) 
was added dropwise over 30 minutes. The mixture was stirred at −78 °C for a further 30 mins, 
then 2-bromobenzaldehyde (2.50 mL, 21.5 mmol) was added via syringe. The flask was 
removed from the cold bath and allowed to return to room temperature overnight. Water (40 
mL) was added to quench any remaining organolithium species, and the aqueous layer 
extracted with EtOAc (3 × 40 mL). The combined organic extracts were dried over MgSO4 
and concentrated under reduced pressure to leave a viscous orange oil. MeCN (40 mL) was 
added, followed by hexamethyldisilazane (HMDS, 2.33 mL, 11.2 mmol). The resulting 
solution was stirred for 15 mins at room temperature, then N-bromosuccinimide (NBS, 
140 mg, 0.8 mmol) added in one portion. The temperature was adjusted to 50 °C and stirring 
maintained for a further 2 hours. The reaction mixture was then concentrated under reduced 
pressure, diluted with hexane (20 mL), and washed through a short plug of silica. The resulting 
solution was then concentrated in vacuo, and the crude oil transferred to a flame-dried, 
N2-purged, 100 mL RBF. THF (40 mL) was added, and the solution cooled to −78 °C. 
n-Butyllithium (2.33 M in hexanes, 6.87 mL, 16.0 mmol) was added by syringe over 
approximately 15 minutes, and the solution allowed to return to room temperature overnight. 
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The mixture was quenched by the addition of H2O (40 mL) and extracted into EtOAc (3 × 40 
mL). The combined organic extracts were dried over MgSO4, concentrated under reduced 
pressure, and the resulting crude solid purified by column chromatography (eluent: 19:1 
hexanes/EtOAc) to afford the title compound as a white solid (3.36 g, 52%). 
1H NMR (400 MHz, CDCl3): δ 7.73 – 7.70 (m, 1H), 7.61 – 7.57 (m, 1H), 7.56 – 7.50 (m, 
1H), 7.47 – 7.40 (m, 2H), 7.38 – 7.29 (m, 2H), 7.16 – 7.11 (m, 1H), 6.17 (d, J = 3.9 Hz, 1H), 
2.11 (d, J = 3.9 Hz, 1H), 0.41 (s, 9H). 
13C NMR (100 MHz, CDCl3): δ 148.7, 144.7, 139.0, 134.7, 130.6 (q, J = 31.6 Hz), 130.1, 
130.0 – 129.9 (m), 128.5, 128.4, 127.7, 124.2 (q, J = 273.0 Hz), 123.9 (q, J = 3.8 Hz), 123.1 
(q, J = 3.9 Hz), 74.1, 0.7. 
19F NMR (376 MHz, CDCl3): δ −62.55 (s) 
νmax(neat)/cm-1: 3292 (br), 2962 (w), 1448 (w), 1435 (w), 1327 (m), 1251 (m), 1176 (m), 1157 
(m), 1118 (s), 1096 (m), 1070 (m), 1027 (m), 906 (w), 889 (w), 836 (s), 796 (m), 776 (m), 753 
(m), 730 (m), 708 (m), 699 (m), 673 (m), 651 (m), 623 (m), 607 (m), 556 (w), 470 (w), 450 
(w), 420 (w). 
HRMS: Calcd. for C17H19OF3Si: 324.1152 [M]+; found (EI+): 324.1148 





Benzylmagnesium chloride (2.0 M in THF, 10.0 mL, 20.0 mmol) was added to a flame-dried 
Schlenk tube (under a N2 atmosphere) and diluted with dry THF (10 mL). The mixture was 
cooled to 0 °C, then 2-Bromobenzaldehyde (2.35 mL, 20.0 mmol) was added dropwise via 
syringe over approximately 10 minutes. Following addition, the mixture was stirred at room 
temperature for 1 hour, then poured into ice (approx. 50 g). 10% w/w HCl was added until all 
of the white precipitate had dissolved, then Et2O (30 mL) added, the layers separated, and the 
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aqueous layer further extracted with Et2O (3 × 30 mL). The combined organic extracts were 
washed with brine (2 × 30 mL), dried over MgSO4, and concentrated under reduced pressure. 
The resulting crude yellow oil was purified by column chromatography (eluent: 9:1 
hexanes/EtOAc) to afford the title compound as a viscous, colourless oil (1.54 g, 28%). 
1H NMR (400 MHz, CDCl3): δ 7.61 (dd, J = 7.8, 1.8 Hz, 1H), 7.55 (dd, J = 8.0, 1.2 Hz, 1H), 
7.39 – 7.24 (m, 6H), 7.16 (ddd, J = 8.0, 7.3, 1.8 Hz, 1H), 5.27 (dt, J = 9.4, 3.1 Hz, 1H), 3.21 
(dd, J = 13.8, 3.0 Hz, 1H), 2.74 (dd, J = 13.8, 9.4 Hz, 1H), 1.99 (d, J = 3.3 Hz, 1H). 
13C NMR (100 MHz, CDCl3): δ 143.0, 138.3, 132.8, 129.6, 129.0, 128.8, 127.9, 127.4, 126.9, 
121.9, 74.2, 44.5. 
νmax(neat)/cm-1: 3306 (br w), 3026 (w), 2947 (w), 1495 (m), 1467 (m), 1452 (m), 1437 (m), 
1253 (w), 1200 (w), 1117 (w), 1077 (m), 1056 (m), 1047 (m), 1035 (m), 1022 (m), 1002 (m), 
943 (w), 863 (w), 850 (w), 746 (s), 716 (m), 701 (m), 678 (m), 649 (m), 619 (w), 567 (m), 508 
(w), 475 (w), 443 (w). 
1H and 13C NMR data are consistent with those reported in the literature.23 
 
2-phenyl-1-[2-(trimethylsilyl)phenyl]ethan-1-ol (207) 
To a flame-dried, N2-purged round-bottomed flask was added 
1-(2-bromophenyl)-2-phenylethan-1-ol (1.42 g, 5.1 mmol) and MeCN (10 mL), followed by 
hexamethyldisilazane (HMDS, 0.73 mL, 3.5 mmol). The resulting solution was stirred for 15 
mins at room temperature, then N-bromosuccinimide (NBS, 45 mg, 0.25 mmol) added in one 
portion. The temperature was adjusted to 50 °C and stirring maintained for a further 2 hours. 
The reaction mixture was then concentrated under reduced pressure, diluted with hexane 
(10 mL), and washed through a short plug of silica. The resulting solution was then 
concentrated in vacuo, and the crude oil transferred to a flame-dried, N2-purged, 50 mL RBF 
(crude mass = 0.70 g). THF (6 mL) was added, and the solution cooled to −78 °C. 
n-Butyllithium (1.6 M in hexanes, 2.00 mL, 3.2 mmol) was added by syringe over 
approximately 10 minutes, and the solution allowed to return to room temperature overnight. 
The mixture was quenched by the addition of H2O (5 mL) and extracted into EtOAc 
(3 × 20 mL). The combined organic extracts were dried over MgSO4, concentrated under 
reduced pressure, and the resulting crude oil purified by column chromatography (eluent: 9:1 
hexanes/EtOAc) to afford the title compound as a viscous colourless oil (0.45 g, 33%). 
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1H NMR (400 MHz, CDCl3): δ 7.74 – 7.69 (m, 1H), 7.57 – 7.46 (m, 2H), 7.40 – 7.27 (m, 
6H), 5.18 (ddd, J = 8.6, 4.6, 2.4 Hz, 1H), 3.13 – 3.01 (m, 2H), 1.91 (d, J = 2.4 Hz, 1H), 0.38 
(s, 9H).  
13C NMR (100 MHz, CDCl3): δ 149.7, 138.6, 137.6, 134.5, 129.9, 129.6, 128.8, 127.4, 126.8, 
126.2, 74.3, 45.8, 1.0. 
νmax(neat)/cm-1: 3401 (br), 3057 (w), 3027 (w), 2950 (w), 1495 (w), 1453 (w), 1432 (w), 1249 
(m), 1122 (w), 1079 (w), 1032 (w), 999 (w), 834 (m), 789 (w), 762 (m), 728 (m), 698 (m), 622 
(w), 551 (w), 467 (w).  
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All trapping competition experiments were performed against the gold-catalysed 
intramolecular cyclisation of 128 to form 129 (Scheme A1).  
 
 
Scheme A1. Cyclisation of 128 to form 129, monitored by in situ 1H NMR. 
The following concentration-time profiles display the formation of product (129) across a 
range of different trap concentrations, as referenced in each figure. Reactions were monitored 
by in situ 1H NMR following the procedure described in Section 5.21. Simulated kinetic data 
(blue lines) was generated by fitting to either Model A or B as denoted in each case, and is 
plotted against experimental data (white circles) for comparison. 
 
 





Scheme A3. Visual representation of Model B. 
 
 
Trapping by (2-methylphenyl)trimethylsilane (113) 
 




























Figure A2. Simulated kinetic fitting for trapping by arylsilane 113 using Model B. 
 
 
Trapping by (2-ethylphenyl)trimethylsilane (132) 
 













































Figure A4. Simulated kinetic fitting for trapping by arylsilane 132 using Model B. 
 
 
Trapping by (2-iso-propylphenyl)trimethylsilane (133)
 













































Figure A6. Simulated kinetic fitting for trapping by arylsilane 133 using Model B. 
 
 
Trapping by (2-cyclohexylphenyl)trimethylsilane (134)
 














































Figure A8. Simulated kinetic fitting for trapping by arylsilane 134 using Model B. 
 
 
Trapping by (2-biphenyl)trimethylsilane (118)
 













































Figure A10. Simulated kinetic fitting for trapping by arylsilane 118 using Model A. 
 
 
Trapping by (2-tert-butylphenyl)trimethylsilane (130)
 














































Figure A12. Simulated kinetic fitting for trapping by arylsilane 130 using Model A. 
 
 
Trapping by (2,6-dimethylphenyl)trimethylsilane (131)
 














































Figure A14. Simulated kinetic fitting for trapping by arylsilane 131 using Model A. 
 
 
Trapping by (2-methylphenyl)ethyldimethylsilane (136)
 













































Figure A16. Simulated kinetic fitting for trapping by arylsilane 136 using Model B. 
 
 
Trapping by (2-methylphenyl)triethylsilane (137)
 






































































The relative rates of bromodesilylation for a number of arylsilane traps were determined 
experimentally in order to reduce the number of variables to be fitted in the kinetic model. A 
stoichiometric competition experiment using the tetrahydrothiophene derived pre-catalyst was 
performed to ensure that the conditions were as close to those used for catalysis as possible 
(Scheme B1).  
 
 
Scheme B1. Stoichiometric competition experiment to determine relative rates of 
bromodesilylation. 
 
The amount of trap that was brominated in each case was calculated based on the amount of 
237 detected (by quantative 19F NMR, against an internal standard). In the absence of any 
added trap, unreacted arylsilane (216) and bromodesilylated product (237) (0.0195 mmol, 
19.5 mol%) were detected, consistent with the loss of two bromide ligands from the catalyst, 
fully sequestered by the arylsilane reagent (Figure B1). The reproducibility of the experiment 





Figure B1. 19F NMR spectra of the crude reaction mixture (Entry 1, Table B1). 
 
The relative rates of bromodesilylation for the series of arylsilane reagents are summarised in 
Table B1. The values are normalised against the ortho-benzyl substituent (128) such that the 
relative rate constants (kT-Br/kS-Br) can be used directly in the kinetic model for catalyst trapping. 
 
Table B1. Summary of bromodesilylation experiments for a series of arylsilane traps. 
R  237 formed (mmol) k236/k216 kT-Br/kS-Br 
- 0.0195a - - 
Me (113)  0.0050b 3.0 3.3 
Et (132) 0.0048b 3.2 3.6 
i-Pr (133)   0.0051 2.9 3.2 
Cy (134) 0.0052 2.8 3.1 
Bn (128) 0.0104b 0.9 1.0 
Ph (118) 0.0142b 0.4 0.4 





The concentration-time profile for catalyst trapping proved highly sensitive to small changes 
in catalyst and trap concentration (particularly at low initial trap concentrations), and therefore 
required careful sample preparation to ensure that good fitting simulations could be generated. 
The use of stock solutions (made to known concentrations) allowed accurate measurement of 
the required amounts of each component, minimising the degree of error in the initial 
concentrations used.  
However, initial attempts to prepare samples by combining aliquots from three separate stock 




Scheme C1. Attempted trapping and kinetic modelling experiment for 133. 
The observation that low trap concentrations were particularly difficult to simulate suggested 


























of trying to identify the source of this experimental error, we noted a disparity between the 
desired, and actual, dosage of stock solutions using microlitre syringes. When attempting to 
add 100 μL chloroform to a screw-capped vial, a consistent and systematic under-dosage (by 
weight) was observed (Figure C1).  
 
Figure C1. Attempted addition of 100 μL aliquots to a screw-capped vial. Volume added 
was determined based on the weight change of the vial between additions. 
This effect proved general (for chloroform) across a range of syringe designs and sizes and 
was confirmed by blind testing carried out by a number of colleagues. Other solvents appeared 
to have different associated systematic errors, some overestimates and others underestimates, 
though were not investigated in detail. Our present assumption is that the syringes are 
calibrated for use with H2O, and therefore small inaccuracies resulting from differences in 
solvent properties (eg. viscosity, surface tension) can be expected. 
In this case, the small (but cumulative) error was sufficient to cause poorly fitting simulations. 
This could be mitigated by using fewer stock solutions (the substrate and catalyst were added 
from one solution) and calculating the amount of trap added by measuring the weight of stock 
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